Integrating traditional microbiology with cutting-edge (meta-)genomics to advance pathogen detection and to elucidate microbiome signatures of infection by Pena Gonzalez, Angela Viviana
INTEGRATING  TRADITIONAL  MICROBIOLOGY  WITH  CUTTING-­
EDGE  (META-­)GENOMICS  TO  ADVANCE  PATHOGEN  


























In  Partial  Fulfillment  
of  the  Requirements  for  the  Degree  
Doctor  of  Philosophy  in  the  














Copyright  ©  Angela  V.  Pena-­Gonzalez,  2018  
  
INTEGRATING  TRADITIONAL  MICROBIOLOGY  WITH  CUTTING-­
EDGE  (META-­)GENOMICS  TO  ADVANCE  PATHOGEN  























Approved  by:        
  
  
     
Dr.  Kostas  Konstantinidis,  Advisor  
School  of  Civil  &  Environmental  Engineering  
Georgia  Institute  of  Technology  
   Dr.  Gregory  Gibson  
School  of  Biological  Sciences  
Georgia  Institute  of  Technology  
  
  
     
Dr.  I.  King  Jordan  
School  of  Biological  Sciences  
Georgia  Institute  of  Technology  
   Dr.  Karen  Levy  




     
Dr.  Frank  Stewart  
School  of  Biological  Sciences  
Georgia  Institute  of  Technology  
     
  
        














I  would  like  to  thank  many  people  who  have  helped  me  throught  the  completition  of  this  
dissertation.  During  my  doctoral  studies,   these  people  helped  me  to  stay   focused,  stay  
strong   and   more   importantly   to   believe   in   my   capabilities.   First,   I   would   like   to  
acknowledge  those  who  guided  my  thinking  through  the  process  of  researching.  To  my  
advisor  Dr.  Konstantinos  T.  Konstantinidis  whose  passion   for   sciences   I   really  admire.  
Kostas   didn’t   doubt   in   starting   a   new   research   line   in   his   laboratory   (Clinical  
Metagenomics)  when   I   joined   his   group.   Thanks   for   giving  me   the   opportunity   to   start  
and  develop  the  clinical  research  line  and  for  the  guidance,  continuous  support,  patience  
and   encouragement.   To   my   thesis   committee   members   –Dr.   Karen   Levy,   Dr.   King  
Jordan,  Dr.   Frank  Stewart   and  Dr.  Gregory  Gibson   –who   have   generously   given   their  
time  and  expertise   to   improve  my  work:   thank   you   for   your   valuable   contributions  and  
advice.  
I   also   want   to   thank   to   those   who   helped   me   get   started   –my   labmates.   To  
Natasha  De-­Leon  and  Shandra  Justicia  who  were  the  first  two  ‘role  models’  I  met  when  I  
started  my  research  at  Kostas  Lab.  To  Juliana  Soto-­Giron,  who  is  the  the  best  labmate  
and  friend  that  anyone  could  wish  for.  To  Luis  Miguel  Rodriguez,  Janet  K.  Hatt,  Carlos  A.  
Ruiz,  Minjae  Kim,  Despina  Tsementzi   and  Eric   Johnston:   each   one   of   you,   directly   or  
indirectly,  have  contributed  to  my  education  and  have  taught  me  to  be  a  better  scientitist.  
Thank  you  for  your  words  of  advice.    
Last  but  not  least,  I  would  like  to  give  a  special  thanks  to  my  friends  and  family.  
Your  love  and  support  were  critical  to  finish  this  chapter  in  my  life.  To  Mom  and  Dad:  you  
guys  don’t  know  how  much  you  helped  me!   I  could  not  have  done   it  without  your   love  
and   support.   This   is   also   your   accomplishment.   Thank   you!   To  my   son   Esteban:   you  
have  been  my  main  motor  and  motivation  to  achieve  what   I  have  accomplished  so  far.  
My  main   blessing   in   life,   you   are.  To  Miguel:   Thank   you   for   being  my  main   emotional  
support   during   this   all   these   years.   Thanks   for   your   patient   and   love   during   what  
sometimes   seemed   to   be   an   endless   journey.   Can’t   wait   to   start   new   life   projects  
together.   To   my   brothers   Camilo   and   Andres,   and   my   extended   family   in   Colombia:  
thanks  for  your  constant  affection  and  cheering.  I  am  the  first  PhD  in  our  family  and  I  am  
very  proud  of  that.  I  hope  to  have  set  a  good  example  for  you  to  follow.    
 v 
TABLE  OF  CONTENTS  
      Page  
ACKNOWLEDGEMENTS      iv  
LIST  OF  TABLES      viii  
LIST  OF  FIGURES      ix  
LIST  OF  ABBREVIATIONS      xi  
SUMMARY      xiii  
CHAPTER        
          1          INTRODUCTION   1  
                                    1.1  Thesis  rationale   1  
                                    1.2  Phylogenomics  to  discriminate  closely  related  species   2  
                                    1.3  Pathogenomics  and  evolution  of  virulence  plasmids  in  Bacillus  
                                                anthracis  
4  
                                    1.4  Genome  diversity  and  population  structure  of  pathogenic  E.  coli  




                                    1.5  Metagenomic-­based  identification  of  the  etiological  agent  of  
                                                infectious  diarrhea  and  microbiome  signatures  of  different  E.  coli  
                                                pathotypes  
8  
                                    1.6  References   10  
  
          2          GENOME-­BASED  DISCRIMINATION  BETWEEN  CLOSTRIDIUM    
                        BOTULINUM  GROUP  I  AND  CLOSTRIDIUM  SPOROGENES:    
                        IMPLICATIONS  FOR  BACTERIAL  TAXONOMY  
14  
                                    2.1  Summary   15  
                                    2.2  Introduction   16  
                                    2.3  Materials  and  Methods   17  
                                    2.4  Results   23  
                                    2.5  Discussion   33  
                                    2.6  Conclusions  and  recommendations   36  
                                    2.7  Acknowledgements   37  
                                    2.8  References   37  
 vi 
          3          GENOMIC  CHARACTERIZATION  AND  COPY  NUMBER  VARIATION  
                        OF  BACILLUS  ANTHRACIS  PLASMIDS  PXO1  AND  PXO2  IN  A    
                        HISTORICAL  COLLECTION  OF  412  STRAINS  
41  
                                    3.1  Summary   41  
                                    3.2  Introduction   42  
                                    3.3  Materials  and  Methods   45  
                                    3.4  Results   50  
                                    3.5  Discussion   66  
                                    3.6  Conclusions  and  recommendations   68  
                                    3.7  Acknowledgements   69  
                                    3.8  References   70  
  
          4          NOVEL,  PATHOGENIC  CLONAL  COMPLEXES  OF  E.COLI  ALONG  A  
                        RURAL  TO  URBAN  GRADIENT  IN  NORTHERN  ECUADOR  
74  
                                      4.1  Summary   74  
                                      4.2  Introduction   75  
                                      4.3  Materials  and  Methods   78  
                                      4.4  Results  and  discussion   83  
                                      4.5  Conclusions  and  recommendations   101  
                                      4.6  Acknowledgements   103  
                                      4.7  References   104  
  
          5          METAGENOMIC-­BASED  IDENTIFICATION  OF  THE  ETHIOLOGICAL  
                        AGENT  OF  INFECTIOUS  DIARRHEA  AND  MICROBIOME    
                        SIGNATURES  CAUSED  BY  DIFFERENT  E.  COLI  PATHOTYPES  
108  
                                      5.1  Summary   108  
                                      5.2  Introduction   109  
                                      5.3  Materials  and  Methods   112  
                                      5.4  Results  and  discussion   119  
                                      5.5  Conclusions  and  recommendations   136  
                                      5.6  Acknowledgements   138  
 vii 
                                        5.7  References  
  
138  
APPENDIX  A    SUPPLEMENTARY  MATERIAL  FOR  CHAPTER  3   144  
                    Section  A.1.  Draft  genome  sequence  of  Bacillus  cereus  LA2007,  
                    a  human-­pathogenic  isolate  harboring  anthrax-­like  plasmids  
144  
APPENDIX  B      SUPPLEMENTARY  TABLES  FOR  CHAPTER  4   148  
                    Table  B.1.  Singleplex  PCR  assays  used  to  detect  the  presence  of    
                    virulence  genes  associated  with  diarrheagenic  E.  coli  pathotypes  
148  
                    Table  B.2.  Clinical  and  demographic  information  of  individuals  from    
                    Ecuador  enrolled  in  the  EcoZUR  study  from  who  pathogenic  isolates  
                    were  cultured  and  sequenced  
149  
                    Table  B.3.  Multilocus  Sequence  Typing  in  the  collection  of  E.  coli    
                    genomes    
158  
APPENDIX  C      SUPPLEMENTARY  TABLES  FOR  CHAPTER  5   171  
                      Table  C.1.  Metagenomic  yield,  human  content  and  read  quality  of    
                      diarrhea  and  control  samples  used  in  this  study  
168  
                      Table  C.2.  Genome  information  and  quality  evaluation  of  E.  coli  isolates  
                      and  MAGs  
173  
                      Table  C.3.  Epidemiology  of  DAEC  isolates  assigned  to  clonal  complexes  
                        based  on  MLSA  and  core  phylogeny  phylogroups  
174  
                      Table  C.4.  Epidemiology  of  ETEC  isolates  assigned  to  clonal  complexes  
                        based  on  MLSA  and  core  phylogeny  phylogroups  
175  
                      Table  C.5.  Epidemiology  of  EPEC  isolates  assigned  to  clonal  complexes  




LIST  OF  TABLES  
Table  2.1.   Characteristic  of  strains  examined  in  this  study   18  
Table  2.2.   Statistics  of  the  genome  sequences  generated  in  this  study   21  
Table  2.3.   Clostridum  sporogenes  clade-­specific  gene  signatures   27  
Table  3.1.   Sequencing   breadth   and   copy   number   variation   of   pXO1   and  
pXO2  plasmids  in  B.  cereus  strains  
63  
Table  4.1.     Demographic   information   of   individuals   enrolled   in   the   EcoZUR  
project   whose   stool   specimens   where   PCR-­positive   for  
pathogenic  E.  coli  gene  markers  
84  
Table  4.2.   Association   of   the   Clermont   phylogroups   with   urban   vs.   rural  
categories  
90  
Table  4.3.   Distribution  of  E.  coli  pathotypes  in  the  Clermont  phylogroups   91  
Table  4.4.   Association   of   the   Clermont   phylogroups   with   diarrheal   disease  
status  
92  
Table  5.1.   Genes   and   primers   used   in   the   PCR   identification   of   E.   coli  
pathotypes  
115  
Table  5.2.   Characteristics  of  study  participants  by  site  and  disease  status   120  
  
     
 ix 
LIST  OF  FIGURES  
Figure  2.1:   Core   genome   phylogenetic   trees   of   C.   sporogenes   and   C.  
botulinum  genomes  
25  
Figure  2.2:   Hierarchical   clustering   based   on   the   presence   or   absence   of  
variable  orthologs  
26  
Figure  2.3:   Gene  signature  by  PCR   28  
Figure  2.4   Neighbor-­joining  tree  of  bont/B  sequences   31  
Figure  2.5:   BLAST  analysis  of  draft  genome  sequences   32  
Figure  3.1:   Copy   number   estimation   of   Bacillus   anthracis   plasmids   pXO1  
and  pXO2  
51  
Figure  3.2:   Lack  of  phylogenetic  conservatism  of  Bacillus  anthracis  plasmid  
copy  number  
52  
Figure  3.3:   Plasmid  copy  number  depends  on  source  of  isolation   54  
Figure  3.4:   Gene  content  variation  of  pXO1  and  pXO2   56  
Figure  3.5:   Genomic  characterization  of  Bacillus  cereus  sensu  lato  group   59  
Figure  3.6:   Genomic  characterization  of  B.  cereus  strains  carrying  complete  
anthrax-­like  plasmids  
61  
Figure  3.7:   Gene   content   comparison   between   B.   anthracis   pXO1/pXO2  
and  B.  cereus  strain  03BB102  plasmids  
62  
Figure  3.8:   Assessment   of   plasmid   lateral   transfer   between   representative  
B.  anthracis  and  pathogenic  B.  cereus  strains  carrying  complete  
pXO1/pXO2-­like  plasmids  
64  
Figure  4.1:   Geographical  map  of  sampling  sites  in  Ecuador   79  
Figure  4.2:   MLSA   profile   of   pathogenic   E.   coli   isolates   circulating   in  
Northern  Ecuador  
87  
Figure  4.3:   Phylogenetic   relationships   and   population   structure   of   the   263  
E.  coli  isolates  
89  
Figure  4.4:   Antibiotic  resistance  gene  profile  of  E.  coli  isolates   93  
Figure  4.5:   Virulence  gene  content  of  E.  coli  isolates   94  




Figure  4.7:   Detection   of   Afa/Dr   adhesion   operons   in   DAEC   isolates  
recovered  from  diarrhea  and  asymptomatic  individuals  
97  
Figure  4.8:   Prevalence   of   Inc   type   plasmids   and   associated   resistance  
genes  among  our  E.  coli  isolates  
99  
Figure  4.9:   Circular  plots  of  the  pRSB107  plasmid   100  
Figure  4.10:   Tanglegram   comparing   tree   topologies   of   maximum   likelihood  
phylogenies   of   the   core   genome   and   the   repA   gene   from   the  
plasmid  F    
101  
Figure  5.1:   Abundance   of   human   reads   and   estimated   coverage   of   the  
metagenomic  datasets  obtained  in  this  study  
123  
Figure  5.2:   16S   rRNA   gene-­based   microbial   community   composition  
differences  between  diarrhea  and  control  samples  
124  
Figure  5.3:   Characteristics   of   samples   where   DAEC   was   most   likely   the  
causative  agent  
127  
Figure  5.4:   Correlation  between  recovered  fraction  of  human  metagenomic  
reads  and  DAEC  pathogen  abundance  
129  
Figure  5.5:   Characteristics   of   samples   where   Enterotoxigenic   E.   coli  
(ETEC)  was  most  likely  the  causative  agent  
130  
Figure  5.6:   Characteristics   of   samples   where   Enteropathogenic   E.   coli  
(EPEC)  was  most  likely  the  causative  agent  
132  
Figure  5.7:   Differentially  abundant   taxa  between  E.  coli   infectious  diarrhea  
and  control  samples  
134  




     
 xi 
LIST  OF  ABBREVIATIONS  
ANI   Average  Nucleotide  Identity  
ANOVA   Analysis  of  Variance  
ARGs   Antibiotic  resistance  genes  
ATP   Adenosine  Triphosphate  
BoNT   Botulinum  Neurotoxin  
CARD   Antibiotic  Resistance  Database  
CDC   Centers  for  Disease  Control  and  Prevention  
CFU   Colony  Forming  Unit  
CI   Confidence  Interval  
DAEC   Diffusely  -­adhering  Escherichia  coli  
DNA   Deoxyribonucleic  Acid  
dPCR   Digital  PCR  
EAEC   Enteroaggregative  Escherichia  coli  
EcoZUR   E.  coli  en  Zonas  Urbanas  y  Rurales  
EF   Edema  Factor  
EIEC   Enteroinvasive  Escherichia  coli  
ELISA   Enzyme-­linked  Immunosorbent  Assay  
ELW   Expected  likelihood  weight  test  
EPECa   Atypical  Enteropathogenic  Escherichia  coli    
EPECt   Typical  Enteropathogenic  Escherichia  coli    
ETEC   Enterotoxigenic  Escherichia  coli  
EYA   Egg  yolk  agar  
FISH   Fluorescent  in  situ  Hybridization  Microscopy  
GEMS   Global  Enterics  Multicenter  study  
gr   Grams  
GS   Genome  sequencer  
HA   Hyaluronic  acid  
HGT   Horizontal  Gene  Transfer  
IBD   Inflammatory  Bowel  Disease  
Inc   Incompatibility  groups  
KH   Maximum  Likelihood  Kishino-­Hasegawa  test  
LF   Lethal  factor  
LT   Heat-­labile  toxin  
MAG   Metagenome-­assembled  genome  
MCL   Markov  Cluster  algorithm  
MiGA   Microbial  Genomes  Atlas  
MKL   MacConkey’s  agar  media  
ML   Maximum-­likelihood  
 xii 
MLST   Multilocus  Sequencing  Typing  
MLVA   Multilocus  variable-­number  tandem  repeat  
MSD   Moderate  to  severe  diarrhea  
ng   Nanograms  
Nr   Non-­redundant  database  
NT   Non-­toxic  strain  
ºC   Centigrade  
OGs   Orthologous  genes  
OTU   Operational  Taxonomic  Unit  
PA   Protective  antigen  
PCA   Principal  Component  Analysis  
pCLD   bont/B1-­bearing  plasmid  
PCR   Polymerase  chain  reaction  
pM   Picomol  
pXO1   Plasmid  XO1  
pXO2   Plasmid  XO2  
qPCR   Quantitative  PCR  
RAST   Rapid  Annotation  using  Subsystems  
RBM   Reciprocal  best  matches  
s.l   Sensu  lato  
s.s   Sensu  stricto  
SH   Shimodaira-­Hasegawa  test  
SRA   Sequence  Read  Archive  
ST   Heat-­stable  toxin  
ST   Sequence  type  
STEC   Shiga  toxin-­producing  Escherichia  coli    
TPGY   Trypticase-­peptone-­glucose-­yeast  extract  
tRNA   Transfer  ribonucleic  acid  
TTSS   Type  III  secretion  system  
UTI   Urinary  tract  infection  
VFDB   Virulence  Factors  Database  
WASH   Water,  Sanitation  and  Hygiene  
WGS   Whole  Genome  Sequencing  
µl   Microliters  
 xiii 
SUMMARY  
Microbes  play  a  central  role  in  human  health.  Through  normal  everyday  activities,  
the   human   body   is   exposed   to   countless   microorganisms   from   the   environment   in  
addition   to   the   hundreds   of   species   that   colonize   the   human   body   and   skin.   A   small  
fraction  of  them  are  pathogens,  which  can  invade  and  damage  the  human  body  through  
direct   or   indirect   means.   How   pathogens   perform   their   in   situ   activities,   interact   with  
other  host-­associated  microorganisms  and  what  factors  control  such  activities  remains  to  
be  fully  understood.  The  availability  of  high  throughput  omics  technologies  coupled  with  
the  development  of  fast,  powerful  computational  tools  for  the  assessment  of  the  resulting  
big   sequencing   data   have   provided   new   opportunities   to   better   examine   pathogenic  
microbes,  not  only   to  accurately  detect   them  and  gain  basic  knowledge   in   their  biology  
but   also   to   understand   how   they   evolve   and   interact   with   other   pathogenic   and   non-­
pathogenic  microorganisms  in  a  multifaceted  habitat  as  the  human  body.  In  this  thesis,  a  
series   of   studies   are   presented   that   integrated   clinical  microbiology,   epidemiology   and  
omics   techniques   to   study   bacterial   pathogens,   their   diversity   and   evolution,   and   to  
elucidate   how   virulent   bacteria   disrupt   the   ecology   of   the   healthy   human  microbiome,  
especially  in  the  intestinal  tract.  In  this  regard,  Chapter  2  presents  a  phylogenomic  study  
performed   to   resolve   the   true   relationships   between  C.   botulinum   and  C.   sporogenes,  
two  closely  related  species   that  pose  differential   risk   for  human  health,  and  assess  the  
frequency   of   horizontal   transfer   of   the   diagnostic   toxin   gene.   Chapter   3   presents   a  
pathogenomic  study  of  Bacillus  anthracis  plasmids  pXO1  and  pXO2,  executed  to  detect,  
quantify   and   characterize   the   variation   among   these   virulent   plasmids.   Chapter   4  
presents  a  phylogenomic  study  executed  to  investigate  the  genome  diversity,  population  
structure,  virulence  potential,  and  antibiotic   resistance  profile  of  279  pathogenic  E.  coli  
strains   isolated   from   individuals   with   diarrhea   and   controls   living   in   urban   and   rural  
regions   in   Northern   Ecuador.   Finally,   Chapter   5   presents   an   epidemiology   and  
metagenomic  study  focused  on  the  detection  of  the  causative  agent  of  diarrhea  and  the  
characterization  of   the  signature  of  Escherichia   coli   infection  on   the  gut  microbiome   in  








1.1  Thesis  rationale  
Genomics   and   metagenomics   can   significantly   enhance   our   understanding   of  
pathogens   and   infectious   diseases.   With   the   development   of   high-­throughput   ‘next  
generation’   sequencing   technologies   and   the   technical   advances   to   generate   high-­
quality   sequencing   data,   the   bottleneck   in   implementing   these   omics   techniques   for  
clinical   purposes   has   shifted   from   obtaining   DNA   sequences   to   post-­sequencing   data  
analysis.   Although   substantial   progress   has   been   already   made,   the   widespread  
implementation   of   DNA   sequencing   in   clinical   and   public   health   microbiology   is   still  
limited,   mostly   due   to   the   lack   of   standardized   bioinformatics   methods   and   quality  
control.  As  sequencing  technologies  continue  to  improve  and  the  costs  continue  to  drop,  
genomic   and   metagenomic   approaches   will   be   increasingly   applied   to   public   health  
laboratories  for  routine  diagnostics,  typing  and  surveillance  as  well  as  the  assessment  of  
virulence   factors   of   pathogens   and   disease   characterization.   Therefore,   there   is   an  
urgent   need   for   validation   of   these   omics   techniques   in   clinical   specimens   and  
standardization   of   high-­resolution   bioinformatic   pipelines   customized   to   deal   with  
challenges   associated   with   clinical   specimens   such   as   the   co-­elution   of   human  
sequences.  This  research  effort  focused  on  developing  novel  bioinformatics  pipelines  to  
process  genomic  and  metagenomic   sequencing  data   in  order   to  distinguish  pathogens  
from  non-­pathogenic  close  relatives  and  to  elucidate   the  signatures  of  enteric  pathogen  
infections  on  the  gut  microbiome.  The  specific  aims  of  this  thesis  were:  1)  to  resolve  the  
true  phylogenetic  relationships  between  two  closely  related  bacterial  species  of  medical  
importance,   Clostridium   botulinum   and   its   innocuous,   close   relative   Clostridium  
sporogenes   on   the   basis   of   their   core   and   variable   genome;;   2)   to   detect,   quantify   the  
copy  number  and  characterize   the  gene  variation  among  the  virulent  Bacillus  anthracis  
plasmids  pX1O  and  pXO2  in  a  large  historical  collection  of  globally  distributed  strains;;  3)  
to   investigate   the   genome   diversity,   population   structure,   virulence   potential,   and  
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antibiotic   resistance   profile   of   pathogenic  E.   coli   strains   isolated   from   individuals   with  
diarrhea  and  controls     living  in  urban  and  rural  regions  in  Northern  Ecuador  and  finally;;  
4)   to   characterize   metagenomic   signatures   of   the   gut   microbiome   during   E.   coli  
infectious   diarrhea   in   young   children   and   determine   whether   pathotype-­specific  
signatures  exists  that  can  be  used  for  diagnostics  of  the  different  pathotypes.  
  
  
1.2  Phylogenomics  to  discriminate  closely  related  species  
As  whole  genome  sequencing  (WGS)  becomes  more  commonly  used  for  microbial  
identification,   it   is   important   to   evaluate   the   taxonomic   affiliation   of   microbes   using  
complete   genome   sequences.   Phylogenomics,   a   concept   first   introduced   by   Jonathan  
Eisen   in   1998   (1),   was   initially   defined   as   the   intersection   between   genomics   and  
evolution   (2,   3).   In   this   sense,   phylogenomics   originally   involved   the   reconstruction   of  
evolutionary  relationships  by  comparing  sequences  of  whole  genomes  or  at   least   large  
portions  of  genomes.   It  also   included   the  characterization  of  gene   family  evolution,   the  
prediction  of  gene  functions  and  the  detection  of  lateral  gene  transfer.    
Bacterial  species,  particularly  pathogenic  ones,  have  been  historically  demarcated  
on  the  basis  of  a   limited  number  of  diagnostic  phenotypic  traits,  usually  virulence  (e.g.,  
toxins)   or   antigen   factors.   For   example,   the   taxonomic   classification   of   Clostridium  
botulinum  and  Clostridium  sporogenes  has  been  based  on   the  production  of  botulinum  
neurotoxin  (BoNT)  by  the  former,  but  not  the  latter  closely  related  species  (4).  However,  
this  phenotypic   trait   (BoNT  production)  does  not  accurately  mirror   the   true  evolutionary  
relationships  between  both   taxa  and  might  pose  a   risk   in  human  health.  For  example,  
non-­toxic,  avirulent  C.  sporogenes   is  usually  used   in   industry  as  a  surrogate  organism  
for  C.  botulinum  in  the  study  of  thermal  processing  for  food  given  its  metabolic  similarity  
to   toxigenic   C.   botulinum   and   the   production   of   heat-­resistant   spores   (5,   6).   C.  
sporogenes  is  also  used  in  academia  as  a  research  model  for  the  study  of  the  biology  of  
toxigenic  C.  botulinum  (7).  If  some  strains  of  C.  sporogenes  could  potentially  acquire  the  
BoNT  via  horizontal  gene  transfer  and  become  highly  virulent,  or  inversely   if  virulent  C.  
botulinum   are   misidentified   as   C.   sporogenes,   harm   and   public   health   issues   could  
occur.  
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Similarly,   the   taxonomy   of   Bacillus   cereus   sensu   lato   group,   which   includes  
Bacillus   cereus,   Bacillus   anthracis   and   Bacillus   thuringiensis,   was   initially   recognized  
and   established   in   early   1990s   on   the   basis   of   distinct   phenotypic   traits   (8,9).   B.  
anthracis   was   identified   as   the   causative   agent   of   anthrax   (10);;   B.   thuringiensis   was  
recognized   as   an   entomopathogenic   bacterium   characterized   by   the   production   of  
parasporal   crystal   proteins   (Cry   and  Cyt)   (11)   and   finally,  B.   cereus   sensu   stricto  was  
initially  recognized  as  a  common  soil-­dwelling  microorganism  that  also  colonized  the  gut  
of   invertebrates   as   a   symbiotic   microorganism   and   was   recently,   recognized   as   an  
opportunistic  human  pathogen  (12),  but  did  not  encode  the  previous  virulence  factors.    
While  the  ability  of  bacteria  to  form  actual  discrete  units  (i.e.,  species)  is  a  topic  of  
intense   research   (reviewed   in   13,   55,   56),   the   reliable   classification   of   species   and  
strains   is   important  not  only   for   the  good  practice  of  clinical  and   industrial  microbiology  
but  also  for  the  establishment  of  a  well-­founded  ecological  and  evolutionary  framework.  
Phylogenetic   analysis   provides   a   way   to   establish   a   valid   and   biologically   meaningful  
classification  system  to  accurately  categorize  bacterial  strains  and  define  new  species,  
especially  for  pathogenic  microorganisms.  Moreover,  the  horizontal  transfer  of  genes  as  
well  as  the  loss  of  toxicity  in  pathogenic  strains  is  widely  recognized  in  bacterial  species.  
Therefore,   transitioning   bacterial   classification   from   laboratory-­assessed   phenotypes  
towards   a   genome-­based   taxonomy   is   critical,   especially   for   applications   in   clinical  
microbiology  and  public  health.    
Chapter   2   provides   an   example   of   a   phylogenomic   pipeline   developed   to  
discriminate   two  closely   related   taxa,  C.  botulinum   and  C.  sporogenes   on   the  basis  of  
the   core   genome   relatedness.   In   particular,   high-­confidence   clade-­specific   gene  
signatures   that   distinguish  C.   sporogenes   from   Group   I  C.   botulinum  were   identified.  
These   genes   are   not   part   of   the   taxonomic   descriptions   of   the   two   species   and   thus,  
provided  new  reliable  means   to  distinguish   the   two  species.   Importantly,  unlike  current  
diagnostic   traits,   the  newly   identified  genes  are  not  encoded  on  mobile  elements  or  be  
prone  to  horizontal  gene  transfer,  providing  stable  diagnostic  traits.  Such  genes  can  be  
also   used   for   rapid   PCR   testing.   In   addition,   we   provide   examples   of   specific   cases  
where  we  detected  horizontal  gene  transfer  of  the  species-­diagnostic  genes  encoding  for  
BoNT   between   both   groups,   which   reinforce   again   the   need   to   apply   comparative  
genomics  to  the  study  of  species  of  medical  or  industry  importance.    
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1.3  Pathogenomics  and  evolution  of  virulence  plasmids  in  Bacillus  anthracis    
Bacterial   plasmids   are   self-­replicating,   extra-­chromosomal,   DNA   elements   that  
can  play  a  key  role  in  microbial  population  pathogenicity,  adaptation  and  evolution  due  to  
the   genes   they   encode   (14).   Plasmids   act   as   ‘vehicles’   for   bacterial   genetic  
communication  and  promote  the  dissemination  of  a  variety  of  traits,   including  virulence,  
enhanced   fitness,   resistance   to   antimicrobial   agents,   and   metabolism   of   otherwise  
unusable  substances  (15,16).    Knowledge  of  the  relationships  between  plasmid  features  
and   host   taxonomy   is   important   in   order   to   understand   how   the   plasmids   are   being  
spread  among  microbes  as  well  as  the  phenotypic  plasticity  of  the  strains  that  harbor  the  
plasmids.   In   this   regard,   comparative   genomics,   defined   as   the   genome   analysis   of  
microbes  (17),  can  facilitate  the  study  of  plasmids  encoding  virulent  traits.  
Bacillus   anthracis,   the   etiological   agent   of   anthrax,   typically   carries   two   large,  
extra-­chromosomal,   double-­stranded   virulence   plasmids   called   pXO1   and   pXO2.    
Plasmid  pXO1  is  ~182Kb  in  size  and  carries  the  genes  that  encode  for  the  anthrax  toxin:  
protective  antigen  (PA),   lethal   factor  (LF)  and  edema  factor  (EF).  These  proteins  act   in  
binary   combinations   to  produce   the   two  anthrax   toxins:   edema   toxin   (PA  and  EF)  and  
lethal   toxin   (PA   and   LF)   (18,19).      Plasmid   pXO2   is   smaller   than   pXO1   (~95Kb)   and  
harbors  the  genes  that  encode  for  the  cap  operon.  The  cap  operon  is  responsible  for  the  
production   of   a   polyglutamate   capsule,   which   allows   the   pathogen   to   evade   the   host  
immune  response  by  protecting  itself  from  phagocytosis  (20).  
Given   that   plasmids   pXO1   and   pXO2   play   a   central   role   in   the   virulence   of  B.  
anthracis,  the  pathogenomic  characterization  of  this  group  is  usually  examined  in  terms  
of   the  plasmids.  Of  particular   interest   is   that  plasmids  similar   to  pXO1  and  pXO2  have  
been  previously   found   in   (non-­B.  anthracis)  close   relatives  of   the  B.  cereus  sensu   lato  
group   such   as   strains   infecting   primates   (21-­24).   These   findings   have   generated  
intriguing  questions  regarding  the  evolution  of   these  self-­replicating  DNA  elements.  For  
example,  has  lateral  transfer  occurred  between  members  of  B.  cereus  and  B.  anthracis?  
If   so,   what   is   the   direction   of   such   transfers?   Also,   the   estimated   phylogenetic  
relationships   of   pathogenic   strains   based   on   the   plasmid   sequences   are   similar   or  
perhaps  dissimilar  to  the  relationships  inferred  based  on  chromosome  sequences?      
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Currently,   B.   anthracis   plasmid   detection   and   quantification   in   public   health  
settings  is  accomplished  by  PCR  amplification  of  diagnostic  genes,  namely  the  anthrax  
toxin   and   related   genes   (25).   However,   this   approach   provides   low-­resolution   results  
because  it  targets  less  than  1%  of  the  plasmid  sequence  and  cannot  provide  information  
about   the   full   gene   content.   High-­throughput,   sequence-­based   approaches   can  
overcome  these  limitations.  They  can  provide  high-­resolution  data  to  not  only  detect  and  
quantify   plasmids   based   on   sequencing   depth   but   also   to   elucidate   their   full   gene-­
content  and  sequence  diversity.  The   resulting  sequenced  data  can  ultimately  allow   for  
the  better  understanding  of  the  pathogenomic  evolution  within  the  group  and  with  other  
close  relatives.  
In  Chapter  3,  we  present  a  study  of  Bacillus  anthracis  plasmids  pXO1  and  pXO2  
in  a  large  collection  of  fully-­sequenced  strains  that  were  recovered  from  human,  animal  
and  environmental  sources  around  the  world.  The  strains  included  in  this  study  were  part  
of   the   Zoonoses   and  Select   Agent   Laboratory’s   historical   collection   at   the  Centers   for  
Disease  Control  and  Prevention  (CDC)  and  were  acquired  since  the  1950s  to  2013.  We  
aimed  to  detect,  quantify  and  characterize  the  full  genomic  content  of  the  plasmids  in  the  
collection  and  compared  the  phylogenetic  diversity  of  B.  anthracis  representatives  with  a  
large   set   of   reference  B.   cereus   sensu   lato   strains   that   included   pathogenic   and   non-­
pathogenic  strains  carrying  pXO1-­like  plasmids.     Our   results   revealed   that  B.  anthracis  
cells  carry,  on  average,  3.86  copies  of  pXO1  and  2.29  copies  of  pXO2,  and  that  positive  
linear   correlations   exist   between   the   copy   numbers   of   both   plasmids.   They   also  
confirmed   the   remarkably   stability   of   gene   content   and   synteny   of   the   plasmids   and  
revealed   in   addition,   no   signal   of   plasmid   exchange   between   B.   anthracis   and  
pathogenic   B.   cereus   isolates   but   predominantly   vertical   descent.   To   the   best   of   our  
knowledge,   this   is   the   largest   study   characterizing  B.   anthracis   plasmid   copy   number  
variation  and  their  gene  content  diversity  using  sequencing  data  to  date  and,  hence,  the  
data  presented   in  Chapter  3  advance  our  understanding  of   the  evolution  and  virulence  
potential  of  B.  anthracis  and  its  plasmids.  
  
1.4   Genome   diversity   and   population   structure   of   pathogenic   E.   coli   strains  
circulating  in  Northern  Ecuador  
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E.   coli   is   a   Gram-­negative,   non-­sporulating   facultative   anaerobe   usually  
inhabiting  the  intestines  and  feces  of  warm-­blooded  animals  and  reptiles  although  it  can  
also   survive,   and   probably   grow,   in   water   and   sediment,   depending   on   nutrient  
availability   and   temperature   (26-­29).   In   the   human   gastrointestinal   tract,  E.   coli   is   the  
most   common   facultative   anaerobe   microorganism,   though   is   heavily   outnumbered  
(~10,000  to  1)  by  strict  anaerobic  bacteria.  E.  coli  strains  reside  in  the  mucus  layers  that  
covers  the  epithelial  cells  along  the  digestive  tract  and  are  shed  into  the  intestinal  lumen  
with  the  degraded  mucus  component  and  excreted  in  feces  (30,  31).  This  bacterial  group  
is  among  the  first  species  to  colonize  the  intestine  during  infancy,  reaching  high  density  
before  the  expansion  of  the  anaerobic  component  (~109  CFU  per  grams  of  faeces)  and  
gradually  decreasing  in  the  elderly  (32).    
The   relationship   of   E.   coli   with   the   host   has   been   traditionally   recognized   as  
commensalism,  in  which  one  of  the  two  organism  benefits  from  the  interaction  between  
them,   whereas   the   other   is   neither   harmed   nor   helped.   However,   this   ecological  
relationship   is  being  challenged  given   that  although   it   is  clear   that  E.  coli  benefits   from  
the   hosts   by   getting   a   steady   supply   of   nutrients   (usually   gluconate   and   low   complex  
sugars),   a   stable   environment,   transport   and   dissemination,   E.   coli   is   also   though   to  
prevent   colonization   by   pathogens   (colonization   resistance)   by   producing   bacteriocins  
and  other  similar  function  compounds  (33).    
Paradoxically,   strains   (varieties)   of   E.   coli   can   be   dangerous   pathogens.   This  
microbial  group  has  the  interesting  characteristic  of  being  both  a  widespread  commensal  
of  vertebrates  and  a  harmful  pathogen  capable  of  killing  more  than  2  million  humans  per  
year  through  intestinal  and  extra-­intestinal  diseases  (34).  Pathogenic  E.  coli  strains  differ  
from   their   commensal   counterparts   in   that   they   have   acquired   distinctive   traits   that  
confer   them   an   increased   ability   to   invade   new   niches   within   the   human   body   and  
persist.   Based   on   virulence   properties   and   mechanism   of   pathogenesis,   several  
diarrhea-­producing  E.   coli   pathotypes  has  been   recognized.  These  pathotypes   include  
Enterotoxigenic  E.  coli  (ETEC),  Enteroinvasive  E.  coli  (EIEC),  Enteroaggregative  E.  coli  
(EAEC),  Enteropathogenic  E.  coli  (EPEC),  Diffusely  adherent  E.  coli  (DAEC)  and  Shiga-­
toxin   producing  E.   coli   (STEC).   From   these,   EPEC   and   ETEC   have   received   special  
attention   in   developing   countries   as   they   been   associated   with   increased   diarrhea  
frequency  in  children  under  five  years  old  (34,  35).  To  understand  how  E.  coli  adapts  to  
human   gut   niche   as   a   commensal   microbe   and   what   factors   trigger   the   transition  
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towards  virulence,  it  is  necessary  to  unravel  how  the  species  is  genetically  structured  on  
a   global   scale.      Humans   have   distinct   body   sizes,   diets,   lifestyles,   microbiotas   and  
hygienic   practices.   These   characteristics   might   substantially   influence   the   prevalence  
and   density   of   pathogenic   E.   coli   populations.   Therefore,   the   relevance   of   this  
microorganism  as  causative  agent  of  disease  might  also  be  determined  in  part  by  those  
extrinsic  forces.    
In   low-­income  countries,  E.   coli   is  highly  prevalent   in  diarrheal  diseases.   It   has  
been  estimated   that,  after  viral   infections,  Enterotoxigenic  E.  coli  (ETEC)   infections  are  
responsible  for  more  than  50%  of  all  diarrheal  deaths  in  children  under  5  years  old  (35).  
In   South   America,   particularly   in   Ecuador,   few   epidemiological   studies   have   reported  
association  between  pathogenic  E.  coli   and  diarrhea   (36-­38).  However,   the  majority  of  
these   studies   have   been   carried   out   in   large   cities,   while   no   study   has   concurrently  
looked  at  the  association  of  E.  coli  with  diarrhea  in  urban  and  rural  sites  over  the  same  
time   period   and   geographic   area.   It   is   widely   recognized   that   urbanization   affects   the  
epidemiology   of   emerging   infectious   diseases   and   questions   regarding  whether   urban  
areas  promote   the  establishment   of  more   virulent  E.   coli   genotypes   than   rural   regions  
have   been   minimally   explored.   For   example,   environmental   factors   such   as   poor  
housing,   inadequately   treated   drinking   water   supplies,   sanitation   and   waste  
management   in   slum   areas,   coupled   with   (often   uncontrolled)   antibiotic   usage   and  
spatial  proximity  in  densely  populated  regions  may  promote  the  establishment  and  rapid  
spread  of  highly  virulent  E.  coli  genotypes  in  large  cities  relative  to  rural  areas.  
In   Chapter   4,   we   present   a   large   genomic   study   of   pathogenic  E.   coli   strains  
circulating   in  urban  and  rural  areas   in  Northern  Ecuador  as  an  effort   to  understand  the  
extend   of   genome   diversity   and   the   population   structure   of   the   strains.   We   used  
molecular   pathotyping   and   whole   genome   sequencing   to   investigate   the   genome  
diversity,   pangenome   structure,   virulence   potential,   and   antibiotic   resistance   profile   of  
more   than   200   pathogenic   E.   coli   strains   isolated   over   17   months   from   individuals  
enrolled   in  a  case-­control   study  of  diarrhea   in   four  sites  along  an  urban-­rural  gradient.  
The  main  findings  from  this  study  suggest,  among  other  things,   that  Ecuadorian  E.  coli  
population   is   phylogenetically   structured   by   pathotype   and   by   host   lifestyle   (urban   or  
rural)  and  that  urban  strains  belonging  to  DAEC  and  atypical  EPEC  pathotype,  carry  on  
average,  more  virulence  factors  than  rural  strains.    
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1.5   Metagenomic-­based   identification   of   the   etiological   agent   of   infectious  
diarrhea  and  microbiome  signatures  caused  by  different  E.  coli  pathotypes  
The  human  gut  microbiome,  referred  as  the  total  collection  of  microbes  (and  their  
genomic   content),   that   reside   on   and   inside   the   digestive   tract   of   humans,   is   an  
extremely   variable,   dynamic   and   complex   habitat,   containing   up   to   1012-­1015  microbial  
cells   per   gram   of   fecal   material   (39).   The   composition   of   this   complex   microbial  
population   is  highly  variable  over  time  and  susceptible  to  both  environmental  and  host-­
specific  modifications  (40,  41).  Several  studies  have  highlighted  the  critical  role  that  the  
gut   microorganisms   play   in   human   health.   Gut   microbes   are   involved   in   a   variety   of  
essential  activities   for   the  host   including  energy  harvest  and  storage,   fermentation  and  
metabolism  of  otherwise  indigestible  carbohydrates,  maturation  of  host  immune-­defense,  
and  even  cognitive  processes  (42-­45).    
During  infectious  diarrhea  the  structure  of  microbial  community  is  often  disrupted.  
Detailed  knowledge  about  how  the  microbial  community   is  disrupted  by  the  abundance  
and   the  signal   (e.g,  excreted  compounds)  of   the  pathogen   is  currently   limited.  Much  of  
the  work  to  date  on  the  gut  microbiome  has  primarily  focused  on  the  relationship  of  gut  
community   composition   to   chronic   diseases   or   conditions   such   as   obesity   (46,   47),  
malnutrition   (48),   inflammatory   bowel   disease   (IBD)   (49)   etc.   A   much   more   limited  
number   of   studies   has   examined   the   impacts   of   acute   diarrhea   on   gut   microbial  
communities  (50,  51)  using  high-­resolution  metagenomic  data.    
As  part  of  the  GEM  study  (The  Global  Enteric  Multicenter  study  sponsored  by  the  
William  and  Melinda  Gates  Foundation  (52)),  Pop  et  al.,  2014  (53)  used  high-­throughput  
16SrRNA  gene  sequencing   to  study   the   fecal  microbiota  composition   in  children  under  
five   years   of   age,  who   had   been   diagnosed  with  moderate   to   severe   diarrhea   (MSD),  
and  compared  their  results  with  diarrhea-­free  controls.  This  study  included  a  total  of  992  
children   from   four   low-­income   countries   in   West   and   East   Africa   (Gambia,   Mali   and  
Kenya)   and   Southeast   Asian   (Bangladesh).      The  main   results   showed   that   there   is   a  
significant   decrease   in   gut   microbiota   diversity   in   diarrhea   samples   compared   with  
control  (which  was  consistently  observed  in  all  four  countries),  and  the  main  differences  
in  microbiota  composition  between  cases  and  control  are  quantitative  differences  in  the  
proportion  of  the  most  prevalent  taxa.    
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To   answer   important   questions   regarding   the   burden   and   pathogen   etiology   of  
childhood  diarrhea  in  developing  countries,  the  GEM  study  reported  the  main  pathogens  
responsible  for  cases  of  MSD  in  seven  impoverished  countries  in  sub-­Sahara  Africa  and  
Southeast   Asia.   Notably,   for   approximately   60%   of   MSD   in   the   GEMS,   no   known  
pathogen  could  be   implicated  by  conventional  diagnostic  methods.  These  observations  
highlighted   the  potential  presence  of  uncharacterized  pathogens,  and/or   the   limitations  
of   conventional   culture-­dependent   methods.   To   address   some   of   these   limitations,  
Huang   et   al.,   2017   (54)   reported   a   metagenomic   study   of   two   severe   foodborne  
Salmonella   outbreaks   in   the   USA   (Colorado   and   Alabama)   with   the   overall   goal   of  
validating   metagenomics   for   foodborne   pathogen   detection   and   comparing   the  
metagenomics   results   to   a   conventional   culture-­based  methodology.   In   this   study,   the  
metagenomic   approach   provided   results   consistent   with   the   traditional   culture-­based  
approach   in   terms   of   identifying   the   exact   pathogen/strain   responsible   for   the   disease  
(Salmonella  enterica  pathovar  Heidelberg)  but  also   identified  cases  of  co-­infection  with  
Staphylococcus   aureus   and   provided   more   precise   estimates   of   in-­situ   pathogen  
abundance  and  intra-­population  diversity.  In  addition,  this  study  reported  an  overgrowth  
of   commensal  E.   coli   as   an   effect   of   the  Salmonella   infection   and   shifts   in   the   overall  
microbiome  structure  during  infection  relative  to  reference  healthy  samples.    
Several   enteric   bacterial   pathogens   can   cause   diarrhea   via   distinctive  
mechanisms   of   pathogenicity.      However,   it   remains   undetermined   whether   different  
pathogens   produce   similar   or   perhaps,   distinct   alterations   in   the   indigenous  microbial  
community   due   to   their   characteristic   mechanism   of   infection   and/or   virulence   factors  
they  produce.  For  example,  Escherichia  coli   is  usually  a  gut  commensal  of  vertebrates,  
including   humans  but   it   can,   nevertheless,   cause   a   broad   range  of   diseases   including  
intestinal  and  extra-­intestinal  infections.  Based  on  virulence  factors,  diarrheagenic  E.  coli  
have  been  divided   into  six  distinct  pathotypes  (DAEC,  EPEC,  ETEC,  EIEC,  EAEC  and  
EHEC),  each  one  with  preferential  colonization  sites,  virulence  mechanisms  and  clinical  
presentations.    
The   six  E.   coli   pathotypes   are   characterized   by   distinct   virulence  mechanisms  
encoded   in   their   respective   genomes,   i.e.,   some   of   them   are   capable   of   invading   the  
cells,   producing  biofilms  or   secreting   toxins.  These  biological   differences  might   disturb  
the  gut  microbial  community  in  different,  distinguishable  ways.  We  hypothesized  that  the  
distinctive   infectious   mechanisms   used   by   different   E.   coli   pathotypes   produces  
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particular   signatures   in   the   sick   gut   microbiome.   However,   until   now,   no   study   has  
comparatively  evaluated   the  effect  of  different  E.  coli  pathovars  on   the  gut  microbiome  
during  active  infections.  It  remains  unknown  whether  or  not  gut  microbial  signatures  exist  
in  the  sick  microbiome  that  discriminate  among  different  E.  coli  pathotypes.  For  example,  
such  signatures  could  include  shifts  in  community  structure  and  composition  that  can  be  
detected   and   quantified   using   metagenomic   approaches.   The   dogma   suggests   that  
during  infection,  the  pathogen  becomes  the  dominant  clone  in  the  gastrointestinal  tract,  
overcoming  the  signal  of  the  commensal  population.      
To   address   these   points,   In   Chapter   5   we   describe   an   integrated   multi-­omics  
approach   combined   with   epidemiology   and   traditional   microbiology   to   investigate   the  
taxonomic   composition   and   metabolic   capability   of   fecal   samples   taken   from   young  
children   in   Northern   Ecuador   suffering   infectious   diarrhea   relative   to   age-­matched,  
healthy   controls.  We   developed   a   bioinformatic   approach   to   detect   samples   where  E.  
coli   was   most   likely   the   pathogen   responsible   for   the   disease   and   identified   several  
Diffusely   Adherent   (DAEC),   Enteropathogenic   (EPEC)   and   Enterotoxigenic   (ETEC)  
strain  infections.  These  results  were  compared  to  results  based  on  E.  coli   isolates  from  
the  same  diarrhea  samples  that  were  categorized  in  the  three  pathotypes  by  PCR,  i.e.,  
these   strains   represented   the   etiological   agents   based   on   conventional   means.   Our  
results   showed   that   although   pathogenic   E.   coli   was   PCR-­detected   in   all   diarrhea  
samples,   only   about   ~50%   of   the   samples   actually   presented   metagenomic   features  
consistent  with  E.  coli  infection.  
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   Taxonomic  classification  of  Clostridium  botulinum   is  based  on   the  production  of  
botulinum  neurotoxin  (BoNT),  while  closely  related,  nontoxic  organisms  are  classified  as  
Clostridium   sporogenes.   However,   this   taxonomic   organization   does   not   accurately  
mirror  phylogenetic  relationships  between  these  species.  A  phylogenetic  reconstruction  
using   2,016   orthologous   genes   shared   among   strains   of  C.   botulinum   group   I   and  C.  
sporogenes   clearly   separated   these   two   species   into   discrete   clades   which   showed  
~93%  average   nucleotide   identity   (ANI)   between   them.  Clustering   of   strains   based   on  
the   presence   of   variable   orthologs   revealed   143  C.   sporogenes   clade-­specific   genetic  
signatures,  a  subset  of  which  were  further  evaluated  for  their  ability  to  correctly  classify  a  
panel  of  presumptive  C.  sporogenes  strains  by  PCR.  Genome  sequencing  of  several  C.  
sporogenes   strains   lacking   these   signatures   confirmed   that   they   clustered   with   C.  
botulinum   strains   in   a   core   genome   phylogenetic   tree.   Our   analysis   also   identified  C.  
botulinum   strains   that   contained   C.   sporogenes   clade-­specific   signatures   and  
phylogenetically   clustered  with  C.   sporogenes   strains.   The   genome   sequences   of   two  
bont/B2-­containing  strains  belonging  to  the  C.  sporogenes  clade  contained  regions  with  
similarity   to  a  bont-­bearing  plasmid  (pCLD),  while   two  different  strains  belonging   to   the  
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C.   botulinum   clade   carried   bont/B2   on   the   chromosome.   These   results   indicate   that  
bont/B2  was   likely  acquired  by  C.  sporogenes  strains   through  horizontal  gene   transfer.  
The  genome-­based  classification  of   these  species  used   to   identify  candidate  genes   for  
the   development   of   rapid   assays   for   molecular   identification   may   be   applicable   to  
additional  bacterial  species  that  are  challenging  with  respect  to  their  classification.  
  
2.2  Introduction  
Botulinum   neurotoxins   (BoNT)   produce   neuromuscular   paralysis   associated   with  
botulism  and  are  produced  by  various  clostridia,  most  notably  Clostridium  botulinum.  C.  
botulinum   is   a   Gram-­positive,   anaerobic,   endospore-­forming   bacillus   that   can   be  
classified  on  the  basis  of  metabolic  properties  into  four  separate  groups  (groups  I  to  IV).  
Group   I  C.   botulinum   strains   are   proteolytic,   saccharolytic,   and   capable   of   producing  
BoNT   types   A,   B,   and   F.   Group   II   C.   botulinum   strains   are   non-­proteolytic   and   can  
produce  BoNT  types  B,  E,  and  F,  while  group  III  strains  produce  BoNT  types  C  and  D.  
Group   IV  strains,  which  are  also   identified  as  Clostridium  argentinense,  produce  BoNT  
type  G.  
The   nontoxic   species   Clostridium   sporogenes   shares   nearly   identical   metabolic  
properties  with  group   I  C.  botulinum,   including   the   formation  of   lipase-­positive  colonies  
when  grown  on  egg  yolk  agar.  Because  of   these  similarities  and   the  comparable  heat  
resistance  of   its  spores,  C.  sporogenes  has  been  used  as  a  surrogate  organism  for  C.  
botulinum  in  the  study  of  thermal  processing  for  foods  (1).  Previous  studies  have  shown  
that   some   strains   of   C.   sporogenes   and   group   I   C.   botulinum   can   be   differentiated  
phenotypically   by   soluble   protein   expression,   measured   by   polyacrylamide   gel  
electrophoresis  (2)  and  gas-­liquid  chromatography  of  trimethylsilyl  derivatives  of  whole-­
cell  hydrolysates  (3).  
Genetic   studies   such   as   DNA-­DNA   hybridization   and   16S   rRNA   gene   sequence  
analysis  have  shown  that  these  species  are  closely  related  (4–7).  While  acknowledging  
a   genetic   relationship   at   the   species   level,   Olsen   et   al.   (8)   proposed   that   the   species  
name   C.   botulinum   be   reserved   for   toxigenic   strains   and   that   C.   sporogenes   be  
conserved   for   non-­toxigenic   strains   in   order   to   prevent   confusion   between   these  
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organisms,   and   this   proposal   has  met   with   wide   acceptance.   As   genome   sequencing  
becomes  more  commonly  used  for  microbial  identification,  it  is  important  to  evaluate  this  
taxonomic   organization   in   a   phylogenomic   context.   Bacterial   species   are   often  
determined   on   the   basis   of   a   limited   number   of   diagnostic   phenotypic   traits,  while   the  
ability  of  bacteria  to  form  actual  discrete  units  (i.e.,  species)  is  a  topic  of  intense  research  
(9–12).   Moreover,   horizontal   gene   transfer   (HGT)   of   genes   encoding   diagnostic   traits  
may  act  to  further  reduce  the  boundaries  between  bacterial  species  (13).    
In   this   study,   we   used   genome   sequence   analysis   to   resolve  C.   sporogenes   and  
group   I  C.   botulinum   strains   on   the   basis   of   genetic   relatedness   between,   as   well   as  
within,   these   named   species.   In   addition,   this   analysis   demonstrated   a   previously  
unrecognized   role   for   HGT   of   some   BoNT/B-­encoding   genes   between   these  
microorganisms.  
  
2.3  Materials  and  Methods  
2.3.1  Initial  microbiological  characterization  of  bacterial  strains  
All   strains   examined   in   this   study   were   grown   in   Trypticase-­peptone-­glucose-­
yeast  extract  (TPGY)  medium  (Remel,  Lenexa,  KS)  at  35°C  under  anaerobic  conditions.  
Single  colonies  were  isolated  from  egg  yolk  agar  (EYA).  Strains  presumptively  identified  
as   C.   sporogenes   (Table   2.1)   based   on   microbiological   characteristics   and   lack   of  
toxicity  using  the  mouse  bioassay  (14)  were  reexamined  using  the  botulinum  toxin  gene  
real-­time   PCR   assay   (distributed   by   the   Laboratory   Response   Network,   CDC)   to  
demonstrate   absence   of   botulinum   neurotoxin   genes   (A   to  G)   and   by   botulinum   toxin  
enzyme-­linked  immunosorbent  assay  (ELISA)  (15)  to  demonstrate  lack  of  toxin  (types  A,  
B,  E,  and  F)  production.  Additional   toxic  and  nontoxic  C.  botulinum  and  C.  sporogenes  





Table  2.1.  Characteristic  of  strains  examined  in  this  study.  
Strain   Toxin  Type   Species   Location   Year   Source  
CDC41370   Ab   C.  botulinum   Mexico   1996   food  




CDC68016   B1   C.  botulinum   West  Virginia   2013   stool  




ATCC7949   B2   C.  botulinum   unknown   unknown   unknown  
Prevot25  
NCASE   B2   C.  botulinum   unknown   unknown   unknown  
Prevot1662   B2   C.  botulinum   unknown   unknown   unknown  
ATCC51387   B2   C.  botulinum   unknown   unknown   unknown  
CDC66221   B6   C.  botulinum   Colorado   2011   stool  
11579   NT   C.  sporogenes   unknown   1972   unknown  
85-­3852   NT   C.  sporogenes   unknown   unknown   unknown  
87-­0535   NT   C.  sporogenes   unknown   unknown   unknown  
88-­0163   NT   C.  sporogenes   unknown   1988   blood  
CDC22719   NT   C.  sporogenes   Colorado   1977   chili  sauce  
CDC22720   NT   C.  sporogenes   Colorado   1977   cheese  
CDC21678   NT   C.  sporogenes   Hawaii   1976   abdominal  drainage  
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Table  2.1  continued  
CDC21494   NT   C.  sporogenes   Germany   1976   canned  ham  
CDC22679   NT   C.  sporogenes   Puerto  Rico   1977   canned  meat  
CDC22680   NT   C.  sporogenes   Puerto  Rico   1977   canned  meat  
CDC22753   NT   C.  sporogenes   South  Carolina   1977   wound  (foot)  
CDC22798   NT   C.  sporogenes   South  Carolina   1977   blood  
CDC23091   NT   C.  sporogenes   Oklahoma   1978   gastric  fluid  
CDC232842   NT   C.  sporogenes   Maryland   1978   abdominal  fluid  
CDC232852   NT   C.  sporogenes   Maryland   1978   peritoneal  fluid  
CDC24474   NT   C.  sporogenes   Maryland   1979   abdominal  fluid  
CDC245453   NT   C.  sporogenes   New  Zealand   1979   dotterel  (bird)  
CDC244423   NT   C.  sporogenes   New  Zealand   1979   dotterel  (bird)  
CDC24533   NT   C.  sporogenes   Arizona   1979   wound  (leg)  
CDC24968   NT   C.  sporogenes   Missouri   1979   stool  
CDC24726   NT   C.  sporogenes   North  Carolina   1979   liver  paste  
NCTC534   NT   C.  sporogenes   Unknown   ~1920   human  
CDC24614   NT   C.  sporogenes   Florida   1979   wound  
CDC351202   NT   C.  sporogenes   California   1980   blood  
CDC351212   NT   C.  sporogenes   California   1980   lung  
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Table  2.1  continued              
CDC35566   NT   C.  sporogenes   Missouri   1980   unknown  
CDC351972   NT   C.  sporogenes   Alaska   1980   wound  drainage  
CDC351962   NT   C.  sporogenes   Alaska   1980   wound  drainage  
1  NT  =  Non-­toxic;;  2  Isolates  from  same  individual;;  3  Isolates  from  identical  culture.  
  
2.3.2  DNA  extraction  and  draft  genome  sequence  assembly  
Genomic  DNA  from  all   isolates  was  extracted  from  TPGY  cultures  as  previously  
described  (16)  and  purified  using  the  DNA  Clean  &  Concentrator-­5  kit  (Zymo  Research,  
Irvine,  CA)  prior  to  library  construction.  Genome  sequencing  was  performed  using  either  
the   Illumina   MiSeq   or   Life   Technologies   Ion   Torrent   PGM   instrument   (Table   2.2).  
Illumina   reads  were   filtered  and   trimmed  at  both   the  5’  and  3’  ends  based  on  a  Phred  
score  threshold  (Q)  of  20  using  SolexaQA  (17).  For  each  isolate,  quality-­trimmed  reads  
were  assembled  first  in  parallel  runs  of  Velvet  v1.0.13  (18)  and  SOAP-­denovo2  (19)  with  
a   range   of  k-­mer   values,   as   described   previously   (20).   The   resulting   pre-­contigs  were  
pooled   and   then   assembled   using   the   Genome   Sequencer   (GS)   de   novo   assembler  
software  v2.0.01.14  (Roche,  Branford,  CT).  Ion  Torrent  reads  were  assembled  using  the  
GS   de   novo   assembler.   For   both   platforms,   assembled   contigs   were   ordered   using  
Mauve   Contig   Mover   (21)   with   C.   botulinum   strain   Loch   Maree   as   a   reference,   and  
assembly   validation   was   performed   with   Mauve   Assembly   Metrics   (22).   The   resulting  
draft  genome  sequences  were  annotated  with   the  Rapid  Annotation  using  Subsystems  
Technology  (RAST)  server  (23).  Despite  a  large  number  of  contigs  in  some  assemblies,  
more   than   95%   of   the   core   genes   were   fully   recovered,   suggesting   that   no   major  
sequencing  gaps  remained.  
The   nucleotide   sequences   of   bont/B2   and   bont/B6   genes   were   determined   by  
sequence  read  mapping  using  CLC  bio  Genomics  Workbench  version  7.5.  For  bont/B2-­
containing   genomes,   the   ATCC   7929   bont/B   sequence   (GenBank   accession   number  
EF028395)  was  selected  as   the   reference   for   read  mapping,  while   the  Okayama  2011  
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bont/B   sequence   (GenBank   accession   number   AB665558)   was   used   for   bont/B6-­
containing   genomes.   Additional   comparative   analysis   included   alignment   of   selected  
genome  sequences  with  pCLD   (from  C.  botulinum  strain  Okra)  using   the  BLAST  Ring  
Image  Generator   (BRIG)   (24)   and   alignment   of   the   chromosomally   located   toxin   gene  
cluster   region  of  specific  genomes  containing  bont/B2  using   the  R  package  genoPlotR  
(25).   The   locations   of   specific   genes   within   these   toxin   gene   clusters   were   predicted  
using  GeneMarkS  (26).  
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CDC41370NT   PGM   695,428   254   30,380   3.8  MB   37X   LAGJ01000000  
CDC68016   PGM   654,420   872   9,380   4.2  MB   33X   LAGK01000000  
CDC68016NT   PGM   392,523   1714   3,800   4.3  MB   18X   LAGL01000000  
ATCC7949   PGM   1,012,546   206   50,992   3.8  MB   57X   LAGE01000000  
Prevot25NCASE   PGM   1,088,680   192   42,026   4.1  MB   56X   LAGN01000000  
Prevot1662   PGM   775,204   593   19,719   4.9  MB   30X   LAGM01000000  
ATCC51387   PGM   1,178,142   302   31,395   4.3  MB   56X   LAGD01000000  
11579   PGM   577,378   317   27,263   4.4  MB   26X   JZJN01000000  
85-­3852   PGM   634,904   305   30,089   4.1  MB   32X   JZJO01000000  
87-­0535   MiSeq   1,078,369   226   46,656   3.8  MB   37X   JZJP01000000  
88-­0163   MiSeq   1,596,670   247   40,700   3.8  MB   53X   JZJQ01000000  
CDC66221   PGM   422,086   818   9,229   4.1  MB   17X   LAGO01000000  
CDC23284   PGM   580,480   506   17,646   4.1  MB   28X   LAGF01000000  
CDC24442   PGM   476,812   368   14,470   3.1  MB   27X   LAGG01000000  
CDC24533   PGM   793,767   344   24,303   4.1  MB   41X   LAGH01000000  
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1PGM,   Life   Technologies   Ion   Torrent   Personal   Genome   Machine;;   MiSeq,   Illumina.   2  
Coverage    
  
2.3.3   Core   genome   phylogenetic   reconstruction   and   genetic   signature  
identification  
All   predicted   protein-­coding   genes   from   each   of   the   sequenced   genomes   and  
available  reference  sequences  were  compared  using  an  all-­versus-­all  BLAST  search  as  
described  previously  (27).  This  analysis   identified  shared  reciprocal  best  matches   in  all  
pairwise   genome   comparisons   (core   orthologs)   of   C.   sporogenes   and   either   all   C.  
botulinum   strains   or   only   group   I   C.   botulinum   strains.   These   core   orthologs   were  
individually  aligned  using  MUSCLE  (28).  The  resulting  alignments  were  concatenated  to  
create  a  whole-­genome  alignment,  and  the  phylogeny  of  genomes  was  reconstructed  by  
computing  a  maximum-­likelihood  distance  matrix  with  RAxML  (29,  30).  
The  collection  of  variable  genes  in  each  genome,  defined  as  genes  absent  in  one  
or  more   genomes,  was   identified   in   the  all-­versus-­all   BLAST   search   described   above.  
The   presence   or   absence   of   these   variable   genes   was   used   to   hierarchically   cluster  
genomes  using  complete  linkage  across  a  centered  Pearson  correlation  similarity  matrix  
using  Cluster  3.0  (31).  Variable  genes  were  considered  C.  sporogenes  specific  if  present  
in   at   least   7   out   of   8   genomes   and   absent   in   all   group   I   C.   botulinum   genomes.  
Conversely,  genes  present  in  11  out  of  13  group  I  C.  botulinum  genomes  but  absent  in  
all   C.   sporogenes   genomes   were   classified   as   C.   botulinum-­specific.   These   ratios  
correspond   to   at   least   80%   of   the   population   of   strains   examined   for   each   species  
(representing   values   >1   standard   deviation   from   the  mean   of   the   population)   and   are  
therefore  expected  to  be  robust  to  spurious  matches.  
Functional   annotation   of   predicted   proteins   encoded   by   species-­specific   genes  
was   bioinformatically   inferred   using   a   combination   of   three   independent   approaches:  
first,   sequences  were   searched  against   the  UniProtKB/Swiss-­Prot   database   (32)  using  
DELTA-­BLAST   (33)   with   a   bit   score   cutoff   of   200.   Second,   conserved   domains   were  
predicted   by   RPS-­BLAST   against   the   position-­specific   score   matrices   of   the   NCBI  
Conserved  Domain  Database  (34)  using  an  e-­value  threshold  of  0.01.  Finally,  a  BLASTX  
search  against   the  NCBI   non-­redundant   (nr)   database  was  performed  with   a   bit   score  
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cutoff  of  200  and  identity  greater  than  96%.  The  results  of  these  independent  searches  
were   manually   inspected,   and   the   corresponding   genes   were   functionally   annotated  
based  on  the  consensus  of  the  three.  
  
2.3.4  Genetic  signature  PCR  and  16SrRNA  sequencing  
A   total   of   143   putative   C.   sporogenes-­specific   orthologs   were   identified,   from  
which   11   candidates   were   selected   for   primer   design   for   PCR   amplification.   The  
annotated   functions  and  corresponding  NCBI   locus   ID   for   the  candidate  signatures  are  
shown  in  Table  2.3.  PCR  amplification  was  performed  on  genomic  DNA  extracted  from  
24  C.  sporogenes   isolates  using  primers  targeting  each  of  the  11  biomarkers  (shown  in  
Table  2.3).  PCR  thermo  cycling  conditions  consisted  of  an  initial  denaturation  at  95°C  for  
3  min  followed  by  35  cycles  of  95°C,  for  30s,  50°C  for  30s,  and  72°C  for  90s  with  a  final  
extension  of   72°C   for   10  min.   The  amplified   products  were  examined  on  1%  ethidium  
bromide-­stained   agarose   gels   and   visualized   under   UV   trans-­illumination.
A   ~1.3-­kb   region   of   the   16S   rRNA   gene   from   presumptively   identified   C.  
sporogenes   strains   was   amplified   and   sequenced   using   primers   that   were   previously  
described   (35).   Sanger   sequencing   was   performed   using   the   GenomeLab   dye  
termination   cycle   sequencing   kit   and   a   CEQ8000   genetic   analysis   system   (Beckman  
Coulter,   Brea,   CA).   Sequences   were   assembled   and   edited   with   Sequencher   v   4.8  
(Gene  Codes,  Ann  Arbor,  MI).  Newly  determined  sequence  data  have  been  deposited  in  
GenBank  under  the  accession  numbers  shown  in  Table  2.2.    
  
2.4  Results    
All-­versus-­all   BLAST   comparison   indicated   that   the   pangenome   for   strains   of  C.  
sporogenes  and  C.  botulinum   (including  groups   I,   II,   and   III)  was  comprised  of  16,229  
genes.   Of   these,   179   genes   were   shared   by   all   strains   (core   orthologs),   and   a  
phylogenetic  reconstruction  based  on  their  concatenated  alignment  revealed  four  distinct  
clades  (Figure  2.1).  As  expected,  strains  from  C.  botulinum  groups  II,  III,  and  I  were  well  
separated.  The  C.  sporogenes  strains  were  most  closely  related  to  a  clade  of  group  I  C.  
botulinum   strains,   consistent   with   previous   genomic   studies   (36,   37),   but   formed   their  
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own  discrete  clade.  The  C.  sporogenes  clade  contained  C.  sporogenes  strains  88-­0163,  
ATCC15579,   87-­0535,   PA3679,   85-­3852,   and   11579   and   two   C.   botulinum   type   B  
strains,  Osaka05  and  Okayama2011.  Furthermore,  the  average  pairwise  genome  
aggregate  average  nucleotide   identity   (ANI)  between  genomes  within   the  group   I  
C.  botulinum  clade  and  the  C.  sporogenes  clade  was  93.4%,  below  the  95%  ANI  cutoff  
frequently   used   for   species   demarcation   (38),   supporting   the   classification   of   these  
strains   into   separate   bacterial   species.   Further   comparison   of   strains   in   the   C.  
sporogenes   and   group   I  C.   botulinum   clades   revealed   a   pangenome   (for   both   clades  
combined)   comprised   of   9,306   orthologs,   of   which   2,016   were   core   and   7,290   were  
variable  among  these  closely  related  genomes.  
Hierarchical   clustering   based   on   presence   or   absence   of   the   variable   genes  
(absent   in  one  or  more  genomes)  among   the  C.   sporogenes  and  C.  botulinum  strains  
examined  in  this  study  again  separated  C.  sporogenes  strains  from  C.  botulinum  group  I,  
group   II,   and   group   III   mirroring   the   phylogenetic   relationships   inferred   from   the   core  
genome   phylogeny   (data   not   shown).  When   the   analysis  was   restricted   to   the   16,412  
variable   genes   present   in   the   C.   sporogenes   and   group   I   C.   botulinum   genomes  
specifically,   the  C.  sporogenes  strains  continued   to   form  a  discrete  cluster,   suggesting  
that  there  exist  clade-­specific  gene  signatures  in  C.  sporogenes  genomes  (Figure  2.2A)  
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Figure   2.1.  Core   genome  phylogenetic   trees   of  C.   sporogenes  and  C.   botulinum  
genomes.   The   initial   tree   was   based   on   the   maximum-­likelihood   distance   calculated  
from  the  alignment  of  179-­shared  orthologous  genes  of  C.  sporogenes  and  C.  botulinum  
groups  II,  III,  and  I.  The  tree  in  the  inset  was  based  on  the  maximum-­likelihood  distance  
calculated   from   the   alignment   of   1,451   shared   orthologous   genes   restricted   to   C.  
sporogenes  and  group  I  C.  botulinum.  Specific  clades  discussed  in  the  text  are  labeled.  
The   BoNT   produced   by   each   strain   in   indicated   in   brackets   (NT,   nontoxic).   Genomes  




























































































Selective   filtering   of   variable   orthologs   identified   143   clade-­specific   genes   that  
were   present   in   at   least   7   out   of   8   available   C.   sporogenes-­clade   genomes   (strains  
11579,  85-­3852,  88-­0163,  ATCC15579,  87-­0535,  PA3679,  Osaka05,  and  Okyama2011)  
and  absent  in  the  genomes  associated  with  the  group  I  C.  botulinum  clade  (Figure  2.2B).  
Of   these,   65   were   annotated   as   encoding   hypothetical   proteins.   Annotation   of   the  
remaining   genes   included   various   functions   related   to   nutrient   uptake   (e.g.,   heme  
transport   and   alkane   sulfonate   uptake)   and   bacterial   cell   defense   against   invasion   of  
foreign   DNA   (e.g.,   type   1   restriction   modification   system).   Similarly,   91   genes   were  
observed  in  at  least  11  out  of  the  13  genomes  associated  with  the  group  I  C.  botulinum  
clade  that  were  absent  from  all  C.  sporogenes  strains  examined.  From  these,  44  genes  
were   annotated   as   hypothetical   proteins,   while   the   remaining   genes   were   functionally  
associated   with   metabolic   pathways   (e.g.,   V-­type   ATP   synthase)   and   cell   wall  
modifications.  
  
Figure  2.2.  Hierarchical  clustering  based  on   the  presence  or  absence  of  variable  
orthologs.   (A)   The   presence   (orange)   or   absence   (black)   of   variable   orthologs   (n  
=16,412)   in  C.   sporogenes   and  C.   botulinum   group   I   genomes   was   used   to   perform  
hierarchical  clustering  using  a  complete   linkage  across  a  centered  Pearson  correlation.  
(B)  Identification  of  143  orthologs  genes  that  are  present  in  the  genomes  of  7  out  of  8  C.  




Eleven  signatures   from   the  set  of  C.  sporogenes  clade-­specific  genomes,  each  
representing   a   different   operon   or   function,   were   further   evaluated   and   annotated   for  
potential  use   in  PCR  assays.  The  candidate  signatures  were  selected   from   throughout  
the  C.   sporogenes  genome   in   order   to   evenly   sample   the   genome   backbone.  Manual  
curation  of  bioinformatic  evidence  was  used  to  infer  the  putative  function  of  each  gene,  
and  these  annotation  assignments  are  summarized  in  Table  2.  
  
Table  2.3.  Clostridium  sporogenes  clade-­specific  gene  signatures.  a  The  pairs  of  
primer  sequences  represent  forward  (top)  and  reverse  (bottom)  primers.  
  
  
A   total   of   24   nontoxic   lipase-­positive   strains   presumptively   identified   as   C.  
sporogenes   were   selected   from   the   CDC   culture   collection   to   test   the   efficacy   of   C.  
sporogenes   clade-­specific   PCR   assays   targeting   the   identified   gene   signatures.  While  
PCR  results  were  variable  for  some  genes,  a  subset  of  five  loci  (hsdMSR,  thiHG,  lipAS,  
























(Figure  2.3).  These  five  conserved  signatures  distinguished  the  24  nontoxic  strains  into  
two   groups;;   those   positive   for   the   presence   of   all   five   signatures   (referred   to   as  
“signature   positive”;;   18   strains)   and   those   negative   for   all   five   signatures   (“signature  
negative”;;  6  strains).    
  
  
Figure   2.3.  Gene   signature   by   PCR.   The   results   of   gene   signature   PCR   assays   for  
each  locus  are  shown  in  the  columns,  which  are  labeled  across  the  top.  The  presence  of  
a  PCR  product   for  each  assay  among  the  strains  examined  (indicated  to  the   left  of   the  
figure)   is   indicated  in  red.  The  dotted  box  indicates  the  loci   that  demonstrated  invariant  
PCR  results  among  the  strains  examined.  
  
Three  putative  C.   sporogenes  strains  were   selected   for   genome  sequencing   to  
determine  whether  the  genetic  signatures  detected  by  PCR  were  predictive  of  the  clade  
assigned   by   core   genome   phylogeny.   As   expected,   strain   CDC23284,   which   was  















CDC24533  and  CDC24442  were  signature  negative,  but  only   the  CDC24533  clustered  
with   the   group   I  C.   botulinum   clade,   while   strain   CDC24442   formed   a   distinct   cluster  
(Figure  2.1).  Notably,  the  genome  sequences  of  these  three  strains  were  also  consistent  
with  the  16S  rRNA  gene  sequence  analysis  of  all  24  strains  (i.e.,  strains   lacking  the  C.  
sporogenes   clade-­specific   signatures   based   on   PCR   analysis   were   phylogenetically  
distinct  from  strains  containing  the  signatures.  The  16S  rRNA  gene  sequences  of  strains  
CDC23284   and   CDC24533   differed   by   0.3%   compared   to   each   other   and   by   ~1%  
compared   to   strain   CDC24442.   Strain   CDC24442   shares   16S   rRNA   gene   sequence  
identity   with   C.   sporogenes   subsp.   tusciae   biovar   pennavorans   (39)   and   clearly  
represents   a   distinct   species,   consistent   with   its   distinct   position   in   the   core   genome  
phylogeny.  
Since   neurotoxin   gene   loss   should   not   affect   core   genome   phylogenetic  
reconstruction,  we  also  sequenced  the  genomes  of  two  additional  pairs  of  strains  where  
a   toxic   and   spontaneous   nontoxic   isolate   were   available.   C.   botulinum   type   B   strain  
CDC68016  was  isolated  from  the  stool  of  an  infant  with  botulism,  and  a  non-­  toxic  isolate  
(CDC68016NT)  was  also  obtained  during  its  laboratory  cultivation.  Both  strains  clustered  
with   the  C.  sporogenes  clade   in   the  core  genome  phylogeny   (Figure  2.1).  While  strain  
CDC68016  was   initially  classified  as  C.  botulinum  based  primarily  on   the  production  of  
botulinum  neurotoxin,  this  strain  and  its  nontoxigenic  progeny  (CDC68016NT)  are  more  
appropriately   viewed   as   belonging   to   the   C.   sporogenes   clade   based   on   their  
phylogenetic  relationships.  These  findings  also  suggest  that  the  type  B  neurotoxin  gene  
present  in  strain  CDC68016  was  horizontally  acquired,  presumably  from  a  C.  botulinum  
donor.   Conversely,   the  C.   botulinum   type   Ab   strain   CDC41370   (isolated   from   a   food  
source)   and   its   corresponding   nontoxic   derivative   (CDC41370NT)   clustered   within   the  
group  I  C.  botulinum  clade.  
In  order  to  examine  whether  strains  containing  the  same  toxin  gene  variant  would  
belong   to   the   same   genomic   clade,   we   sequenced   strain   CDC66221.   This   strain  
contains  the  bont/B6  variant  (Figure  2.4),  similar  to  strains  Osaka05  and  Okyama2011,  
which  belong  to  the  C.  sporogenes  clade  (Figure  2.1).  However,  core  genome  phylogeny  
placed  strain  CDC66221  within  the  C.  botulinum  clade.  Hence,  strain  CDC66221  can  be  
considered   a   member   of   C.   botulinum   according   to   a   genome-­based   taxonomy,  
suggesting  that  strains  with  the  same  neurotoxin  gene  variant  do  not  always  group  within  
the  same  clade.  
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To  better   appreciate   the   frequency  of   horizontal   exchange  of   neurotoxin  genes  
between   strains   belonging   to   either   the   C.   botulinum   or   C.   sporogenes   clade,   we  
analyzed   four   additional   C.   botulinum   type   B   strains   (Prevot1662,   ATCC   51387,  
Prevot25   NCASE,   and   ATCC   7949)   containing   the   neurotoxin   gene   variant   bont/B2  
(Figure  2.4).  Two  strains  (ATCC  51387  and  Prevot  1662)  were  positive  and  two  strains  
(ATCC  7949  and  Prevot  25  NCASE)  were  negative  or  the  C.  sporogenes  clade-­specific  
locus  hsdS  by  PCR   (data   not   shown).   Not   surprisingly,   the   two  hsdS-­negative   strains  
clustered  with   the  C.  botulinum  clade  and   the   two  hsdS-­positive   strains   clustered  with  
the  C.   sporogenes   clade   in   the   core   genome   phylogeny.   Taken   together,   these   data  
reveal  that  the  transfer  of  type  B  neurotoxin  genes  between  strains  belonging  to  clades  
representing  C.   botulinum   and  C.   sporogenes   has   occurred   in   multiple   genomes   and  
involved  different  bont/B  sequence  variants  (e.g.,  strains  ATCC  51387  and  Prevot  1662,  
carrying   bont/B2,   and   Osaka05   and   Okyama2011,   carrying   bont/B6;;   all   four   strains  
group  within  the  C.  sporogenes  clade).  
Comparison  of   the  bont/B2-­containing  genomes  of  C.  sporogenes  clade  strains  
ATCC  51387  and  Prevot  1662  with   the  bont/B1-­bearing  plasmid   (pCLD)  of  strain  Okra  
(Fig.   2.5A)   revealed   a   high   level   of   nucleotide   sequence   similarity.   These   findings   are  
consistent  with  the  presence  of  a  PCR  product  for  the  previously  described  PL-­6  plasmid  
marker   (40)   in   strains   ATCC   51387   and  Prevot   1662   (data   not   shown).   In   contrast   to  
these  strains,  which  may  have  acquired  bont/B2  via  the  transfer  of  plasmid  DNA,  the  C.  
botulinum   clade   strains   ATCC   7949   and   Prevot25   NCASE   appear   to   contain   bont/B2  
within  their  chromosomes,  colocated  within  the  oppA-­  brnQ  operon  (Figure  2.5B),  similar  










Figure   2.4.   Neighbor-­joining   tree   of   bont/B   sequences.   bont/B2   sequences   are   in  
blue,   and   bont/B6   sequences   are   in   red.   Representative   sequences   of   other   bont/B  
variants   were   retrieved   from   GenBank   as   follows:   B1,   strain   Okra   (NC_010379);;   B3,  
strain   CDC795   (EF028400);;   B4,   strain   17B   (EF051570);;   B5,   strain   CDC4013  


























Figure   2.5.   BLAST   analysis   of   draft   genome   sequences.   (A)   Genomes   were  
compared  using  BRIG  with  the  bont/B-­bearing  plasmid  (pCLD)  in  the  C.  botulinum  type  
B  strain  Okra  (GenBank  accession  number  NC_010379).  Genomes  shown  include  (from  
innermost  to  outermost  ring)  ATCC  7949,  Prevot  25  NCASE,  ATCC  51387,  Prevot  1662,  
Osaka05   (extrachromosomal   element   2),   Okayama2011,   CDC66221,   CDC41370NT,  
CDC41370,   CDC68016NT,   and   CDC68016.   Regions   with   >50%   nucleotide   identity  
compared   to   pCLD   are   shaded.   Shading   color   corresponds   to   the   bont/B   sequence  
variant,  as  follows:  blue,  bont/B2;;  red,  bont/B6;;  green,  bont/B5;;  and  purple,  bont/B1.  The  
positions  of   toxin  gene  cluster  genes  are   indicated  by  black  arrows.  (B)  The  nucleotide  
sequence   similarities   of   contigs   containing   the   bont/B   neurotoxin   gene   complex   from  
assembled  draft  genome  sequences  ATCC  7949  and  Prevot25  NCASE  were  compared.  
As   a   reference,   the   oppA-­brnQ   operon   of   C.   botulinum   type   A(B)   strain   NCTC2916  
(GenBank  accession  number  NZ_ABDO02000001)  was  also  compared  to  ATCC  7949.  
Regions  sharing  high  nucleotide  similarity  are  shaded.  
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Similarly,   the   genomes   of   bont/B6-­containing   strains   Okayama2011   and   CDC66221  
also   shared   a   high   level   of   similarity   with   pCLD.   The   sequence   of   a   185-­kb   extra-­
chromosomal  element   in  strain  Osaka05   (GenBank  accession  number  NZ_BA000059)  
also   contains   the   bont/B6   toxin   gene   cluster   but   shares   less   similar-­   ity   with   pCLD  
(Figure   2.5A).  While   all   three   of   these   bont/B6-­containing   strains   appear   to   carry   the  
toxin   gene   on   a   plasmid,   they   differ   with   respect   to   their   core   genome   phylogeny,  
suggesting  that  such  a  plasmid  may  be  able  to  exist  in  strains  of  either  the  C.  botulinum  
or  C.  sporogenes  clade.  
  
2.5  Discussion  
Previous  studies  have  highlighted   the  challenging   taxonomy  of  C.  botulinum  and  
C.  sporogenes  (7,  37).  In  one  study,  the  16S  rRNA  genes  gene  sequences  belonging  to  
110   Clostridium   species   were   compared   to   identify   molecular   markers   capable   of  
differentiating   various   Clostridium   species   (7).   However,   C.   botulinum   and   C.  
sporogenes  were  found  to  cluster  together  in  a  single  clade  of  the  resulting  phylogenetic  
tree.  Additionally,  comparative  analysis  of   in  silico  restriction  enzyme  digestion  showed  
that  both  species  have  exact  profiles  for  the  restriction  enzymes  AluI,  BfaI,  HaeIII,  RsaI,  
Tru9I,  and  SmaI.  The  digestion  profile  for  DpnII  demon-­  strated  that  C.  sporogenes  was  
segregated  into  two  separate  populations,  one  of  which  showed  exact  homology  with  C.  
botulinum  while   the   other  was   distinct   from   all   other  Clostridium   species.   These   data,  
along  with  variations  in  DNA-­DNA  hybridization  among  different  strains  of  C.  sporogenes  
compared  to  C.  botulinum  (4,  5),  suggest  that  C.  sporogenes  may  be  polyphyletic.  
More   recently,   Bradbury   et   al.   (37)   reported   the   genome   sequencing   and  
annotation   of   Clostridium   sporogenes   strain   PA3679,   which   has   been   used   as   a  
surrogate  for  group  I  C.  botulinum   in  thermal  processing  of  foods  for  over  70  years  (41,  
42).  The  percentage  of  shared  k-­mers  (k  =  25  bp)  between  the  C.  sporogenes  PA3679  
genome  and  several  genomes  of  C.  botulinum   revealed   that  more   than  85%  of   the  C.  
sporogenes  PA3679  genome  matches  group  I  C.  botulinum  strains  (containing  bont/A1).  
In  addition,  alignment  of  16S  rRNA  gene  sequences  indicated  a  99  to  100%  nucleotide  
similarity  between  PA  3679  and  several  proteolytic  C.  botulinum  strains,  as  well  as  other  
C.  sporogenes  strains.  
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In  this  study,  we  compared  draft  genome  sequences  to  resolve  C.  sporogenes  and  
C.  botulinum  group  I  strains  by  both  core  genome  phylogeny  and  variable  gene  content  
analysis.   Several   bont-­containing  C.   botulinum   group   I   strains,   such   as   Osaka05   and  
Okayama2011,   were   more   closely   related   to   C.   sporogenes   strains.   Recent   work   by  
Kenri  et  al.  (43)  using  whole-­genome  SNP  analysis  demonstrated  that  these  two  strains  
were   distantly   related   to   other  C.   botulinum   group   I   strains   examined.   These   results  
emphasize   the   conflictive   nature   of   taxonomic   designations   based   on   the   presence   or  
absence   of   the   botulinum   neurotoxin   gene,   which   does   not   reflect   true   phylogenetic  
relationships  between  strains.  
Kalia   et   al.   (7)   suggested,   “It   may   not   be   too   inappropriate   to   suggest   that   C.  
sporogenes  is  perhaps  a  sub-­species  of  C.  botulinum  or  it  may  find  its  appropriate  place  
if  C.  botulinum  can  be   reclassified  as  4  different   sub-­species”.  Our   results   support   the  
latter,  namely,   that  C.  sporogenes   is  a  distinct  species  of   the  genus,  closely   related   to  
group   I   C.   botulinum,   because   C.   sporogenes   strains   are   monophyletic   on   the   core  
genome  tree,  show   less   than  95%  ANI   to   their  group  I  C.  botulinum   relatives  but  more  
than   95%   ANI   among   themselves,   and   are   characterized   by   specific   genes   and  
pathways  that  are  rarely  found  in  their  relatives  (Table  2.3).  These  genes  may  underlie  
important  phenotypic  differences  between  C.  sporogenes  and  group  I  C.  botulinum  that  
remain  to  be  elucidated.  Identifying  the  associated  phenotypes  should  be  the  subject  of  
future   work   toward   developing   fast   diagnostic   tests   for   each   of   these   two   important  
bacterial   taxa.  While   it   is  possible   that  some  of   the  gene  signatures   for  C.  sporogenes  
may  be  found  in  other  clostridial  (or  even  non-­clostridial)  species,  phylogenetic  analysis  
would  likely  distinguish  C.  sporogenes  from  other  species.  
Among  a  panel  of  24  nontoxic  presumptive  C.  sporogenes   isolated  primarily  from  
clinical  samples,  18  were  positive  for  C.  sporogenes  clade  signatures.  While  the  majority  
of  BoNT-­producing  isolates  examined  in  this  study  belonged  to  the  C.  botulinum  group  I  
clade,  we  observed  some  type  B  toxin  producing  isolates  within  the  C.  sporogenes  clade  
suggesting   that   some   toxin   gene   variants   may   be   highly   mobile   between   these   two  
groups  of  organisms.  Consistent  with  these  findings,  Carter  et  al.  (44)  identified  only  one  
named  C.   botulinum   type   B   strain   that   grouped   together   with   various  C.   sporogenes  
strains  examined  based  on  hybridization  of  a  larger  collection  of  strains  against  a  ATCC  
3502-­specific  (a  group  I  C.  botulinum  type  A  strain)  DNA  microarray.  
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In  a  study  of  63  C.  botulinum  type  B  strains,  Franciosa  et  al.  (45)  found  that  more  
than  half  contained  bont/B  on  a  plasmid.  Interestingly,  neurotoxin  gene-­bearing  plasmids  
were  found  among  multiple  bont/B  sequence  variants.  At   least  some  of   these  plasmids  
are  likely  to  be  mobile  by  conjugation,  as  shown  by  Marshall  et  al.  (46).  These  findings  
are  consistent  with  the  results  reported  here  that  at  least  five  C.  sporogenes-­like  strains  
(CDC68016,  ATCC  51387,  Prevot  1662,  Osaka05,  and  Okayama2011)  appear  to  have  
acquired   the   neurotoxin   gene   via   the   horizontal   transfer   of   plasmid   DNA.   Similar   to  
another  report  (47),  we  also  observed  type  B  toxin  gene  loss  in  strains  CDC41370  and  
CDC68016.   The   non-­toxic   strain   CDC24533   belonging   to   the   C.   botulinum   clade,  
specifically  within  a  subclade  containing  strains  that  carry  their  toxin  genes  on  plasmids  
(36,   48),   presumably   underwent   plasmid   loss.   This   strain   was   isolated   from   necrotic  
tissue  of  a  leg  wound  and  was  not  associated  with  a  case  of  wound  botulism,  indicating  
that  loss  of  toxicity  by  this  strain  probably  occurred  prior  to  infection  of  the  wound  rather  
than  during  subsequent  laboratory  cultivation.    
Collectively,  these  results  further  support  the  conclusion  that  the  current  practice  of  
classifying  strains  as  C.  botulinum  or  C.  sporogenes  based  on  the  presence  or  absence  
of  the  botulinum  toxin  genes,  respectively,  cannot  be  highly  reliable  from  a  phylogenetic  
perspective,   because   toxin   gene   loss   can   result   in   confounding   classification   of   the  
resulting   nontoxic   progeny.   In   this   study,   two   strains   containing   bont/B2  on   a   plasmid  
were  associated  with   the  C.  sporogenes  clade,  while   strains  carrying   this  gene  on   the  
chromosome   were   located   within   the   C.   botulinum   clade.   Smith   et   al.   (49)   recently  
reported   that   the   genome   sequence   of   another   bont/B2-­containing   strain   (Prevot   594)  
with   its   neurotoxin   gene   on   a   plasmid  was  more   related   to   strain  Osaka05   than   other  
toxigenic  strains  examined,  suggesting  that  it  was  also  a  member  of  the  C.  sporogenes  
clade.  Similarly,   in  silico  multilocus  sequencing  typing  of  the  draft  genome  sequence  of  
C.  botulinum  strain  450   (isolated   from  a  case  of  wound  botulism  and   found   to   contain  
bont/B2)   demonstrated   a   close   phylogenetic   relationship   with   C.   sporogenes   strain  
ATCC   15579   (50).   Future   work   should   include   the   study   of   a   larger   population   of  
bont/B2-­containing  strains  to  determine  the  frequency  at  which  bont/B2  is  plasmid  borne  
among  strains  belonging  to  the  C.  sporogenes  clade.  The  results  presented  here,  which  
are  based  on  a  limited  number  of  strains,   indicate  that  the  transfer  of  neurotoxin  genes  
among  these  clades  may  not  be  a  rare  event.  
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2.6  Conclusions  and  recommendations  
Collectively,   the  results  presented  here  show  that  genome-­derived  data  can  offer  
robust  resolution  and  classification  of  C.  botulinum  or  C.  sporogenes  strains,  even  in  the  
presence   of   HGT.   These   approaches   provide   a   more   phylogenetically   accurate  
classification  C.  botulinum  and  C.  sporogenes  strains  and  promote  a  coherent  bacterial  
species   concept   for   these   groups.   Our   results   also   underscore   the   limitations   of   the  
current  bacterial  classification  system,  which  is  frequently  based  on  laboratory-­assessed  
phenotypes   that   can   be   easily   transferable   between   genetically   distinct   species,   while  
providing  an  example  of  how  to  advance  bacterial  classification  toward  a  genome-­based  
taxonomy.   This   work   should   be   applicable   to   additional   bacterial   taxa   that   are  
challenging  with  respect  to  classification.  
Distinguishing   C.   sporogenes   strains   from   C.   botulinum   isolates   that   have   lost  
toxicity   has   important   implications.   Since   nontoxic   isolates   from   distinct   phylogenetic  
clades  may  have  different  phenotypic  properties,  it  may  be  useful  to  consider  a  broader  
range  of   nontoxic  organisms   for  C.  botulinum  surrogates   (especially   in   food  protection  
studies)  than  simply  those  identified  as  C.  sporogenes.  
Genomic  and  metagenomic  approaches   for  microbial   identification  will   likely   lead  
to   fewer   laboratories   attempting   to   detect   botulinum   toxin   in   culture.   The   results  
presented  here  clearly  suggest  that  genomic  sequencing  technologies  are  highly  reliable  
and   robust   in   correctly   classifying   new   strains   and   assessing   their   toxin   production  
potential  (i.e.,   identification  of  neurotoxin  genes).  While   it   is  difficult   to  determine  based  
on   traditional   techniques   whether   a   nontoxic   strain   with   microbiological   properties  
resembling  proteolytic  C.  botulinum  or  C.  sporogenes  may  simply  be  the  result  of   toxin  
gene   loss,   the   genetic   signatures   developed   in   this   study   can   help   in   determining   the  
genomic  background  of   these  nontoxic  and   toxic  strains  and  also  correctly   interpreting  
previous   strain   classifications.   The   presence   of   C.   sporogenes   clade-­specific   genes  
would   provide   investigators   with   a   high-­confidence   genomic   signature   for   “true”   C.  
sporogenes   strains.   Nontoxic   strains   lacking   such   signatures   may   well   be   nontoxic  
isolates   of   C.   botulinum   and,   in   the   context   of   a   botulism   case   investigation,   may  
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Bacillus   anthracis   plasmids   pXO1   and   pXO2   carry   the   main   virulence   factors  
responsible  for  anthrax.  However,  the  extent  of  copy  number  variation  within  the  species  
and  how   the  plasmids  are   related   to  pXO1/pXO2-­like  plasmids   in  other   species  of   the  
Bacillus  cereus  sensu  lato  group  remain  unclear.  To  gain  new  insights  into  these  issues,  
we   sequenced   412   B.   anthracis   strains   representing   the   total   phylogenetic   and  
ecological   diversity   of   the   species.   Our   results   revealed   that   B.   anthracis   genomes  
carried,   on   average,   3.86   and   2.29   copies   of   pXO1   and   pXO2,   respectively,   and   a  
positive  linear  correlation  between  the  copy  numbers  of  pXO1  and  pXO2.  No  correlation  
between   the   plasmid   copy   number   and   phylogenetic   relatedness   of   the   strains   was  
observed.  However,  strains   isolated   from  animal   tissues  generally  maintained  a  higher  
plasmid   copy   number   than   genomes   of   strains   from   environmental   sources   (p<0.05,  
Welch  two  sample  t-­test).  Comparisons  against  B.  cereus  genomes  carrying  complete  or  
partial   pXO1   and   pXO2   -­like   plasmids   showed   that   plasmid-­based   phylogeny  
recapitulated  that  of  the  main  chromosome,  indicating  limited  plasmid  horizontal  transfer  
between  or  within  these  species.  Comparison  of  gene  content  revealed  a  closed  pXO1  
and   pXO2   pangenome,   e.g.,   plasmids   encode   <8   unique   genes,   on   average,   and   a  
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single   large   fragment   deletion   of   pXO1   in   one   B.   anthracis   strain   (2000031682)   was  
detected.  Collectively,  our  results  provide  a  more  complete  view  of  the  genomic  diversity  
of  B.  anthracis  plasmids,  their  copy  number  variation  and  the  virulence  potential  of  other  
Bacillus  species  carrying  pXO1/pXO2-­like  plasmids.    
  
3.2  Introduction  
Bacillus  anthracis,   the  etiological  agent  of  anthrax,   is  a  gram-­positive  endospore-­
forming  bacterium  belonging  to  the  Bacillus  cereus  sensu  lato  group  (1,  2).  The  spores  
are   the   infecting   form   of   the   bacterium   and   can   remain   viable   in   soils   for   decades   as  
dormant,   highly   stable   spores   (2-­5).     B.  anthracis   has   two  circular,   extra-­chromosomal  
DNA  plasmids  named  pXO1  and  pXO2,  which  carry  the  major  virulence  factors  required  
for   pathogenesis   (6).   pXO1   carries   the   genes   that   encode   for   the   anthrax   toxin  
component:  the  protective  antigen  (PA),  the  lethal  factor  (LF)  and  the  edema  factor  (EF).  
These   proteins   act   in   binary   combinations   to   produce   the   two   anthrax   toxins:   edema  
toxin  (PA  and  EF)  and  lethal  toxin  (PA  and  LF)  (6-­8).    Plasmid  pXO2  harbors  the  genes  
that  encode   the  cap  operon  responsible   for   the  production  of  a  polyglutamate  capsule,  
which  allows  the  pathogen  to  evade  the  host  immune  response  by  protecting  itself  from  
phagocytosis  (6-­8).    
Given   the   severity   of   the   disease   and   the   fact   that   this  microorganism   can   be  
easily  turned  into  a  biological  weapon,  it  is  important  to  characterize  the  diversity  of  the  
two   plasmids   in   a   large   collection   of   strains.   Currently,   plasmid   detection   is   mainly  
accomplished   by   amplification   of   specific   markers   through   PCR   (6,   9).   Although   this  
approach   is   relatively   rapid,   it   can  miss  plasmids   that  have  diverged   in  sequence,  and  
cannot  reveal  the  full  gene  content  of  plasmids.  In  addition,  it  is  still  not  clear  what  is  the  
plasmid   copy   number   and   the   extent   of   copy   number   variation   among  members   of  B.  
anthracis.   (8).   For   example,   by   using   quantitative   PCR   (qPCR),   Coker   et   al.   (2003)  
reported   ratios  of  up   to  40.5  copies  of  plasmid  pXO1  and  5.4  copies  of  plasmid  pXO2  
per  genome  (7),  while  Pilo  et  al.  (2011)  reported  10.89  as  the  average  number  of  copies  
for  pXO1  and  1.59  for  pXO2  (10).  Using  digital  PCR  (dPCR)  in  three  isolates,  Straub  et  
al.   (2013)   reported   that   there  are   likely  3-­4   copies  of   pXO1  per   cell   and  1-­2   copies  of  
pXO2  (11).  Sequence-­based  projects  have  also  revealed  that  there  are  likely  2-­3  copies  
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of  pXO1  per  chromosome  copy  (12).    An  important  limitation  in  these  previous  estimates  
is  that  they  have  been  performed  in  a  relatively  small  number  of  isolates,  which  can  bias  
the  characterization  of  the  ‘true’  population  copy  number  variation.    In  addition,  previous  
studies   have   shown   that   virulence   of  B.   anthracis   strains   carrying   both   plasmids   can  
differ,  depending  on  the  copy  number  of  the  plasmids  (7).  These  results  underscore  the  
necessity  to  accurately  quantify  plasmid  copy  variation  in  a  large  collection  of  diverse  B.  
anthracis   isolates,   and   evaluate   if   copy   variation   is   a   phylogenetically   conserved   trait.  
High-­throughput,   sequence-­based   methods   can   not   only   detect   and   quantify   plasmid  
copy  number  but  also  to  elucidate  gene-­content  and  sequence  diversity,  which  ultimately  
allows  a  better  understanding  of   the  pathogenomic  evolution  within   the  group  and  with  
other  close  relatives.    
Further,   the   B.   anthracis   genome   is   rich   in   mobile   elements   (transposases,  
resolvases  and  integrases),  which  could  be  an  important  factor  in  plasmid  gene  content  
diversification  and  horizontal  transfer  (13).  Whether  or  not  the  pXO1  and  pXO2  plasmids  
are  mobile  and  can  be  transferred  between  B.  anthracis  genomes  as  well  as  with  other  
members  of   the  Bacillus  cereus  sensu   lato  group,   remains  speculative,  but   it  might  be  
directly   related   to   the   virulence   of   the   genomes   and   the   evolutionary   history   of   the  
plasmids.  Gene   transfer   and  deletion  are  also   important   for   classification   since   strains  
are  typically  classified  based  on  their  plasmid  and  virulent  factor  content  (as  opposed  to  
phylogeny)  in  this  group.  
Finally,   the  phylogenetic  relationships  within  the  Bacillus  cereus  sensu  lato  (s.l.)  
group  are  still  problematic.  B.  anthracis  belongs  to  the  B.  cereus  sensu  lato  group,  which  
includes  besides  B.  anthracis  two  other  main  species:  B.  cereus  sensu  stricto  (s.s.)  and  
B.   thuringiensis   (14,   15).   These   species   were   initially   recognized   and   established  
because   they   exhibited   distinct   phenotypic   traits:   B.   anthracis   was   identified   as   the  
causative   agent   of   anthrax   (14),   B.   thuringiensis   was   recognized   as   an  
entomopathogenic   bacterium   characterized   by   the   production   of   parasporal   crystal  
proteins   (Cry   and  Cyt),  which   have   been  widely   used   as   a   natural   pesticide   (15),   and  
finally,  B.  cereus  s.s.  was  initially  recognized  as  a  common  soil-­dwelling  microorganism  
but  it  was  later  found  to  colonize  the  invertebrate  guts  as  a  symbiotic  microorganism  (16,  
17).    
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DNA  hybridization  techniques,  16S  rRNA-­based  typing  and  Multilocus  Sequence  
Typing   (MLST)   schemes   have   progressively   revealed   that   these   species   are   more  
closely   related   than   initially   considered,   and   there   exist   limited   genomic   dissimilarities  
that   allow   differentiation   of   these   species   (18).   This,   and   the   fact   that   the   main  
phenotypic   traits   for   classification   are   carried   in   plasmids,   has   led   to   discussion   on  
whether   or   not   B.   cereus   s.l.   group   should   be   considered   as   a   single   species   with  
characterized   ecotypes   and   pathotypes   (15,   18).   Therefore,   full   genome   analysis   of  
newly   sequenced  B.   anthracis   strains   and   representative   strains   in   the  B.   cereus   s.l.  
group  is  critical  to  better  elucidate  the  true  phylogenetic  relationships  within  the  group.  In  
addition,   B.   cereus   strains   encoding   genetic   determinants   that   confer   pathogenic  
capabilities   similar   to   those   of   B.   anthracis   have   been   previously   described   (19-­23).  
Hoffmaster   et   al   (2004,   2006)   reported   the   isolation   of   B.   cereus   strains   producing  
anthrax-­like  diseases  in  humans  with  clinical  presentations  of  pneumonia  and  cutaneous  
lesions   in   North-­America   (20,   21).   More   recently,   Antonation   (2016)   reported   the  
isolation   of   four   atypical  B.   cereus   isolates   (designated   as  B.   cereus   biovar   anthracis)  
from  death  mammals  (chimpanzees,  gorillas,  elephants  and  goats)  in  West  and  Central  
Africa   (22).   These   isolates   harbored   virulence   plasmids   similar   to   those   of   classic  B.  
anthracis.    
We   have   also   recently   described   the   genome   of   B.   cereus   strain   LA2007,   a  
human-­pathogenic   isolate   carrying   a   pXO1-­like   plasmid   that   showed   99.70%  Average  
Nucleotide   Identity   (ANI)   with   B.   anthracis   Ames   pXO1   (24)   (Appendix   A.1).  
Interestingly,   the   pXO1-­like   plasmids   of   pathogenic  B.   cereus   strains   reported   to   date  
are  similar  but  not   identical   to   those   found   in  B.  anthracis.  Therefore,  determining  how  
diverse   are   the   anthrax-­like   plasmids   in   terms   of   genetic   backbone,   modularity   and  
phylogeny   is   critical   not   to   only   develop   more   accurate   detection   tools   but   also   to  
understand   the  pathogenomic  evolution  of   virulence  determinants  within   the  B.   cereus  
s.l.  group.    
In   this   study  we   used   next   generation   sequencing   data   to   detect,   quantify   and  
characterize   the   full   genomic   content   of   B.   anthracis   plasmids   pXO1   and   pXO2   in   a  
collection  of  412  newly  sequenced  strains  that  represent  well   the  global  diversity  of  the  
species  recovered  to  date.  We  also  compared  the  phylogenetic  diversity  of  B.  anthracis  
representatives  with  a  set  of  106  B.  cereus  sensu   lato  strains   that   included  pathogenic  
and  non-­pathogenic  strains  carrying  anthrax-­like  plasmids.    
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3.3  Materials  and  Methods  
3.3.1  Collection  description  
The   collection   of   genomes   analyzed   in   this   study   is   part   of   the   Zoonoses   and   Select  
Agent   Laboratory’s   historical   strain   collection   at   the   Centers   for   Disease   Control   and  
Prevention.   The   strains   included   in   the   study  were   acquired   from  human,   animal,   and  
environmental  sources  worldwide   from   the  1950s   to  2013.  The  complete  set  has  been  
deposited  in  the  NCBI  Sequence  Read  Archive  (SRA)  under  BioProject  ID  264742   
3.3.2  Growth  conditions,  DNA  extraction  and  sequencing  
DNA   from   isolates   was   extracted   using   QIAamp   DNA   Blood   Mini   Kit   (Qiagen,  
Valencia,   CA)   or   Maxwell   16   Instrument   (Promega,   Madison,   WI).   For   the   QIAamp  
extraction,  cells  were  grown  overnight  in  heart  infusion  broth  (Remel,  Lenexa,  KS).  Cells  
were  pelleted  by   centrifugation   for   10  min  at   5,000   x   g.  Broth  was   removed  and  DNA  
was  extracted  using   the  Qiagen  QIAamp  DNA  Blood  Mini  Kit   following  manufacturer’s  
protocol   for   isolating   gram-­positive   bacteria.     For   DNA   extractions   on   the   Maxwell  
instrument,   cells   were   grown   overnight   on   trypticase   soy   agar   with   5%   sheep   blood.  
Cells  were  mechanically  disrupted  by  vortexing  for  2  min  in  a  suspension  of  silica  beads  
and  TE  buffer.  The  suspension  was  centrifuged  for  30  seconds  at  10,000  x  g.  300  µL  of  
the  resulting  supernatant  was  used  for  DNA  extraction  following  manufacturer’s  protocol  
for   blood   and   cells.   Sequencing   was   performed   on   an   Illumina   GAIIx   using   TruSeq  
chemistry.    
3.3.3  Read  quality  control,  assembly,  and  gene  prediction  
Raw  reads  were  initially  screened  for  adaptor  sequences  using  Scythe  (32)  and  
trimmed  at  both  5’  and  3’  ends  based  on  a  PHRED  score  cutoff  of  20  using  SolexaQA++  
(33).  Reads  <  50  bp  after  trimming  were  discarded.  Quality-­filtered  reads  were  de  novo  
assembled   using   IDBA-­UD  with   pre-­corrections   (34)   and   the   percent   of   contamination  
and  genome  completeness  were  assessed  based  on  either  recovery  of  lineage-­specific  
marker   genes   using   CheckM   (35)   or   recovery   of   essential   genes   (single   copy)   in  
bacterial   and   archaeal   genomes   using   the   script   HMM.essential.rb   available   at  
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Enveomics   collection   (36).   Protein-­coding   sequences   were   predicted   using  
MetaGeneMark  (37),  and  16S  rRNA  gene  sequences  were  identified  using  barrnap  0.6  
(https://github.com/tseemann/barrnap).      All   predicted   genes   from   the   assemblies   were  
taxonomically  annotated  using  MyTaxa  (38)  and  the  taxonomic  distributions  of  adjacent  
genes   (in   windows   of   10   genes)   in   the   concatenated   assembly   were   inspected   for  
possible  contamination   through  barplots.  The  above-­described  methods  and  scripts   for  
read  quality  control,  assembly  and  gene  prediction  were  used  as  part  of  MiGA  (Microbial  
Genomes   Atlas),   a   system   developed   in   our   laboratory   for   data   management   and  
processing  of  microbial  genomes  and  metagenomes  (http://microbial-­genomes.org/).    
3.3.4  B.  anthracis  and  B.  cereus  s.l.  reference  genomes  
Assembled  sequencing  data   for  36  additional  B.  anthracis   and   raw  sequencing  
reads   for   130   B.   cereus   sensu   lato   reference   strains   were   downloaded   from   the  
nucleotide   database   or   the   Sequencing   Read   Archive   (SRA)   at   NCBI  
(http://www.ncbi.nlm.nih.gov/sra)  with  the  accession  numbers  described  in  Supplemental  
Table  2.  Reference  strains  were  processed   in  parallel  with  CDC  B.  anthracis  collection  
as   described   above.   After   quality   control   inspection,   26   B.   cereus   reference   strains  
showing   ≥   20%   contamination   as   calculated  with  CheckM   (see   above)  were   excluded  
from  the  analysis.  
3.3.5  Plasmid  copy  number  estimation  
Whole   genome   sequencing   enabled   us   to   estimate   the   copy   number   for   each  
plasmid  relative  to  the  chromosome  copies  in  each  sequence  library.  Copy  number  was  
estimated  as  the  ratio  of  the  average  number  of  reads  mapping  to  the  plasmid  and  the  
chromosome   with   ≥   95%   nucleotide   identity.   To   speed   up   computational   processing,  
read  sets  were   randomly  subsampled   to  a   level  where  conclusions  would  not   change.  
We   varied   library   sizes   and   calculated   the   pXO1   copy   number   for   three   libraries   of  
different  sizes  (large,  medium  and  small),  and  as  low  as  10%  of  the  library  size  did  not  
have   an   effect   in   copy   number   estimation.   Quality-­filtered   sequence   libraries   were  
therefore   subsampled   to   10%   of   their   size   and   blastn   mapped   to   three   targets:   the  
reference   B.   anthracis   Ames   ancestor   (GCF_000008445.1)   plasmids   pXO1  
(NC_007322.2)  and  pXO2  (NC_007323.2)  and  each  assembled  genome.  Read  depths  
were   calculated   for   each   library   using   the   function   ‘enve.recplot’   incorporated   in   the  R  
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package   ‘enveomics.R’   (36).   Using   the   same   R   function,   read   recruitment   plots   were  
generated  per  each  library  to  quantify  and  visualize  the  coverage  across  the  full  length  of  
the   reference   plasmids   and   determine   the   presence/absence   of   the   entire   plasmid.  
Presence  was  considered  true  if  the  calculated  average  sequencing  depth  across  the  full  
reference  was  ≥  2X  in  the  subsampled  library.  
3.3.6  Average  Nucleotide  Identity  (ANI)  distances  and  medoids  
The  Average  Nucleotide  Identity  (ANI)  (39,  40)  between  the  set  of  genomes  were  
calculated   using   the   command   line   interface   of   MiGA   (Microbial   Genome   Atlas,  
https://github.com/bio-­miga/miga).  Briefly,  MiGA  calculated  a  matrix  of  distances  with  1-­
ANI  for  all  pairs  of  genomes  considered  in  the  database.  After  this,  clusters  in  the  matrix  
were   identified  using   the  PAM  algorithm   (Partitioning  Around   the  Medoids)   (41)  with  k  
medoids,  where  k  was  determined  by  the  local  gain  in  the  average  Silhouette  width  (42)  
for  each   level  of  clustering  until  a  group  of   five  or   fewer  genomes  was   reached.  Here,  
medoids  are  representative  strains  in  the  diversity  space.  After  this,  a  dendrogram  was  
built  based  on  ANI  distances  (1-­ANI)  using  hierarchical  agglomerative  clustering  with  the  
Ward  criterion  (43).    
3.3.7  Phylogenetic  signal  in  plasmid  copy  number  
Phylogenetic  conservatism  of  plasmid  copy  number  was  determined  through  the  
calculation  of  the  Blomberg’s  K  statistic  (44)  included  in  the  function  ‘phylosignal’  of  the  
R  package  ‘Picante’  (45).  K  values  of  1  correspond  to  a  Brownian  motion  process,  which  
implies   some   degree   of   phylogenetic   signal   or   conservatism.  K   values   closer   to   zero  
correspond  to  a  random  or  convergent  pattern  of  evolution,  while  K  values  greater  than  1  
indicate  strong  phylogenetic  signal  and  conservatism  of  traits.  
3.3.8  Phylogenomic  relationship  of  plasmids  and  chromosome  based  on  ANI    
Large  contigs  (≥  500bps)  with  ≥  80%  identity  and  ≥  80%  query  coverage  to  either  pXO1  
or  pXO2  B.  anthracis  Ames  ancestor  reference  sequences  were  considered  to  be  pXO1  
or  pXO2  homologous  and  were  extracted  from  the  assemblies.  Dendrograms  based  on  
ANI  distances  were  built  for  the  plasmids  and  chromosomes  as  described  previously  and  
subsequently  compared  through  tanglegrams  using  the  R  package  Dendextend  version  
1.2.0  (46).  Statistical  correlation  between  pairs  of  dendrograms  was  evaluated  with  two  
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parameters:  Baker’s  Ω  index  correlation  (47)  and  the  cophenetic  distant  correlation  (48),  
both  of  them  included  in  the  R  package  Dendextend.    
3.3.9  Read-­based  genomic  gene  content  analysis  
   pXO1  and  pXO2  orthologs  genes  among  B.  anthracis  genomes  were  identified  
using  a  reciprocal-­best  match  (RBMs)  blastn  approach  as  described  in  Weigand  (2015)  
(49).   In   brief,   the   sequences   of   the   predicted   genes   in   the   plasmid   sequence   of   one  
strain  were  searched  against  the  predicted  genes  of  all  remaining  set  of  strains  in  a  pair-­
wise   fashion   using   blastn   (50).  Reciprocal   best  matches   (RBMs)  were   identified  when  
the  best  match  was  bidirectional  for  the  pair  of  strains  being  compared  and  there  was  at  
least   70%   nucleotide   identify   and   70%   query   gene   coverage   using   rbm.rb   (36).   Next,  
orthologous   groups   (OGs)   in   reciprocal   best   matches   were   identified   using   the  
unsupervised   Markov   Cluster   algorithm   (MCL)   implemented   in   ogs.mcl.rb   in   the  
Enveomics  collection  (36)  with  default  settings:  1.5  inflation  parameter  and  Bit-­score  as  
parameter   to   weight   edges.   Descriptive   statistics   on   the   set   of   orthology   groups  were  
estimated   using   the   script  ogs.stats.rb   (Enveomics   collection).  Genes   conserved   in   all  
genomes  were  denoted  as  core  orthologous  genes.  Genes  conserved   in  some  but  not  
all   of   the   strains   were   identified   as   variable   orthologous   genes.   Representative  
orthologous  genes   from  the  previous  analysis   (including  both  core  and  variable  genes)  
were  randomly  selected  and  extracted  to  generate  a  pangenome  or  ‘bag  of  genes’.    To  
better   determine   the   presence/absence   of   the   genes   included   in   the   pangenome,   we  
recruited   raw   sequencing   reads   against   the   predicted   genes   on   the   plasmid.   For   this,  
FastA  libraries  were  subsampled  to  500,000  reads  per  sample  and  mapped  against  the  
set   of   representative   orthologous   genes   using   blastn.   The  maximum  number   of   target  
sequences   in   the   database   was   set   to   1   (best   match).   After   this,   the   observed   and  
estimated  sequencing  depth  as  well  as   the  number  of   reads  mapping   to  each  gene   in  
the   database   was   calculated   using   the   script   ‘BlastTab.seqdepth_ZIP.pl’   from   the  
enveomics   collection   (36)   assuming   a   Zero-­Inflated   Poisson   Distribution   to   correct   for  
non-­covered  positions  with  parameters  estimated  as  described   in   (Beckett,  2014)   (51).  
Orthologous  genes  with  zero-­inflation  ≥  0.3,  which  represent  the  fraction  of  the  gene  that  
is  not   covered,  were  excluded.   In  other  words,  only  genes  with  ≥  70%  coverage  were  
considered   to   be   present.   The   calculated   average   sequencing   depth   for   the   genes   in  
pXO1  was  32.2X  and  for  the  genes  in  pXO2  was  19.9X.  To  determine  the  copy  number  
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of   the  genes   in  each  plasmid,   the  sequencing  depth   calculated   for  each  gene   in  each  
strain   was   normalized   by   the   median   sequencing   depth   of   each   strain   and   reported  
through  a  dendrogram  of  hierarchical  clustering.    
  
3.3.10   Genomic   characterization   of   B.   anthracis   and   B.   cereus   strains   carrying  
pXO1  and/or  pXO2-­like  plasmids  
Orthologous   genes   among   B.   anthracis   medoids   and   B.   cereus   genomes  
carrying  anthrax-­like  plasmids  were  identified  through  the  reciprocal-­best  match  (RBMs)  
blastn   approach   as   described   above.      Core   genes   were   extracted   and   aligned   to  
estimate  phylogenetic  relationships  between  B.  cereus  and  B.  anthracis.  The  set  of  core  
genes  were  filtered  to  remove  in-­paralogous  genes  and  aligned  using  MUSCLE  v3.8.31  
(52)  with  default  parameters.  The  aligned  outputs  were  saved   in  FastA   format  and   the  
script  Aln.cat.rb   from   the   Enveomics   collection   was   used   to   concatenate   the   multiple  
alignments  into  a  single  file  and  to  remove  invariable  sites,  defined  as  columns  with  only  
one  state  and  undefined  characters.  Phylogenetic   reconstructions  were  performed  with  
either  RAxML  version  8.1.21  (53)  or  or  FastTree  version  2.1.7  (60)  with  the  GTR  model  
for   nucleotides   in   both   cases.   On   the   other   hand,   the   collection   of   variable   genes,  
defined  as  genes  absent  in  1  or  more  genomes,  were  identified  as  described  above  and  
the   presence   or   absence   of   these   variable   genes   was   used   to   cluster   genomes  
hierarchically  using  a  complete  linkage  across  a  centered  Pearson  correlation  similarity  
using  the  function  ‘heatmap2’  contained  in  the  R  package  gplots  v3.0.1  (https://CRAN.R-­
project.org/package=gplots).   Functional   annotation   of   variables   genes   was  
bioinformatically   inferred  through  a  BLASTp  search  against  the  RefSeq  protein  and  the  
UniProtKB/Swiss-­Prot   databases   with   percent   identity   greater   than   45%   and   minimal  
query  coverage  of  70%.    
Tests   for   incongruence   between   phylogenetic   trees   were   calculated   using   Tree  
Puzzle   5.2   and   Maximum   Likelihood   (ML)   (55).   ML   analysis   was   carried   out   using  
empirically   derived   base   frequencies,   transitions   to   transversions   ratio   estimated   from  
dataset,  the  HKY  model  of  substitution,  a  gamma  distribution  model  for  site  rate  variation  
with   α-­parameter   estimated   from   dataset   and   four   (4)   gamma   rate   categories.  
Topological   variability   or   distances   among   trees   derived   from   individual   orthologous  
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genes  (OGs)  were  calculated  using  the  Kendall  and  Colijn  metric  (61)  implemented  in  R  
package   ‘treeSpace’   (62).   Tanglegram  entanglements  were   calculated  as  described   in  
(46).    
  
3.4  Results    
3.4.1  Estimated  plasmid  copy  number  and  covariance    
In   this   study,   a   total   of   412   B.   anthracis   strains   were   newly   sequenced.   The  
whole-­genome   comparison   of   these   genomes   will   be   reported   elsewhere;;   here,   we  
focused  our  analyses  on  the  plasmid  sequences.  Libraries  had  an  average  sequencing  
depth   of   135.4X   with   a   median   value   of   128.3X   and   a   minimum   value   of   9.8X.   To  
estimate   pXO1   and   pXO2   copy   number,   we   calculated   the   ratio   of   plasmid   sequence  
depth   (using  B.   anthracis  Ames   ancestor   plasmid   sequences   as   references   to   recruit  
reads)  to  the  average  sequencing  depth  for  the  chromosome.  We  identified  a  total  of  58  
and   42   strains   that   completely   lacked   pXO1   and   pXO2,   respectively,   or   had   too   few  
reads   (i.e.,   <2X   sequencing   depth   after   subsampling;;   see   Materials   and   Methods   for  
details)   mapping   on   the   plasmid   (i.e.,   42   and   62   strains   for   pXO1   and/or   pXO2,  
respectively),  and  therefore  were  not  included  in  the  estimations.    
By   calculating   the   ratio   of   plasmid   to   chromosome   sequencing   depth,   we  
estimated   that   B.   anthracis   cells   maintain   on   average   3.86   copies   of   plasmid   pXO1  
(Stdev   =1.27)   and   2.29   copies   of   pXO2   (Stdev   =0.54)   indicating   a   general   pattern   in  
which   there   are   almost   twice   (1.68   times)   as   many   copies   of   pXO1   relative   to   pXO2  
(Figure   3.1A).   In   addition,  we   observed   a   large   variation   in   copy   number  where   some  
strains   carried   up   to   7.8   copies   of   pXO1,   contrasting  with   pXO2,  where   the  maximum  
number   of   copies   was   4.5   and   it   was   generally   less   variable.   We   also   observed   a  
considerable   degree  of   positive   linear   correlation   between   the   copy   numbers   of   pXO1  




Figure   3.1.   Copy   number   estimation   of   Bacillus   anthracis   plasmids   pXO1   and  
pXO2.   (A)  Plasmid  copy  number  distribution  calculated   for  strains  carrying  one  or  both  
plasmids.   We   estimated   that   B.   anthracis   cells   maintain   in   average   3.86   copies   of  
plasmid  pXO1  and  2.29  copies  of  pXO2  indicating  a  general  pattern   in  which  there  are  
almost   twice   (1.68   times)   as   many   the   number   of   pXO1   than   pXO2.   (B)   Correlation  
analysis   between   pXO1   and   pXO2   estimated   copy   number   showed   a   high   degree   of  
linear  positive  correlation  (Pearson’s  r  =  0.68,  Spearman’s  ρ=0.62).  Red  line  shows  the  
estimated  linear  regression  model  and  the  dashed  blue  lines  depict  the  upper  and  lower  
confidence  intervals  at  95%.    
  
3.4.2  Plasmid  copy  number  variation  and  genomic  relatedness    
   Next,   we   evaluated   whether   plasmid   copy   number   in   B.   anthracis   is   a  
phylogenetically  conserved  trait.  To  test  this  hypothesis,  we  calculated  the  Blomberg’s  K  
statistics   (43),   which   relates   the   amount   of   phylogenetic   signal   to   expectation   under  
Brownian   motion   of   character   evolution   using   a   dendrogram   derived   from   an   ANI  
distance   tree   (Figure   3.2).   We   observed   no   correlation   between   the   plasmid   copy  
number   and   genome-­average   nucleotide   identity   (ANI)   distances   among   strains  
(Blomberg’s  K  =  0.013,   for  pXO1  and  K  =  0.014,   for  pXO2;;  and  Figure  3.2),   indicating  
that   plasmid   copy   number   is   not   phylogenetically   conserved.   Thus,   closely   related  
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Figure  3.2.    Lack  of  phylogenetic  conservatism  of  Bacillus  anthracis  plasmid  copy  
number.  Dendrogram  was  constructed  based  on  the  Average  Nucleotide  Identity  (ANI)  
distances  calculated   for  412  B.  anthracis  strains.  Presence  or  absence  of  pXO1  (inner  
circle   in   blue)   and   pXO2   (inner   circle   in   red)   and   estimated   plasmid   copy   number  
(barplots)  are  shown.  Strains  with  high  and  low  plasmid  copy  numbers  were  found  to  be  
dispersed   across   the   three   main   clades   A   (397),   B   (12)   and   C   (3),   and   no   apparent  
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3.4.3  Plasmid  copy  number  depends  on  source  of  isolation  
To  evaluate  any  correlation  existing  between  the  estimated  plasmid  copy  number  
and  the  source  of  the  strains,  a  comparative  analysis  was  performed  on  127  strains  for  
which   biological   source   information   was   available.   Biological   source   was   defined   as  
human,   animal   or   environmental   based   on   the   sample   from   which   each   strain   was  
isolated.   Results   showed   that   B.   anthracis   isolated   from   human   and   animal   sources  
generally   maintained   a   higher   plasmid   copy   number   than   strains   isolated   from  
environmental  sources  (p  =  9.7e-­5  for  pXO1  and  p  =  0.05  for  pXO2,  Welch  two  sample  t-­
test)  (Figure  3.3).    
To  exclude  the  possibility   that   this  observation  was  the  result  of  DNA  extraction  
method,  given  that  two  protocols  were  implemented  (Qiagen  and  Promega;;  see  Methods  
and  Materials  for  further  details),  we  performed  a  two-­sample  t-­test  analysis  comparing  
plasmid   copy   number   between   the   two   extraction   methods.   The   results   reveled   no  
significant  difference  (p  =  0.11  for  pXO1;;  p  =  0.81  for  pXO2).  In  addition,  we  performed  
an  analysis  of  variance  (ANOVA)   to  determine   the   influence  of  DNA  extraction  method  
and   biological   source   (two   independent   variables)   in   explaining   the   values   of   plasmid  
copy  number  (the  continuous  dependent  variable).  The  results  showed  that  the  variation  
explained  by  the  biological  source  was  significant  (F  =  6.23,  p  =  0.01)  while  the  variation  



















Figure   3.3.   Plasmid   copy   number   depends   on   source   of   isolation.   B.   anthracis  
isolates  obtained  from  animal  sources  (both  human  and  animal)  maintain,   in  general,  a  
higher   plasmid   copy   number   than   strains   isolated   from   environmental   sources.   Top:  
distribution   of   pXO1   (left)   and   pXO2   (right)   copy   number   for   each   group   of   genomes.  
Boxplots  represent  the  first  and  third  quartile  and  the  horizontal  segment  represents  the  
median  value.  Bottom:  table  with  the  statistic  of  the  copy  number  distribution  observed.  
Note   that   the   average   number   of   pXO1   plasmids   in   strains   from   animal   origin   was  
significantly   higher   than   the   mean   copies   estimated   for   strains   obtained   from  
environmental   samples   (p-­values   were   calculated   based   on   parametric  Welch’s   two  
sample  t-­test).  
  
3.4.4  Plasmid-­  vs.  chromosome-­based  phylogenetic  relationships  
To   determine   whether   plasmid-­based   ANI   clustering   resembled   that   of   the  
chromosome,  we  analyzed  strains  for  which  plasmid  pXO1  and/or  pXO2  were  detected,  
in   addition   to   36  B.   anthracis   reference   strains   that  were   sequenced   previously.   Initial  

































N Mean SD p"value N Mean SD p+value 
Total 125 127 
Animal 65 4.55 1.59 69 2.41 0.56 
Environmental 60 3.58 1.07 9.7e+05*** 58 2.22 0.47 0.05* 
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showed  that  the  total  set  of  strains  were  grouped  in  three  main  clades:  A  (397  strains),  B  
(12  strains)  and  C  (3  strains),  with  clade  A  containing   the  majority  of  strains,  similar   to  
what   has   been   previously   described  with   other   typing  methods   such   as  multiple-­locus  
variable-­number   tandem   repeat  analysis   (MLVA)   (Figure  3.2).  When  we  compared   the  
clustering  profile  for  both  plasmids  versus  that  of  the  chromosome,  we  observed  a  high  
topological  correlation.    To  quantify  the  strength  of  the  correlation  we  used  two  metrics:    
the   cophenetic   distance,   defined  as   the   intergroup  distance  at  which   two  observations  
are   first   combined   into   a   single   cluster,   and   the  Baker’s  Ω   index,   defined   as   the   rank  
correlation  between   the  stages  at  which  pairs  of  observations  combine   in  each  one  of  
the  two  dendrograms  being  compared.  For  pXO1,  the  calculated  cophenetic  correlation  
was   0.70   and   the   Baker’s   Ω   index   correlation   was   0.62.   For   pXO2,   the   calculated  
cophenetic  correlation  was  0.89  and  the  Baker’s  Ω  correlation  was  0.93,  which  indicated  
that,  in  general,  pXO1  and  pXO2  phylogenies  recapitulate  that  of  the  chromosome.  
  
3.4.5  Gene  content  variation  of  pXO1  and  pXO2  
To  avoid   limitations  of   the  assembly   process   such  as  gaps  or   truncated  genes  
and  mis-­assemblies,  we  assessed  gene  content  variation  of   the  plasmids  by   recruiting  
high-­quality   (trimmed)   Illumina   reads   against   the   predicted   genes   on   the   plasmid   and  
determining   gene   presence/absence   by   the   number   of   reads   recruited   (or   not)   on   the  
gene.   Genomes   containing   one   or   both   plasmids   showed   a   highly   conserved   gene  
content  in  general  (Figure  3.4AB).    
The  calculated  pXO1  pangenome  was  composed  of  197  orthologous  genes;;  179  
of  them  (91%)  were  present  in  all  strains  (strict  core),  195  (99%)  were  present  in  at  least  
95%  of   all   the   strains   (relaxed   core)   and  only   two  genes  were   found   to  be   variable   in  
pXO1.  108  genes  composed  the  pXO2  pangenome;;  96  genes  were  part  of  the  strict  core  
(89%)   while   102   genes   were   part   of   the   relaxed   core.   Only   6   genes   composed   the  
variable   genome.   Although   no   large   plasmid   gene   content   diversity   was   generally  
observed  between  any  two  genomes  analyzed,  we  identified  a  large  fragment  deletion  in  
the  pXO1  plasmid  of  one  strain:  2000031682  (Figure  3.4C).  The  deleted   fragment  was  
about  ~46.3  Kb   in   length  and  contained  39  genes   in   total,   including   the  main  virulence  
factors  responsible  for  anthrax  toxin:  cya,  pagA  and   lef  and  the  transcriptional  activator  
 56 
atxA.  We   also   identified   a   number   of   integrases,   resolvases   and   transposases   in   and  
around   the   deleted   fragment   (Figure   3.4D).   Re-­sequencing   and   re-­assembling   of   this  
particular  strain  confirmed  the  large  gene  deletion.    
In   addition,   we   identified   orthologous   genes   present   in   both   plasmids   that  
showed   higher   sequencing   depth   compared   to   the   majority   of   plasmid   genes.   These  
genes  were  most  likely  multi-­copy  genes.  In  pXO1  we  identified  three  multi-­copy  genes  
that  were  observed  to  have  two  copies,  on  average,  consistently  across  the  complete  set  
of  strains.  In  pXO2,  we  identified  three  genes  with  consistent  multi-­copy  pattern  in  most  
of  the  strains  characterized  in  this  analysis.  In  both  plasmids,  these  genes  corresponded  





Figure  3.4.  Gene  content  variation  of  pXO1  and  pXO2.  (A)  Hierarchical  clustering  of  
B.   anthracis   strains   containing   plasmid   pXO1   (columns)   based   on   the   estimated  
sequencing   depth   for   each   representative   orthologous   gene   (rows)   normalized   by   the  
median  sequencing  depth   for  each  genomic   library   (columns).   (B)  Shows   the  same  as  
(A)   but   for   plasmid   pXO2.   (C)   Read   recruitment   plot   showing   the   absence   of   read  
coverage   in   strain   2000031682   in   a   region  of   ~   46.3Kbp  while   the   calculated  average  
sequencing  depth  of  the  covered  region  was  144X.  (D)  Circular  plot  comparing  pXO1  in  
B.  anthracis  strain  Ames  ancestor  (in  green)  and  strain  2000031682  (in  purple).  Mapping  
coverage   from   sequencing   reads   of   strain   2000031682   along   the   plasmid   is   shown   in  
blue   (innermost   circle).   The   deleted   fragment   is   shown   along   with   the   functional  
annotation   of   the   genes   identified   in   the   region.   Red   arrows   denote   the   position   and  
strand  of  anthrax  virulence  determinant  genes  identified  in  the  missing  region  while  blue  
arrows   identify  mobile  elements  and  black  arrows  denote  genes  encoding  hypothetical  
proteins.  
  
3.4.6  Comparison  to  pXO1/pXO2-­like  plasmids  of  other  members  of  the  B.  cereus  
sensu  lato  group    
To   increase   understanding   of   the   evolutionary   relationships   of   B.   anthracis  
plasmids   with   those   of   other   (non-­B.   anthracis)  members   of   the  B.   cereus   sensu   lato  
group,   we   performed   an   ANI-­based   clustering   analysis   of   selected   strains   from   our  
dataset  together  with  available  reference  B.  cereus  s.l.  strains.  The  final  set  included:  94  
B.  cereus  strains,  11  representative  B.  anthracis  strains  identified  from  our  dataset,  11  B.  
thuringiensis  strains  and  one  B.  mycoides  isolate.  Results  showed  that  strains  clustered  
in   3  main   groups:   clade   I,   clade   II   and   clade   III   (Figure   3.5A).   Representative   strains  
from  B.   anthracis   were   grouped   in   clade   I,   the   same   group   where   several  B.   cereus  
isolates  of  clinical  origin  were  placed.  The  majority  of  B.  thuringiensis  strains  (7  out  11)  
were   grouped   in   cluster   III,   although   four   of   them   were   assigned   to   clade   I.   These  
relationships  were  consistent  with  previous  phylogeny  characterization  based  on  MLST  
schemes  or  chromosomal  core  proteins,  which  have  shown  that  B.  cereus,  B.  mycoides  
and   B.   thuringiensis   are   not   confined   within   discrete   clades   and   are   therefore,   not  
monophyletic  species  (26-­28).    
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   We  then  attempted  to  identify  non-­B.  anthracis  genomes  that  carried  a  complete  
or  partial  genomic  backbone  with  pXO1  and/or  pXO2.  To  achieve  this  goal,  we  followed  
two   approaches   since   our   genome   sequences   were   incomplete   (draft).   First,   we  
identified  large  contigs  (≥  500bp)  with  ≥  80  %  identity  and  ≥  80  %  sequence  coverage  to  
reference  pXO1  and  pXO2  plasmids  from  B.  anthracis  Ames  Ancestor  (we  called  these  
contigs   ‘pXO1/2-­like   contigs’);;   and   second,   we   generated   read   recruitment   plots   to  
visualize  and  quantify  the  sequencing  depth  coverage  provided  by  reads  of  the  genomic  
library  of  the  corresponding  strain  along  the  reference  plasmid  sequence  (see  Methods  
and   Materials).   We   identified   33   genomes   containing   pXO1-­like   contigs,   12   of   which  
were   assignable   to   clade   I,   two   to   clade   II,   and   20   to   clade   III.  We   also   identified   17  
strains  containing  pXO2-­like  contigs;;   four  were  assignable   to  clade   I,   three   to  clade   II,  
and  10  to  clade  III  (e.g.,  Fig.  3.5A).  Functional  characterization  of  the  genes  predicted  in  
pXO1-­like   contigs   (365   in   total)   showed   that   the   majority   of   those   genes   were  
hypothetical   proteins   (97%)   and   only   42   genes   (3%)   could   be   functionally   annotated.  
From   these,   five   genes   encoded   for   hyaluronan   synthase   (Figure   3.5B).   However,   no  
anthrax  toxin  genes  were  identified  among  these  sequences.  
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Figure   3.5.   Genomic   characterization   of   Bacillus   cereus   sensu   lato   group.   (A)  
Clustering  of  species  within  Bacillus  cereus  sensu  lato  group  based  on  ANI  distances.  B.  
anthracis  members  are  colored   in  yellow;;  B.  cereus  sensu  stricto  strains  are  colored   in  
pink;;  B.   thuringiensis   members   are   colored   in   green   and   the   single   representative  B.  
mycoides   is   colored   in  purple.  The   right   colored  strip   indicates   the  source  of   isolation.  
Filled  or  empty  circles  indicate  the  presence  (filled)  or  absence  (empty)  of  pXO1  (in  blue)  
and  pXO2  (in  red).  Filled  stars  denote  the  strains  for  which  pXO1-­like  (blue)  or  pXO2-­like  
(red)   contigs   were   identified.   (B)   The   number   of   functionally   annotated   (excluding  
hypothetical)   coding   sequences   predicted   in   pXO1-­like   contigs   (42   in   total,   3%   of   the  
total   number).   (C)   Example   of   B.   cereus   strain   VD014   showing   partial   pXO1-­like  
backbone  homologous  to  pXO1  from  B.  anthracis  Ames  Ancestor.    
  
We   also   added   to   the   analysis   described   above   11   previously   characterized  
pathogenic   B.   cereus   genomes   carrying   complete   pXO1   and/or   pXO2   plasmids.   In  
particular,   five   B.   cereus   biovar   anthracis   strains   (RCA_A_364-­1,   RCA_A_363-­2,  
DRC_14-­0024-­1,  CAM  and  CI),  which  were  isolated  from  dead  mammals  with  an  illness  
consistent   with   anthrax   (chimpanzees,   gorillas,   elephants   and   goats)   in   West   and  
Central  Africa  (23),  and  six  pathogenic  B.  cereus  strains   isolated  from  human  cases  of  
pneumonia   or   cutaneous   lesions   (G9241,   BcFL2013,   LA2007,   03BB87,   03BB102   and  
Elc2).   These   strains  were   compared   to   11   representative  B.   anthracis   genomes   (from  
our  dataset)  and  an  additional  B.  cereus  strain  (03BB108,  isolated  from  dust  at  the  same  
worksite  where  a  Texas  welder  contracted  fatal  pneumonia  in  2003),  that  carried  partial  
homology  to  the  backbone  of  pXO1.    
Clustering   analysis   based   on   ANI   dissimilarity   revealed   four   groups   (Figure  
3.6A):  one  highly  clonal  group  composed  by  B.  anthracis  strains  with  0.04  average  intra-­
group  ANI  distance  (i.e.,  99.96  identity),  the  second  group  was  composed  by  B.  cereus  
biovar   anthracis   isolates   which   was   also   highly   similar   with   an   average   of   0.03   ANI  
distance.   The   third   group,   which   we   labeled   as  B.   cereus   group   I,   was   composed   by  
three   B.   cereus   isolates   (03BB108,   03BB102   and   Ecl2)   and   had   1.01   average   ANI  
distance   among   them.   Finally,   the   fourth   group,   labeled   as   B.   cereus   group   II,   was  
composed  of  four  human-­pathogenic  B.  cereus  strains  (LA2007,  BcFL2013,  G9241  and  
03BB87)  and  showed  an  average  0.01   intragroup  ANI  distance,   the  smallest  observed  
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intragroup  diversity.  B.  cereus  group  II  was  the  most  divergent  to  all  other  groups,  with  
an  average  inter-­group  ANI  distance  of  5.27  (Figure  3.6B).    
  
  
Figure   3.6.   Genomic   characterization   of   B.   cereus   strains   carrying   complete  
anthrax-­like  plasmids.  (A)  Whole  genome  ANI  distance  tree  between  representative  B.  
anthracis   strains   and   pathogenic  B.   cereus   strains   carrying   anthrax-­like   plasmids.   (B)  
Average   intra-­   and   inter-­group   ANI   distance   calculated   for   the   set   of   strains   carrying  
anthrax   or   anthrax-­like   plasmids.   (C)   Read-­based   detection   and   characterization   of  
plasmids   pXO1   and   pXO2   in   anthrax-­like  B.   cereus   strains   isolated   from   human   and  
mammal   tissues   in   the   West   and   Central   Africa   and   North   America.   Strain   CI   was  
chosen  as  a  representative  strain  for  the  B.  cereus  biovar  anthracis  group.    
  
   Plasmid  detection  and  quantification  based  on   read  coverage  confirmed   that  all  
B.  cereus  biovar  anthracis  strains  carried  complete  pXO1  and  pXO2-­like  plasmids  while  
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strains   BcFL2013,  G9241,   03BB87,   LA2007   and  Elc2   harbored   a   complete   pXO1-­like  
but   not   a   pXO2-­like   plasmid   (Figure   3.5C).   03BB102,  which  was   isolated   from   a   fatal  
pneumonia  in  TX,  differed  from  these  other  strains  in  that  it  does  not  harbor  a  full  length  
pXO1   or   pXO2-­like   plasmid,   although   partial   sequence   homology   to   the   pathogenicity  
island  was   detected   (51.72%  of   the   total   genes   of   the   island  were   present).   (22).  Our  
sequence-­based  analysis   revealed   that   03BB102  harbors   the   typical   anthrax   virulence  
genes  but  lacks  about  half  of  the  canonical  pXO1  gene  content  (Figure  3.5C).    
Further   gene-­based   characterization   showed   that   this   plasmid   (p03BB102)  
carried  a  complete,  5.1  Kbp  pXO2  cap   locus  with  93%  nucleotide   identity   to   the  Ames  
strain   cap   locus   (accession   number   AE017335)   and   was   flanked   by   IS   elements.   In  
addition,   duplicate   homologs   of   protective   antigen   genes   (pagA   and   pagR)  were   also  
identified;;  one  homolog  showed  ~99%  nucleotide   identity   to   its  ortholog   in  pXO1  Ames  
Ancestor   while   the   second   showed   92%-­94%   (respectively),   indicating   that   these  
homologs   have   already   begun   to   diverge   (Figure   3.7).   Although   pXO1/pXO2-­like  
plasmids  seem  to  be  remarkably  conserved  in  terms  of  gene  content  and  synteny,  strain  
03BB102   is   an   exception   to   this   rule,   which   suggests   that   plasmid   diversity   in   nature  
may  be  higher  than  previously  thought.    
  
Figure   3.7.   Gene   content   comparison   between   B.   anthracis   pXO1/pXO2   and   B.  
cereus   strain   03BB102   plasmids.   The   connecting   lines   show   the   presence   and  
location  of  shared  genes  while  the  gray  scale  represents  the  level  of  nucleotide  identity.  





in   reference  pXO2  (B.  anthracis   ‘Ames  Ancestor’  accession  number  AE017335)  and   is  
flanked  by  IS  elements.  A  duplicate  homolog  of  pagA  and  pagR  genes  is  also  present  in  
p03BB102;;   one   homolog   showing   99%   identity   compared   to   its   pXO1   B.   anthracis  
homolog   (B.   anthracis   ‘Ames  Ancestor’   accession   number  AE017336)   for   both   genes,  
while  the  second  shows  92%  and  94%  respectively.    
In   addition,   we   also   calculated   plasmid   copy   number   in   the   set   of   B.   cereus  
strains   carrying   anthrax-­like   plasmids   (Table   3.1).   Sequencing   breath   (or   breadth   of  
coverage)   was   calculated   as   the   percentage   of   bases   of   the   reference   B.   anthracis  
Ames   Ancestor   plasmid   sequences   that   were   covered   by   reads   of   the   corresponding  
genome   (rows)   at   ≥   2X   sequencing   depth.   Plasmid   copy   number   was   estimated   as  
described   in   the   Materials   and   Methods   section.   The   estimated   average   pXO1   copy  
number   in   B.   cereus   biovar   anthracis   strains   was   1.8   while   for   the   set   of   human-­
pathogenic   B.   cereus   was   2.32,   which   was   similar   to   the   estimated   average   for   B.  
anthracis   (3.86).   For   pXO2,   the   estimated   average   copy   number   in   B.   cereus   biovar  
anthracis  was  2.12,  similar  to  the  estimated  copy  number  in  B.  anthracis  (2.29).    
  
Table   3.1.   Sequencing   breadth   and   copy   number   variation   of   pXO1   and   pXO2  

















CI' B.'cereus'bv.'anthracis' 99.90$ 99.35$ 1.3$ 1.1$
CAM' B.'cereus'bv.'anthracis' 99.91$ 99.17$ 1.8$ 0.8$
DRC_14G0024G1' B.'cereus'bv.'anthracis' 77.92$ 98.95$ 1.3$ 5.6$
RCA_A_364G1' B.'cereus'bv.'anthracis' 99.94$ 99.48$ 2.3$ 1.6$
RCA_A_363G2' B.'cereus'bv.'anthracis' 99.94$ 99.48$ 2.3$ 1.5$
FL2013' B.'cereus'GGII' 96.71$ 1.7$ 4.4$ -$
G9241' 'B.'cereus'GGII' 97.90$ 1.9$ 1.4$ -$
03BB87' B.'cereus'GGII' 96.89$ 1.8$ 1.0$ -$
LA2007' B.'cereus'GGII' 97.98$ 1.8$ 2.5$ -$
03BB102' B.'cereus'GGI' 51.72$ 6.5$ -$ -$
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3.4.7  Assessing  origin  and  vertical  vs.  horizontal  transmission  of  plasmids  
To   determine   if   the   pXO1/pXO2-­like   plasmids   have   been   transferred   between  
members   of  B.   cereus   and  B.   anthracis,   we   contrasted   the   phylogenetic   relationships  
among  the  genomes  based  on  the  chromosomal  genes  relative  to  those  of  the  plasmids.  
Phylogenetic   reconstruction   based   on   plasmid   core   orthologous   genes   of   the   strains  
harboring   a   complete   pXO1   (139   genes)   and/or   pXO2   (88   genes)   showed   a   similar  
topology   to   the   one   observed  with   whole   genome   ANI   distance   based   on   tanglegram  
analysis   (Figure  3.8A,   3.9B),   indicating   limited  mobilization  of   the  plasmids  among   the  
genome.  For   pXO1,  B.  cereus   biovar   anthracis   strains  were   closer   to   the  B.  anthracis  
group  than  they  were  to  the  set  of  human-­pathogenic  B.  cereus  group  II,  and  Elc2  was  
the  most  divergent  strain.  For  pXO2,   three  main  clades  were  observed,  one  containing  
all  B.  anthracis  strains,  one  containing  strain  B.  cereus  CI  and  one  clade  containing  the  
remaining  B.   cereus  biovar   anthracis   strains   (RCA_A_364-­1,  RCA_A_363-­2,  DRC_14-­
0024-­1,  and  CAM).  Strain  CI  was  more  similar   to   the  B.  anthracis  group  than   it  was   to  
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Figure   3.8.   Assessment   of   plasmid   lateral   transfer   between   representative   B.  
anthracis   and   pathogenic   B.   cereus   strains   carrying   complete   pXO1/pXO2-­like  
plasmids.   Comparison   of   phylogenetic   relationships   based   on   core   genome   for   the  
chromosome  and  pXO1   (A)  and   for   the  chromosome  and  pXO2   (B)   in  strains  carrying  
one   or   both   plasmids.   Phylogenetic   reconstructions   in   panel   A   were   based   on   the  
alignment   of   210,123   variable   positions   found   in   the   concatenated   alignment   of   4,233  
core  orthologous  genes  for  the  chromosome  and  458  variable  positions  identified  in  the  
concatenated   alignment   of   149   pXO1   core   orthologous   genes.   Phylogenetic  
relationships  in  panel  B  were  constructed  from  the  alignment  of  74,389  variable  positions  
found   in   the   concatenated   alignment   of   4,616   core   orthologous   genes   for   the  
chromosome  and  120  variable  positions   identified   in   the  concatenated  alignment  of  88  
pXO2   core   orthologous   genes.   No   signal   of   plasmid   lateral   transfer   between   both  
phylogroups  was  apparent.  
  
Further,  clustering  based  on  the  presence/absence  of  the  variable  genes  of  both  
plasmids  showed  a  similar  grouping  pattern   to   that  of   the  chromosome,   indicating   that  
(higher)   gene-­content   variation   largely   correlates   to   (higher)   genome   divergence.  
Collectively,  these  results  indicated  limited  horizontal  transfer  of  the  plasmid  between  B.  
cereus   and   B.   anthracis.   Accordingly,   B.   cereus   genomes   harboring   the   B.   anthracis  
plasmids  appear   to  have  maintained   these  plasmids  since   their   last   common  ancestor  
with   B.   anthracis.   However,   we   did   observe   topological   incongruences   between   the  
chromosome   and   pXO1   core   gene   trees   within   B.   anthracis   (entanglement   =   0.20),  
indicating   that   the   plasmid  might   have   undergone   horizontal   transfer  within   the   group.  
For   instance,   the   chromosome-­   versus   plasmid-­based   topologies   were   significantly  
incongruent  by  all   three   tests  applied,   i.e.,   the  one-­sided  Maximum  Likelihood  Kishino-­
Hasegawa   test   (KH)   (57),   the   Shimodaira-­Hasegawa   test   (SH)   (56)   and   the   expected  
likelihood  weight  test  (ELW)  (58)  (pval-­1sKH  =  0.005,  pval-­SH  =  0.002,  c-­ELW  =  0.002;;  
all  tests  were  applied  with  5%  significance  level  and  1,000  re-­samplings  using  the  RELL  
method).  However,   individual  gene-­level  assessment  showed   that   the  abovementioned  
topological   inconsistence   was   predominantly   due   to   recombination   and/or   varied  
selection   pressures   in   only   five   genes,   and  was   not   plasmid-­wide.  When   these   genes  
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were   removed   from   the   core   gene   alignment,   the   plasmid   tree   and   the   chromosome  
were   topologically  more   congruent   (entanglement   =   0.05).  We   also   observed   that   the  
complete   pXO1   and   chromosome   trees   grouped   in   the   same   cluster   (less   distance  
between   them)   in   a   low-­dimensional   representation   of   the   topological   variability   of   the  
trees   evaluated   using   the   Kendall   and   Colijn   metric   (see   methods   and   materials).  
Collectively,   our   analyses   revealed   no   strong   evidence   of   plasmid   lateral   transfer  
between  or  within  B.  anthracis  and  B.  cereus.    
  
3.5  Discussion  
In   this   study,  we  estimated  plasmid   copy  number   in  a   large  collection  of   newly  
sequenced   B.   anthracis   strains,   characterized   their   full   plasmid   gene   content,   and  
compared   the   phylogenetic   diversity   of   representative   genomes   with   other   Bacillus  
species   carrying   complete   or   partial   pXO1/pXO2-­like   plasmids.   Our   major   findings  
revealed   that  B.   anthracis   cells   maintain,   on   average,   3.86   copies   of   pXO1   and   2.29  
copies   of   pXO2,   and   reveal   that   there   is   positive   linear   correlation   in   the   number   of  
copies   between   both   plasmids,   which   was   consistent   with   two   previously   reported  
sequence-­based   studies   (12,   13).   The   gene   content   of   these   anthrax-­plasmids   is  
remarkably  stable  although  a  few  genomes  (e.g.,  strain  2000031682)  lacked  large  parts  
of  the  plasmids.  Further,  the  number  of  plasmid  copies  that  B.  anthracis  genomes  harbor  
seems   influenced   by   the   source   from   where   the   strains   were   isolated   (animal   or  
environmental)   but   not   phylogeny.  We   also   identified   several   environmental  B.   cereus  
s.l.  strains  containing  pXO1  and  pXO2-­like  plasmids,  some  previously  reported  (31).  We  
found  no  strong  evidence  of  plasmid  exchange  between  B.  anthracis  and  B.  cereus  s.l.  
genomes,  which  suggests  plasmid  maintenance  since  the  last  common  ancestor  of   the  
two   species.   We   noted,   however,   statistically   significant   topological   incongruences  
between   the   chromosome   tree   and   those   of   a   few   individual   plasmid   genes   within  B.  
anthracis,   indicating   that   horizontal   exchange   and/or   intra-­genomic   recombination   of  
individual  plasmid  genes  has  occurred  in  the  recent  evolutionary  time.    
Our   estimates   reveal   a   lower   number   of   pXO1   copies   per   chromosome,   on  
average  (n  =  3.86),  compared  with  earlier  studies  based  on  molecular  methods  such  as  
qPCR.   For   example,  Coker  et   al.   (2003)   estimated   ratios   of   up   to   40   copies   of   pXO1  
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while  Pilo  et  al.  (2011b)  reported  10-­11  copies  of  the  same  plasmid.  In  both  cases,  the  
estimation  based  on  quantities  of  a  portion  of  a  single  gene  per   replicon,   representing  
~0.1%   of   the   total   replicon   length,   seem   to   be   inflated   compared   with   our   more  
comprehensive   shotgun   sequence-­based   estimations.  However,   for   pXO2,   both   qPCR  
and   sequencing   provided   similar   estimates   of   approximately   1-­2   copies   per   cell,  
indicating   that   PCR   may   have   overestimated   pXO1   abundance   (since   the   competing  
hypothesis   that  sequencing  was  biased  against  pXO1  abundance  but  not   that  of  pXO2  
appears  to  be  less  parsimonious),  although  we  have  also  identified  strains  carrying  up  to  
4.5   copies   of   pXO2.   The   fact   that   plasmid   copy   number   is   not   a   phylogenetically  
conserved   trait   indicates   that   extrinsic   forces,   perhaps   environmental   factors   such   as  
temperature,  pH,  soil  moisture,  cation  levels,  among  others,  might  play  a  more  important  
role   in   determining   the   number   of   replicons   that   B.   anthracis   cells   maintain.   In   other  
words,   the   plasmid   copy   number   is   a   trait   that   may   be   adjusted   in   response   to  
environmental  cues.  Studies  of   the  ecology  of  B.  anthracis  have  shown   that   the  global  
distribution  of  anthrax  is  largely  determined  by  climatic  factors  and  land  features,  where,  
for   example,   soils   with   high   calcium   levels   and   a   pH   above   6.1   foster   better   spore  
survival  (6,  9,  29).    
In   this   study   the   gene   content   diversity   of   the   plasmids   across   a   set   of   strains  
carrying   one   or   both   plasmids   was   characterized.   Our   results   confirmed   the   highly  
conserved   gene   content   and   synteny   for   both   plasmids   (>97%   of   total   plasmid   genes  
shared)  similar   to  what  has  been  previously  described   for   this  species.   In  addition,  we  
identified   a   single   strain   (2000031682)   with   a   large   fragment   deletion   in   the   pXO1  
plasmid.   The   deleted   fragment   size   was   approximately   46.3   Kb   and   carried   the  main  
virulence  genes  responsible  for  anthrax  toxin  production:  cya,  pagA,  lef  and  atxA.  While  
the  history  of  this  strain  is  not  clear,  it  was  originally  archived  at  CDC  in  1964  on  an  agar  
slant   and   stored   at   room   temperature.   The   strain   was   recovered   from   the   slant   and  
frozen  at  -­70oC  in  2001.  We  previously  reported  that  numerous  strains  in  this  collection  
were   cured  of   plasmids  during  decades  of   room   temperature   storage   (54).  We  cannot  
ascertain  whether   this   stain  was   received   in   this   condition  or   if   the  deletion  may  have  
occurred  during  storage.    
Environmental  B.  cereus  s.l.  strains  possessing  partial  or  complete  pXO1/pXO2-­
like   plasmids,   other   than   B.   cereus   biovar   anthracis,   which   encoded   complete   B.  
anthracis   plasmids  were  also  studied.  Through  bioinformatic  approaches,  we   identified  
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50  strains  having  contigs  homologous  to  pXO1  and/or  pXO2.  We  confirmed  that  pXO1  
and  pXO2-­like  contigs  are  widely  prevalent  in  environmental  isolates  of  the  B.  cereus  s.l.  
group,   similar   to  what  was  previously   revealed  by  Van  der  Auwera  et  al.   (2013)  using  
PCR-­based  approaches   (31).   The  annotation   of   the   genes  present   in   pXO1/pXO2-­like  
contigs  showed  that  most  of  them  were  hypothetical  proteins,  with  few  of  them  predicted  
to  be  involved  in  DNA  insertion  and  transposition  (for  example  retron-­type  RNA-­directed  
DNAases  and  ribonucleases;;  see  Fig  4B)  but  no  genes  encoding  for  anthrax  toxins  were  
identified.   However,   we   found   genes   encoding   for   hyaluronic   acid   (HA)   capsule  
formation  in  these  contigs,  a  trait  that  provides  pathogenic  bacilli  with  capsular  material  
to   escape   the   innate   host   immune   response   and   is   involved   in   the   pathogenesis   of  
anthrax-­like  diseases.  Given   that  all   these  B.  cereus  s.l.  strains  analyzed  here  were  of  
environmental   origin,   these   findings  might   indicate   that   at   least   some   of   the   virulence  
factors   encoded   on   the   B.   anthracis   plasmids   (e.g.,   HA   capsule   formation)   may   be  
important  for  survival  in  the  environment  outside  the  human  host.      
A  potential  limitation  in  our  study  is  that  some  strains  could  have  lost  some  or  all  
of   their   plasmids   during   successive   subculturings.   The   rate   of   plasmid   loss   during  
recurrent   subculturing   could   have   been   accelerated   under   stressing   laboratory  
conditions   (54),   which   might   potentially   have   biased   our   estimation   of   the   ‘true’   copy  
number   variation.   To   minimize   this   issue,   the   original   culture   stock   was   used   for  
preparing  DNA  for  sequencing,  not  derived  subcultures.     Further,  a   larger  effort  on  soil  
field   sampling  would  be  necessary   to  evaluate  how   frequently  B.   cereus   group  strains  
carry   complete   or   partial   pXO1/pXO2-­like   plasmids   and   if   these   are   exchanged  or   not  
with  B.  anthracis.    
  
3.6  Conclusions  and  recommendations  
In   summary,   by   using   next   generation   sequencing   data,  we   have   estimated  B.  
anthracis   plasmid   copy   number,   characterized   their   genomic   diversity   and   compared  
representative   strains   with   clinical   and   environmental   B.   cereus   s.l.   strains   carrying  
pXO1/pXO2-­like   plasmids.   The   results   derived   from   this   study   advance   our  
understanding   of   the   biology   of   the   B.   cereus   group,   improve   the   ecological   and  
evolutionary   framework  used   to  classify  species,  and  appropriately  define  phylogenetic  
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relationships  and  taxonomic  assignments  within  the  B.  cereus  s.l.  group.  Our  results  also  
highlighted   the   advantages   of   using   genomic   relatedness   (as   measured   by   ANI,   for  
example),   instead   of   plasmid-­encoded   traits,   to   assign   taxonomy   and   robustly   resolve  
the   relationships   among   closely   related   members   of   the   B.   cereus   s.l.   group.   These  
results   and   interpretations   were   also   consistent   with   previous   studies   of   plasmid-­
encoded   traits   in   other   bacterial   species   such   as   Clostridium   botulinum   [e.g.,59].  
Therefore,   the   results   derived   from   our   study   will   help   to   improve   the   ecological   and  
evolutionary   framework   used   to   classify   species   and   appropriately   define   phylogenetic  
relationships,   especially   in   a   bacterial   group   that   exhibits   high   phenotypic   diversity   as  
Bacillus  cereus  s.l.    
Although   the   collection   size  of   the  B.   anthracis   strains   sequenced   in   this   study  
and  the  number  of  strains  deposited  in  public  databases  is  likely  still  small  compared  to  
the  total  natural  diversity  of  the  species,  to  the  best  of  our  knowledge,  this  is  the  largest  
study  characterizing  B.  anthracis  plasmid  copy  number  variation  and  their  gene  content  
diversity  using  sequencing  data  to  date.  Hence,  the  data  presented  here  should  facilitate  
future   studies   of   B.   anthracis   and   its   virulence   plasmids.   Finally,   the   bioinformatic  
approaches   used   in   this   study   can   also   be   applied   as   a   reference   framework   for  
epidemiological  studies  involving  this  and  other  microorganisms  of  medical  relevance.    
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4.1  Summary  
Pathogenic   Escherichia   coli   is   a   leading   cause   of   diarrhea.   In   South   America,  
particularly   in   Ecuador,   previous   epidemiological   studies   have   reported   a   significant  
association   of  E.   coli   strains   with   diarrhea,   yet   the   population   structure   and   virulence  
content   of  E.   coli   populations   in   this   region   remain   poorly   studied.   To  provide   insights  
into  the  latter  issues,  we  used  molecular  pathotyping  and  whole  genome  sequencing  of  
279  E.  coli   strains  belonging   to  six  pathotypes   (DAEC,  EPECa,  EPECt,  ETEC,  EAEC,  
EIEC).   The   strains   were   isolated   over   17   months   from   individuals   enrolled   in   a  
case/control  study  of  diarrhea   in   four  sites  along  an  urban  to  rural  gradient  of  Northern  
Ecuador.   Our   results   revealed   a   high   genomic   diversity   among   the   strains,   covering  
almost   the   complete  E.   coli   phylogenetic   tree.  Despite   the  high  diversity,   however,  we  
identified   several   DAEC,   ETEC   and   EIEC   clonal   complexes   that   were   significantly  
(p<0.05)  or  exclusively  associated  with  diarrhea  relative  to  control  samples  and  encoded  
the  hallmark  virulence   factors   (VFs)  of   the  pathotype,  suggesting   that   they  might  have  
caused  small-­scale  outbreaks  in  both  rural  and  urban  settings.  Notably,  several  of  these  
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complexes  represented  DAEC  strains,  which  are  generally  thought  to  not  be  as  virulent  
as  strains  of  other  pathotypes.     Comparison  of  VF  content   revealed   that  urban  strains  
harbor,   in   general,  more   virulence   genes,   but   not   antibiotic   resistance   genes   (ARGs),  
than  rural  strains  and  that  this  observation  was  mainly  driven  by  two  pathotypes,  DAEC  
and  EPECa.  Collectively,  our  results  revealed  novel  genomic  diversity  of  E.  coli  related  
to  diarrheal  disease  in  Ecuador,  and  plausible  explanations  for  the  stronger  association  





Escherichia   coli   (E.   coli)   is   a   gut   commensal   of   vertebrates,   including   humans  
(1).   This   bacterial   species   plays   a   critical   role   in   human   health,   either   contributing   to  
metabolism   and   wellbeing   or   as   causative   agent   of   disease.   As   a   commensal  
microorganism,  E.  coli   is  a  minor  component  of   the  colonic  gut  microbiome   in  humans  
where  it  typically  represents  less  than  0.1%  of  the  total  bacterial  cells  (~108  cells/ml)  (2,  
3).   Nonetheless,   this   low   abundant   microbial   group   contributes   to   human   physiology  
through   the   digestion   of   food,   production   of   vitamin   B   and   K   (4),   and   it   has   been  
suggested   that   it   could  also  have  a   role  protecting  against   invading  enteric  pathogens  
(5).  Certain  strains  (varieties)  of  E.  coli,  however,  can  cause  a  broad  range  of  diseases,  
including  enteric  and  extra-­intestinal  infections.  Pathogenic  E.  coli  strains  differ  from  their  
commensal  counterparts  in  that  they  have  acquired  unique  ‘fitness’  attributes  that  confer  
an   increased  ability   to  adapt   to  new  niches  within   the  human  body  and  growth,  which  
produces  directly  or  indirectly  a  broad  spectrum  of  diseases,  including  diarrhea  (6).      
Based   on   the   presence   of   virulence   factors,   diarrheagenic   E.   coli   have   been  
divided  into  six  distinct  pathotypes:  Enterotoxigenic  E.  coli  (ETEC),  which  produces  the  
heat  stable  (ST)  and/or  heat  labile  (LT)  enterotoxins  (6,7);;  Enteroinvasive  E.  coli  (EIEC),  
which   harbors   plasmid-­encoded   virulence   genes   that   allow   the   invasion   of   intestinal  
epithelial  cells  (8),  a  subset  of  which  form  the  so  called  Shigellae  pathotype  (previously  
thought   that   it   belonged   to   a   different   genus   Shigella);;      Enteroaggregative   E.   coli  
(EAEC),   identified   by   its   aggregative   adherence   pattern   to   cultured   HEp-­2/HeLa   cells  
and  the  formation  of  a  biofilm  on  the  gut  mucosa  (9);;  Enteropathogenic  E.  coli  (EPEC),  
which   induces   attaching   and   effacing   lesions   on   the   enterocytes   (6,   10);;   Diffusely  
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adherent  E.  coli  (DAEC),  which  has  been  identified  by  its  diffusive  pattern  of  adherence  
in  culture  of  epithelial  HEp-­2/HeLa  cells  and  appears   to   form  an  heterogeneous  group  
with   unknown   virulence   factors   (11);;   and   Shiga-­toxin   producing  E.   coli   (STEC),   which  
produces  one  or  more  types  of  Shiga-­toxins  (Stx1  and/or  Stx2)  (12).    While  a  variety  of  
infectious   mechanisms   can   be   exploited   by   these   different   E.   coli   pathotypes,   the  
development   of   severe   diarrhea   in   infected   individuals   is   often,   but   not   always,   a  
common  symptom.  Accordingly,  E.  coli   is  epidemiologically  highly  relevant   for  diarrheal  
diseases.   It   has   been   estimated   that,   after   viral   infections,   E.   coli  infections   are  
responsible   for  more   than  50%  of   all   diarrheal   deaths   in   children  under  5   years  old   in  
developing  countries  (13-­15).  Of  particular  concern  is  the  long-­term  effect  of  diarrhea  in  
young  children  with  undeveloped  gut  microbiomes.  
In   South   America,   particularly   in   Ecuador,   only   a   few   epidemiological   studies  
have   reported  association  between  pathogenic  E.   coli   and  diarrhea   in   urban  and   rural  
settings  (16-­18).  However,   the  majority  of   these  studies  have  been  carried  out   in   large  
cities  or  rural  regions,  but  no  study  to  date  has  concurrently  evaluated  the  association  of  
E.  coli  with  diarrhea  and  population  structure   in  urban  and  rural  regions  over   the  same  
time   interval.  The   increased  relocation  of  people   in  urban   locations  (urbanization)  have  
likely   increased   health   risks   and   challenges   associated   with   the   occurrence   and  
prevalence  of  pathogens  causing  diarrheal  diseases  (19).  Environmental  factors  such  as  
poor   housing,   inadequately   treated   drinking   water   supplies,   sanitation   and   waste  
management   in   slum   areas,   coupled   with   (often   uncontrolled)   antibiotic   usage   and  
spatial  proximity  in  densely  populated  regions  may  promote  the  establishment  and  rapid  
spread   of   highly   virulent  E.   coli   genotypes   in   large   cities   relative   to   rural   areas.   How  
urbanization  affects   the  epidemiology  of  emerging   infectious  diseases   is  unknown,  and  
questions   such   as   whether   urban   areas   promote   the   establishment   of   more   virulent  
genotypes  than  rural  regions  have  been  minimally  explored  (52,  53).  Currently,  the  most  
rapid  growth  in  urban  populations  is  expected  to  occur  in  developing  countries  (20,  21).  
Therefore,  the  characterization  of  the  virulence  potential  of  E.  coli  pathotypes  circulating  
in   large   cities   (≥100,000   inhabitants)   and   rural   areas   (≤5,000   inhabitants)   is   critical   in  
order  to  evaluate  potential  risks.  A  better  understanding  of  the  health  risk  may  also  lead  
to   improved   city   planning   and   surveillance   programs   that   would   help   decrease   the  
burden   of   communicable   diseases.      In   Ecuador,   no   study   to   date   has   focused   on  
evaluating  whether  pathogenic  E.  coli  strains  circulating  in  urban  areas  harbor  more,  or  
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perhaps  less,  virulence  determinants  than  those  circulating  in  rural  areas,  as  well  as  the  
occurrence  and  prevalence  of  antibiotic  resistance  genes.    
  
The   excretion   of   enteropathogens   by   human   subjects   without   diarrhea   is   a  
common   observation   in   epidemiological   studies   (22,   23).   Clinical   studies   have   often  
observed   the   detection   of   enteropathogens   in   healthy   individuals   not   suffering   of  
diarrhea.  Several   factors,   including   the  genomic  makeup  of   the  pathogen,   the   immune  
system  of  the  host,  and  environmental  parameters  (e.g.,  the  indigenous  gut  microbiome)  
might   play   a   role   in   the   outcome.   Given   that   the   excretion   of   enteropathogens   in  
asymptomatic   individuals   deeply   obscures   our   understanding   of   the   role   of   those  
pathogens   as   etiological   agents,   it   is   important   to   explore   whether   differences   in  
pathogen   genomic   content   are   detectable   between   strains   isolated   from   individuals  
whom   developed   diarrhea   versus   asymptomatic   individuals.   In   cases   of   E.   coli  
infections,  it  has  not  been  determined  whether  or  not  the  virulence  content  is  reduced  in  
asymptomatic   individuals   excreting  E.   coli   pathotypes   compared  with   those   individuals  
who  developed  diarrhea.    
To   address   these   questions,   we   designed   a   case/control   study   of   diarrhea   (named  
EcoZUR   for  E.   coli  en  Zonas  Urbanas  y  Rurales)   in   four   sites  along  an  urban   to   rural  
gradient   of  Northern  Ecuador   in   order   to   evaluate   the   role   that   human   travel   between  
urban  and  rural  areas  played  in  determining  the  distribution  of  pathogenic  E.  coli,  and  to  
characterize  E.   coli   genome   diversity   and   population   structure.   Preliminary   findings   of  
the   EcoZUR   study   revealed   that   local   travelling   to   urban   areas   is   a   risk   factor   for  
diarrheal  disease  and  that  the  prevalence  of  different  E.  coli  pathotypes  can  vary  across  
an   urban-­to-­rural   gradient   (unpublished   data).      As   part   of   the   EcoZUR   project,   stool  
specimens   collected   from   individuals   enrolled   in   the   study   were   subjected   to   PCR  
screening   for   the   presence   of   six   different  E.   coli   pathotypes   (DAEC,   atypical   EPEC,  
typical  EPEC,  EIEC,  ETEC,  and  EAEC).  Pure  E.  coli  cultures  from  those  stool  samples  
that  provided  positive  PCR  (+)  signal  for  any  of  the  marker  genes  tested  were  subjected  
to   whole   genome   sequencing   (see   Materials   and   Methods).   Here,   we   report   on   the  
phylogenomic  characterization  of  those  pathogenic  E.  coli  strains.  Therefore,  the  aims  of  
this  study  were  to  expand  the  EcoZUR  project  and  use  the  resulting  sequencing  data  to  
evaluate  the  extend  of  genomic  diversity  of  the  selected  pathogenic  isolates,  determine  
their  virulence  potential,  and  characterize  their  antibiotic  resistance  profile.  
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4.3  Materials  and  Methods  
4.3.1  Study  design  
The   genomes   analyzed   in   this   study   were   part   of   the   EcoZUR   project.   In   the  
EcoZUR  project  fecal  samples  from  individuals  with  diarrhea  and  age-­matched  controls  
living   in   four   regions  along  a  gradient   of   urban   to   rural   areas  were   taken   (Figure  4.1).  
The   four  main  regions  corresponded   to  1)  Quito   (Ecuador’s  capital)  with  approximately  
1.6  million   inhabitants;;   2)  Esmeraldas,   a   coastal   city   in   the   northwest   of  Ecuador  with  
162,000   inhabitants;;   3)   Borbón,   a   town   in   the   Esmeraldas   Province   with   ~7,000  
inhabitants,  and  4)  several  villages  (~150  villages)  located  along  three  main  rivers:  The  
Cayapas,  the  Santiago,  and  the  Onzole,  with  50  to  500  inhabitants  each  one.  Individuals  
sampled   from   Quito   and   Esmeraldas   composed   the   set   of   urban   specimens   while  
Borbón   and   the   villages   composed   the   set   of   rural   samples.   The  more   urban   centers  
(Quito   and   Esmeraldas)   are   densely   populated   regions   with   greater   access   to   clean  
water,   sanitation,   roads,   and   medical   infrastructure;;   whereas,   the   more   rural   regions  
























Figure  4.1.  Geographical  map  of  sampling  sites  in  Ecuador.  The  map  highlights  the  
four   territories   that  comprised   the  EcoZUR  study:  Quito,  Esmeraldas,  Borbón  and  rural  
villages.  Copyright  ©  Google  Maps.  2018.  Ecuador,  [-­2.2995171,  -­79.7940547,6z].  
  
Individuals  of  all  ages  were  recruited  between  April  2014-­September  2015   from  
the   Ecuadorian  Ministry   of   Health   hospitals   and/or   clinics   of   each   location   (Centro   de  
Salud  N°4  Chimbacalle  in  Quito,  Hospital  Delfina  Torres  de  Concha  in  Esmeraldas,  and  
Hospital  Básico  de  Borbón  in  Borbón).  Participants  from  the  rural  villages  were  recruited  
either  through  scheduled  Ministry  of  Public  Health  clinical  visits  to  these  rural  areas  or  at  
Borbón   Hospital   if   they   visited   the   hospital   for   medical   attention.   Individuals   were  
recruited   for   the   study   if   they   presented   diarrhea   (self-­reported),   defined   as   three   or  
more  loose  stools  in  a  24-­hour  period  and  not  antibiotic  intake  in  the  previous  7  days  of  
the  sampling  day.  Control  subjects  were  recruited  if  they  visited  the  same  medical  facility  
with  a  non-­diarrheal  illness,  and  not  vomiting  or  antibiotic  intake  in  the  previous  week  (7  
days).   Oral   consent   for   participation   was   obtained   at   both   the   village   and   household  
levels.  Permission  for  the  study  and  approval  of  human  subjects  was  obtained  from  the  
Ecuadorian   Ministry   of   Public   Health   (MSP-­DIS-­2014-­0055-­O),   Emory   Institutional  
Review   Board   (IRB)   (IRB00065781)   and   the   Universidad   San   Francisco   de   Quito  
(USFQ)  Ethical  Committee  (2013-­145M).  All  participants  completed  an  electronic  survey  
about   patient/family   demographics,   socioeconomic   status,   medical   history,   WASH  
practices,   and   travel   history.   Additionally,   participants   were   asked   to   provide   a   stool  
sample   for  enteric  pathogen  analysis.  Upon  receipt  of   the  stool  sample,  staff  members  
filled   two  cryoconservation   tubes  with   fecal  material   and   stored   them   immediately   in  a  
liquid   Nitrogen   dewar   for   transport   to   the   USFQ   laboratory   in   Quito,   where   the   tubes  
were  transferred  to  a  -­80ºC  freezer  for  storage  prior  to  analysis.  A  total  of  907  subjects  
enrolled   successfully   completed   the   survey   and   85%   of   those   (771)   provided   a   stool  
sample.   In  addition,   fresh  stool  samples  were   immediately   tested  for   rotavirus  antigens  
using  the  RIDA  Quick  Rotavirus  test  (r-­biopharm,  Darmstadt,  Germany).  
  
4.3.2  Growth  conditions  and  strain  pathotyping  
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For   each   stool   sample,   five   lactose-­positives   colonies   were   isolated   on  
MacConkey’s  agar  media  (MKL)  and  non-­lactose  fermenting  isolates  were  cultured  and  
tested   on   Chromocult   agar   media   (Merck,   Darmsladt,   Germany)   (CC)   for   β-­
glucoronidase   (MUG)   activity.   Colonies   unable   to   ferment   lactose   were   identified   by  
biochemical   tests   as   Shigella   or   E.   coli   using   the   API   20E   test   (BioMérieux,   Marcy  
l’Etoile,  France).  The  five  colonies  were  pooled,  re-­suspended  in  300µl  of  sterile  distilled  
water,  boiled  for  10  minutes  to  release  the  DNA,  and  the  resulting  supernatant  was  used  
for  PCR  testing.  Singleplex  PCR  assays  were  used  on  a  set  of  nine  different  primers  to  
detect   the   presence   of   virulence   genes   associated   with   each   diarrheagenic   E.   coli  
pathotype  (Appendix  B.1).  Positive  pools  for  eaeA  were  subsequently  tested  for  stx1  and  
stx2  genes  for  the  differentiation  of  potential  EHEC  infections.  If  a  pooled  sample  tested  
positive  for  any  virulence  factor,  then  each  of  the  five  isolates  were  re-­tested  individually  
to  identify  the  specific  isolate  carrying  the  virulence  gene.    
  
4.3.3  DNA  extraction,  sequencing  and  data  availability  
DNA  from  E.  coli  colonies  was  extracted  using  the  Wizard  Genomic  DNA  Purification  kit  
(Promega).  The  purity  and  concentration  of   the  DNA  was  estimated  using  a  NanoDrop  
spectrophotometer   (Thermo  Scientific)   and  the  Qubit   2.0   dsDNA  high-­sensitivity   assay  
(Invitrogen,  Carlsbad,  CA).    DNA  sequencing  libraries  were  prepared  using  the  Illumina  
Nextera  XT  DNA  library  preparation  kit  (Illumina)  according  to  manufacturer’s  instruction.  
After  this,  libraries  were  run  on  a  High  Sensitivity  DNA  chip  using  the  Bioanalyzer  2100  
instrument   (Agilent)   to   determine   library   insert   sizes.   An   equimolar   mixture   of   the  
libraries   (final   loading   concentration   of   10   pM)   was   sequenced   on   an   Illumina   MiSeq  
instrument   (School   of   Biological   Sciences,   Georgia   Institute   of   Technology),   using   a  
MiSEQ  reagent  v2  kit  for  500  cycles  (2  x  250  bp  paired  end  run).  Adapter  trimming  and  
demultiplexing  of  sequenced  samples  was  carried  out  using  the  MiSEQ  control  software  
v2.4.0.4.  In  total  316  E.  coli  isolates  tested  positive  for  any  of  the  nine  PCR  assays  and  
from  those,  279  were  successfully  sequenced.  The  complete  set  of  strains  sequenced  in  
this   study   has   been   deposited   in   the   NCBI   Sequence   Read   Archive   (SRA)   under  
BioProject  ID  PRJNA486009.      
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4.3.4  Read  quality  control,  assembly  and  gene  prediction  
Raw  reads  were  initially  screened  for  adaptor  sequences  using  Scythe  (24)  and  
trimmed  at  both  5’  and  3’  ends  based  on  a  PHRED  score  cutoff  of  20  using  SolexaQA++  
(25).  Reads  ≤  50  bp  after  trimming  were  discarded.  Quality-­filtered  reads  were  de  novo  
assembled   using   IDBA-­UD  with   pre-­corrections   (26)   and   the   percent   of   contamination  
and  genome  completeness  was  assessed  based  on  recovery  of  lineage-­specific  marker  
genes   using   CheckM   (27).   Protein-­coding   sequences   were   predicted   using  
MetaGeneMark  (28),  and  16S  rRNA  gene  sequences  were  identified  using  barrnap  0.6  
(https://github.com/tseemann/barrnap).      All   predicted   genes   from   the   assemblies   were  
taxonomically  annotated  using  MyTaxa  (29)  and  the  taxonomic  distributions  of  adjacent  
genes   (in   windows   of   10   genes)   in   the   concatenated   assembly   were   inspected   for  
possible   contamination   through   barplots   named   ‘MyTaxaPlots’.   The   above-­described  
methods  and  scripts  for  read  quality  control,  assembly  and  gene  prediction  were  used  as  
part  of  MiGA  (Microbial  Genomes  Atlas),  a  system  developed  in  our  laboratory  for  data  
management  and  processing  of  microbial  genomes  and  metagenomes  (http://microbial-­
genomes.org/)  (30).  
  
4.3.5  Bioinformatics  inference  of  Warwick  Multilocus  sequence  type  
Sequence   type   (ST)  was  bioinformatically  determined  using   the  Warwick  MLST  
scheme   (31),   a   genotyping   approach   relying   on   the   nucleotide   diversity   of   seven  
housekeeping  genes:  adk,   fumC,  gyrB,   icd,  mdh,  purA,   and   recA.  The  Warwick  MLST  
database   was   downloaded   from   the   Enterobase   website  
(http://enterobase.warwick.ac.uk/species/ecoli)   and   the   complete   set   of   predicted  
protein-­coding  genes  were  searched  against  the  database  using  the  BLASTn  algorithm  
(32).  Alleles  were  assigned  to  a  ST  if  the  BLASTn  hit  had  ≥  80%  nucleotide  identity  and  
≥   80%   query   coverage.   In   most   cases,   the   sequences   matched   the   alleles   in   the  
database  with  100%  nucleotide  identity  and  100%  coverage.  STs  were  assigned  based  
on  the  allele  combination  of  the  seven  genes,  as  described  previously  (31).    A  minimum  
spanning  tree  with  the  sequence  types  assigned  to  each  bacterial  isolate  was  built  using  
BioNumerics   software   v7.6.1   (Applied  Maths,   Sint-­Martens-­Latem,   Belgium).   Clermont  
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phylogroup   membership   was   determined   based   on   the   correspondence   between  
Warwick  sequence  type  number  and  triplex  PCR  genotype  as  described  in  (31).  
  
4.  3.6  Pan-­genome  and  phylogenetic  reconstruction  
Predicted-­coding   genes   from   all   bacterial   genomes   were   compared   using   the  
scripts   rbm.rb   and   ogs.mcl.rb   from   the   Enveomics   collection   (33)   to   identify   shared  
reciprocal   best  matches   in   pairwise  genome  comparisons  and  extract   the  unique   core  
genome  (orthologs  present   in  all  genomes   in  one  copy).  Core  orthologous  genes  were  
aligned  using  MUSCLE  v3.8.31  (34),  with  default  parameters.  The  script  Aln.cat.rb  from  
the  Enveomics  collection  was  used  to  concatenate  the  multiple  alignments  into  a  single  
file.   Phylogenetic   tree   was   constructed   using   FastTree   version   2.1.7   (35)   with   1,000  
bootstrap  replicates  and  the  GTR-­GAMMA  substitution  model  for  nucleotides.  The  core-­
genome-­based   phylogenetic   tree   was   cross-­referenced   with   metadata   and   visualized  
using  iTOL  (36).  
  
4.3.7   Virulence,   antibiotic   resistance   profile   and   IncN-­type   plasmid  
characterization  
The  Virulence  Factors  Database  (VFDB)  (37)  was  used  to  detect  virulence  genes  in  our  
collection   of  E.   coli   genomes.      To   avoid   limitations   of   the   assembly   process   such   as  
gaps   or   truncated   genes   and  miss-­assemblies,   virulence   gene   content   was   assessed  
using  two  approaches:  first,  by  BLASTp  searches  of  predicted  ORFs  against  the  VFDB  
using  a  cutoff  ≥  40%  amino  acid  identity  at  least  80%  coverage  of  the  subject  sequence  
length;;  and  second,  by  recruiting  high-­quality   reads  against   the  virulence  genes  on   the  
VFDB   and   determining   gene   presence/absence   by   the   number   of   reads   recruited   (or  
not)   on   the   gene.   Predicted   genes   involved   in   antibiotic   resistance  mechanisms   were  
identified  with  BLASTp  searches  against  the  antibiotic  resistance  database  (CARD)  (38)  
using   a   detection   threshold   of   at   least   40%   amino   acid   identity   at   least   80%   of   the  
subject  sequence  covered  by  the  BLASTp  alignment.  Putative  plasmid  contigs  for  each  
E.   coli   library   were   identified   and   assembled   using   plasmidSPAdes   (39).   Plasmid  
annotation  based  on  incompatibility  (Inc)  groups  was  performed  with  PlasmidFinder  v1.3  
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(40)  using  the  Enterobacteriaceae  database  as  a  reference.  Incompatibility  groups  were  
assigned  based  on  a  cutoff  of  ≥  95%  nucleotide  sequence  identity.  
  
4.3.8  Statistical  Analysis  of  Association    
All   analysis   in   association   between   clinical   status,   lifestyle   or   pathotype   with  
bioinformatically   determined   phylogroups   was   completed   using   R   Studio   Statistical  
Software   (http://www.rstudio.org/).   Unadjusted   odds   ratios   and   corresponding  p-­values  
were  computed  using  the  Pearson’s  Chi  Square  Test.  If  any  expected  counts  were  less  
than   five,   the   Fisher’s   Exact   Test   was   used   instead.   Significant   associations   were  
determined  using  an  alpha  level  of  0.05  for  all  p-­values  in  addition  to  assessing  Wald’s  
95%  confidence  intervals  for  the  inclusion  of  the  null.  
  
4.4  Results  and  discussion  
  
4.4.1  Characteristics  of  individuals  enrolled  in  the  EcoZUR  project  
  
In  this  study,  a  total  of  279  E.  coli  strains  that  were  PCR  positive  for  at  least  one  
of   the   nine   pathogenicity   marker   genes   evaluated   (see   methods   and   materials)   were  
isolated  from  stool  specimens  from  individuals  with  diarrhea  and  controls  living  in  urban  
and   rural   areas   in   Northern   Ecuador   and   sequenced.   We   comparatively   studied   the  
population   structure   of   these   strains   in   three  main   categories:   1)  clinical   status,  which  
denoted   whether   the   isolate   was   obtained   from   an   individual   with   diarrhea   or   an  
individual  excreting  pathogenic  E.  coli  but  who  had  not  developed  diarrhea  (we  refer  to  
the   latter   as   asymptomatic   samples   or   infections),   2)   lifestyle,   which   corresponded   to  
whether  the  isolate  was  obtained  from  an  individual  living  in  a  urban  or  rural  region  (see  
Materials  and  Methods   for  details),   and  3)  pathotype,  which  corresponded   to   the  PCR  
detection  of  any  of  the  markers  genes  that  were  used  to  discriminate  among  different  E.  
coli  pathotypes.  
  
To   determine   if   any   host-­associated   biases   existed   in   the   collection   of   isolates  
that  were   included   in   this  study,  we   first  evaluated   the  demographic   information  of   the  
sampled   individuals.  We   specifically   evaluated   if   significant   differences   related   to   age  
and  gender  existed  between  urban  and  rural  sites.  Our  cohort  of  individuals  was  mostly  
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composed  by   young   children  between  0-­24  months  of   age  at   both   sites.  No   statistical  
differences  in  age  category  or  gender  were  observed  between  individuals  living  at  urban  
or   rural   sites   (Table   4.1).   Therefore,   we   ruled   out   any   potential   bias   in   population  
structure  of  E.  coli  strains  that  were  introduced  by  demographic  structuring  of  the  hosts.    
  
Table  4.1.  Demographic  information  of  individuals  enrolled  in  the  EcoZUR  project  
whose  stool  specimens  where  PCR-­positive  for  pathogenic  E.  coli  gene  markers.  
From  the  set  of  279  isolates  that  were  successfully  sequenced  in  total,  168  were  
obtained  from  cases  of  diarrhea  and  110  were  detected   from  control   individuals,  which  
indicated   a   state   of   asymptomatic   infection.   139   strains  were   isolated   from   individuals  
living   in   urban   regions   (Quito   or   Esmeraldas)   while   140  were   cultured   from   people   in  
rural  settings  (Borbón  or  rural  villages).  DAEC  was  the  most  abundant  pathotype  found  
in   the  dataset   (n=99),   followed  by  atypical  EPEC   (n=66),  ETEC   (n=48),  EAEC   (n=45),  
EIEC  (n=15),  and  typical  EPEC  (n=4)  (Appendix  B.2).    
  
4.4.2  Genome  assembly  and  quality  checking  
  
The   assembled   genomes   consisted   of   330   contigs   on   average,   with   a   G+C%  
content   of   50.7%   and   an   estimated   genome   size   of   4.9Mb.   They   were   predicted   to  
contain,  on  average,  a  total  of  4,894  putative  protein-­coding  genes  sequences,  7  rRNA  
operons   and   86   tRNA   genes.   In   addition,   the   average   coverage   of   the   genomes  
sequenced   in   this  study  was  124X  (min=7X,  max=1,731X).  To  determine   the  quality  of  
our  assembled  genomes,  we  estimated  the  completeness  and  contamination  percent  of  
!! Urban&(n&=&131),&n&(%)& Rural&(n&=&128),&n&(%)& Total&(n=259),&n(%)& pval%
Gender& ! ! ! ! ! !!
Male! 74!(56.4)! 70!(54.6)! 144!(55.6)! !!
Female! 57!(43.5)! 58!(45.3)! 115(44.4)! !!
!! ! ! ! ! ! !!
Age&
(months)! #&counts& mean&(SD)& #&counts& mean&(SD)& ! !!
0324!! 49! 14.2!(6.3)! 49! 14.0!(4.9)! 98!(37.8)! 0.54%
25360!! 18! 41.2!(11.3)! 30! 38.5!(10.9)! 48!(18.5)! 0.42%
613180!! 27! 115!(31.4)! 21! 119!(35.6)! 48!(18.5)! 0.85%
>181!! 37! 455!(195.6)! 28! 491!(213)! 65!(25.1)! 0.42%
!
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the   assembled   genome   and   manually   inspected   the   taxonomic   affiliation   of   adjacent  
genes,   in   windows   of   10   genes,   using   MyTaxaScan   plots   (30)   (see   Materials   and  
Methods).   The   estimated   average   percent   of   completeness   and   contamination   for   our  
dataset   were   98.5%   (SD±1.9)   and   0.97%   (SD±0.9),   respectively.   However,   for   16  
isolates  a  substantial  signal  of  genomic  contamination  with  Klebsiella  pneumoniae  (10  to  
50%   of   the   total   genome   size,   depending   on   the   genome   considered)   was   detected  
including   universal   genes   that   are   usually   found   in   single   copy   and   are   not   often  
subjected   to   lateral   transfer.   Therefore,   we   concluded   that   these   isolates   were   most  
likely  contaminated  by  K.  pneumoniae  DNA   instead  of  displaying  a  signal  of  horizontal  
gene  transfer  (HGT)  and  therefore,  were  discarded  from  further  analysis.      
  
4.4.3   Bioinformatic   detection   of   E.   coli   marker   genes   used   for   PCR-­based  
pathotyping  
  
To  evaluate   if   the  PCR-­based  pathotyping  was  consistent  with  genome  content  
recovered  from  the  assembly  of  each  isolate,  we  performed  a  bioinformatic  detection  of  
the  panel  of  virulence  genes  screened  by  PCR.    We  assessed  the  level  of  agreement  by  
using  a  read-­based  approach  in  which  high-­quality  reads  were  recruited  against  a  E.  coli  
reference   marker   genes   and   the   presence/absence   of   each   marker   gene   was  
determined  by  the  number  of  reads  recruited  (or  not)  on  the  gene  and  the  percent  of  the  
gene  length  that  was  covered  (see  Materials  and  Methods).  Overall,  our  results  showed  
a   high   level   of   agreement   where   81.3%   (214   isolates   out   263   total)   of   the   genomes  
showed  consistent  results  between  PCR  and  bioinformatic  pathotyping.  Only  7   isolates  
showed   disagreement   (2.6%)   where   bioinformatic   analysis   detected   a   different   gene  
than  the  one  detected  with  PCR.  In  42  isolates  (16%)  no  marker  gene  was  detected  with  
the  bioinformatic  approach,   indicating  a  false-­positive  PCR  amplification.  However,   in  7  
isolates,  we  detected  the  presence  of  an  additional  marker  gene  that  was  not  identified  
through  PCR  (Appendix  B.2).    
  
4.4.4  Multilocus  sequence  analysis  (MLSA)  
To  perform  an  initial  screening  of  the  genetic  diversity   in  our  E.  coli  dataset,  we  
carried  out  an   in  silico  Multilocus  Sequence  Analysis  (MLSA)  characterization  based  on  
the  allelic  diversity  of  seven  housekeeping  genes  included  in  the  Warwick  E.  coli  MLST  
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scheme  (adk,  fumC,  gyrB,  icd,  mdh,  purA  and  recA)  (31).  We  used  a  minimal  spanning  
tree  (Figure  4.2a)  to  visualize  the  diversity  and  clonality  of  the  assigned  sequence  types  
(ST)  to  our  genomes.  Overall,  our  results  revealed  a  high  genetic  diversity  in  the  strains  
circulating   in   urban   and   rural   areas   in   Northern   Ecuador   (Appendix   B.3).  We   found   a  
total  of  84  unique  STs,  from  which  26  STs  (31%)  were  equally  distributed  between  urban  
and   rural  areas,  22  STs   (26%)  were  specific   for  urban  areas,  and  36  STs   (43%)  were  
found  only   in   rural   regions.  The   top   five  most  prevalent  STs   found   in  our  dataset  were  
ST10   (n=34),   ST38   (n=15),   ST131   (n=14),   ST4   (n=11),   and   ST270   (n=8).   This  
distribution  was  consistent  with  previous  MLSA  studies  showing  that  ST10  is  one  of  the  
most  frequently  found  STs  in  human  fecal  samples  and  in  food  samples  (43).    
In   general,   ST270,   ST4,   ST131,   and   ST38   were   more   prevalent   in   cases   of  
diarrhea   while   ST10   was   more   prevalent   in   asymptomatic   individuals   (Figure   4.2b).    
When  sequence   type  assignations  were  evaluated   for   lifestyle,  we  observed   that  ST10  
was   equally   distributed   between   urban   and   rural   areas   (17   rural   and   17   urban),  while  
ST38  and  ST131  were  more  abundant   in  urban  areas  and  ST4  and  ST270  were  more  
prevalent  in  rural  regions  (Figure  4.2c).  When  evaluated  by  pathotype,  we  observed  that  
DAEC  strains  were  assigned  to  ST131  and  ST38  mainly,  ETEC  was  restricted  to  one  ST  
(ST4)  and  EIEC  was  mostly  assigned  to  ST270  (Figure  4.2d).    We  also  found  25  isolates  
presenting  22  new  alleles  combinations   that  have  not  been  described  previously   in   the  
reference   database   as   August   2018   (Appendix   B.3).   Of   particular   interest   was   the  
observation   that   ST131,   a   highly   dispersed   and   potentially   virulent   group   of   E.   coli  
strains   that  has  been   linked   to  a   rapid  global   increase  and  prevalence  of  antimicrobial  
resistance,  was  found  to  be  among  the  most  prevalent  STs   in  our  dataset  and  present  
mostly   in   individuals   living   in   urban   regions.   A   recent   study   by   Chiluisa-­Guacho   2018  
(44,  45)  also   reported   the  detection  of  several  B2-­ST131  clones   isolated   from  patients  
diagnosed   with   urinary   tract   infections   (UTI)   in   Quito-­Ecuador,   which   appear   to   have  
been  disseminated  in  hospitals  and  community  settings.  This  finding  highlights  the  need  
to  maintain  a  surveillance  system  for  the  detection  of  E.  coli  clones  that  might  represent  


























Figure   4.2.   MLSA   profile   of   pathogenic   E.   coli   isolates   circulating   in   Northern  
Ecuador.  Panel  a  shows  a  minimum  spanning  tree  based  on  the  combination  of  allelic  
variants   of   the  Warwick   MLST   profile.   Each   node   represents   a   single   sequence   type  
(ST)  and  the  size  of  the  node  is  proportional  to  the  number  of   isolates  that  belong  to  a  
given  ST.  The  length  of  the  branch  between  each  node  is  proportional  to  the  number  of  
distinct   alleles   that   differ   between   the   two   linked  nodes.  Nodes   in   dark  grey   represent  
new  alleles  combinations  not  observed  in  the  Warwick  MLST  database.  Only  nodes  with  
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show  the  prevalence  of   the   top   five  most  prevalent  STs  detected   in  our  E.  coli  dataset  
per  clinical   status   and   lifestyle,   respectively.   Panel   c   shows   the   relative   abundance   of  
each  pathotype  in  the  top  5  most  abundant  STs.  
  
  
4.4.5  Population  structure  of  the  E.  coli  isolates  
  
To   gain   insights   into   the   evolutionary   relationships   of   E.   coli   pathotypes  
circulating  in  Northern  Ecuador,  we  characterized  the  pangenome  of  the  isolates  in  our  
dataset   and   estimated   the   phylogenetic   relationships   based   on   the   core   genome.   The  
pangenome   was   composed   by   17,596   orthologous   genes   (OGs)   in   total,   from   which  
1,875   were   part   of   the   strict   core   genome   (present   in   all   strains)   and   3,661   were  
observed  in  at  least  90%  of  the  strains.  13,935  OGs  were  part  of  the  accessory  genes.  
We  used  core  OGs  present   in  all  strains  with  exactly  one  gene  per  genome   to  build  a  
maximum   likelihood   (ML)   phylogeny   and   determine   whether   evidence   of   population  
structure   by   clinical   status   (case/asymptomatic),   lifestyle   (urban/rural)   or   pathotype  
(EAEC,   EIEC,   ETEC,   EPECt,   EPECa,   DAEC)   could   be   detected.   Phylogroup  
membership   was   assigned   based   on   the   corresponding   ST   as   described   in   (31)   and  
confirmed  by   visualizing  branching  patterns   in   the  ML   tree.   To  evaluate   the  pathotype  
category,  we  only  screened   those  strains   for  which   the  pathotype  diagnostic  gene  was  
detected  both  experimentally  and  bioinformatically  (n=224).  
  
Initial   phylogenomic   characterization   showed   that   the   total   set   of   strains   was  
distributed   in   five  main   clades:  A   (115   strains),  B1   (68   strains),  D   (49   strains),  B2   (30  
strains)  and  E  (one  strain)  (Figure  4.3a).  Only  one  strain  (E5.5)  belonging  to  clade  E  was  
observed   in   our   dataset   and   a   single   isolate   (B37.6)   fell   into   the   cryptic   clade   that  
branches   outside   of   the   established   E.   coli   sensu   stricto.      These   observations   were  
consistent   with   previous   studies   in   South   America   (French   Guiana,   Colombia   and  
Bolivia)   reporting   that   strains   isolated   from   this   tropical   region   belonged  mainly   to   the  
phylogenetic   groups  A   (55%)   and  B1   (21%),  whereas   strains   from   the   phylogroups  D  





Figure  4.3.  Phylogenetic  relationships  and  population  structure  of  the  263  E.  coli  
isolates.      Panel   a   shows   a   phylogenetic   reconstruction   calculated   from   the  
concatenated  alignment  of  1,200  core  orthologous  genes  using  FastTree  2.1.7  with  the  
GTR  model  for  nucleotide  evolution  and  1,000  SH-­like  local  support  replicates.  The  tree  
is  also  cross-­referenced  with  metadata   in   three  categories:  1)   lifestyle   (urban,  rural),  2)  
clinical   status   (diarrhea,   asymptomatic)   and   3)   pathotype   (DAEC,   EPECa,   EPECt,  
ETEC,  EIEC  and  EAEC).  Panels  b,  c  and  d  show  the  relative  abundance  of  each  one  of  
the  above-­mentioned  categories  by  phylogroup.  Asterisks  denotes  those  phylogroups  for  
which  significant  associations  with  each  tested  category  were  found.    
  
  
Initial   characterization   by   lifestyle   showed   that   clades   A   and   B1   had   higher  
prevalence   of   isolates   from   individuals   living   in   rural   areas   while   clades   B2   and   D  
contained  more  isolates  circulating  in  urban  areas  (Figure  4.3d).  Accordingly,  significant  
associations  were  detected  between  clade  D  (OR  =  2.05,  95%  CI  =  1.02-­4.12,  p=0.04)  
and  B2  (OR  =  2.37,  95%  CI  =  1.08-­5.21,  p=0.03)  with  urban  isolates  (Figure  4.3a,  Table  
4.2).  In  other  words,  we  found  that  E.  coli  pathotypes  present  in  phylogroups  B2  and  D  




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































structure  of  both  commensal  and  pathogenic  E.  coli  strains   is   thought   to  be  shaped  by  
multiple   host   and   environmental   factors.   As   it   has   been   previously   illustrated,   host  
characteristics  such  as  diet,  gut  morphology,  microbiome  structure  and  body  mass  seem  
to  be  important  predictors  of  the  distribution  of  E.  coli  phylogenetic  groups  (48-­49).  It   is  
possible   that  socio-­demographic   factors  such  as  dietary  habits  and  sanitation  practices  
might  have  contributed  to  the  population  structure  observed  in  our  collection  of  genomes  
although  a  sampling  artefact  should  also  be  considered.  However,  our  initial  screening  of  
the  demographic  composition  of  the  host  (individuals)  showed  no  significant  differences  
by   gender   or   age   group,   in   both   rural   and   urban   groups.   Roughly,   an   equal  
representation  of  rural  and  urban  genomes  was  included  in  this  study  (Table  4.1),  which  
support  the  observed  differences  in  genetic  structure  by  host  lifestyle.  
  
Table  4.2.  Association  of  the  Clermont  phylotypes  with  urban  vs.  rural  categories.  
Note  that  E.  coli   isolates  affiliated  with  phylogroup  B2  and  D  were  twice  as   likely   to  be  










OR  (95%  CI)   p-­value  
A   94  (42.0)   44  (36.1)   50  (49.0)   0.59  (0.34,  1.00)   0.05  
B1   47  (21.0)   20  (16.4)   27  (26.5)   0.54  (0.28,  1.04)   0.07  
B2   35  (15.6)   25  (20.5)   10  (9.8)   2.37  (1.08,  5.21)   0.03*  
D   44  (19.6)   30  (24.6)   14  (13.7)   2.05  (1.02,  4.12)   0.04*  
Shigella   4  (1.8)   3  (2.25   1  (1.0)   2.55  (0.26,  24.9)   0.63  
 
Statistical  analysis  by  pathotype  also  showed  a  non-­random  distribution  of  pathogroups  
in   the  phylogenetic   tree   (Table  4.3).  DAEC  was  most   likely   to  be   found   in  clade  A,  B2  
and  D   (p<0.001)  while  EAEC  and  ETEC  were  both  most   likely   found  on  phylogroup  A  
(p=0.008   and   p<0.001,   respectively).   EPECa   and   EIEC   were   predominately   found   on  
clade  B1  (p<0.001  in  both  groups)  while  EPECt  was  only  found  in  clades  A  and  B2  but  
not   significant   association   was   detected.   Analysis   by   clinical   status   however,   showed  
that   all   strains   obtained   from   either   cases   of   diarrhea   or   asymptomatic   samples   were  
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distributed  along  all  five  phylogroups  and  not  significant  association  was  detected  in  any  
phylogenetic  group  (Figure  4.3b,  Table  4.4).  Overall,  our  results  suggested  that  a  degree  
of  population  structuring  exits  in  our  collection  of  E.  coli   isolates,  which  is  mainly  driven  
by  pathotype  and  host  lifestyle  but  not  by  diarrhea  disease.    
  
Table  4.3.  Distribution  of  E.  coli  pathotypes  in  the  Clermont  phylogroups.  
  
Table  4.4.  Association  of  the  Clermont  phylogroups  with  diarrheal  disease  status.  
No   significant   differences   were   observed   for   isolates   of   different   phylogroups   with  




















0.70  (0.41,  1.21)  
  
0.20  
B1   47  (21.0)   26  (19.3)   21  (23.6)   0.77  (0.40,  1.48)   0.44  
B2   35  (15.6)   24  (17.8)   11  (12.4)   1.53  (0.71,  3.31)   0.27  
D   44  (19.6)   29  (21.5)   15  (16.9)   1.35  (0.68,  2.69)   0.39  











A! B1! B2! D! Shigella!
n!(%)! n!(%)! n!(%)! n!(%)! n!(%)! n!(%)!
DAEC! 88!(39.3)! 31!(35.2)! 3!(3.4)! 20!(22.7)! 34!(38.6)! 0!(0.0)! <0.001!
EAEC! 46!(20.5)! 26!(56.5)! 12!(26.1)! 0!(0.0)! 8!(17.4)! 0!(0.0)! 0.008!
EPECa! 38!(17.0)! 9!(23.7)! 17!(44.7)! 10!(26.3)! 1!(2.6)! 1!(2.6)! <0.001!
ETEC! 34!(15.2)! 25!(73.5)! 7!(20.6)! 1!(2.9)! 1!(2.9)! 0!(0.0)! <0.001!
EIEC! 13!(5.8)! 1!(7.7)! 8!(61.5)! 1!(7.7)! 0!(0.0)! 3!(23.1)! <0.001!
EPECt! 5!(2.2)! 2!(40.0)! 0!(0.0)! 3!(60.0)! 0!(0.0)! 0!(0.0)! 0.07!






4.4.6  Resistome  of  E.  coli  isolates    
To  evaluate   the  antimicrobial   resistance  profile  of  our  set  of  E.  coli   isolates  and  
determine  which  are  the  most  abundant  antibiotic  resistance  genes  (ARGs)  encoded  in  
their   genomes,  a  gene  content  analysis  was  performed  using  as   reference  sequences  
1,371   genes   included   in   the   Comprehensive   Antibiotic   Resistance   Database   (CARD)  
(38).  Presence  of  a  reference  genes  was  defined  as  a  BLASTp  match  of  ≥  40%  percent  
identity   and   ≥   80%  of   the   query   length   being   covered   (aligned).  Detected  ARGs  were  
grouped   in  nine  classes  according   to   the  antibiotic   they  confer   resistance   to,  and   their  
relative   frequency   of   the   classes  was   examined   based   on   three   categories   as   above:  
clinical  status,  lifestyle,  and  pathotype.    
  
Our   results   showed   that   fluoroquinolones   were   the   most   abundant   group   of  
ARGs  found  in  the  collection  of  genomes,  followed  by  animocoumarins,  and  polymyxins.  
Fluoroquinolone   class,   which   include   antibiotics   compounds   used   to   treat   a   variety   of  
common   illnesses   such   as   respiratory   and   urinary   tract   infections   (ciprofloxacin,  
gemifloxacin,   levofloxacin,   among   others)   included   a   total   of   nine   genes,  while   eleven  
genes   composed   the   animocoumarin   class   and   four   genes   composed   the   polymyxin  
class.   No   significant   differences   were   observed   when   the   E.   coli   resistome   was  
compared   among   isolates   by   clinical   status,   lifestyle   or   pathotype.   However,   we  
observed  a   trend  of   increased  abundance  of  beta-­lactamases  and  macrolides   in  urban  
areas  compared  to  rural  areas,  which  did  not  reach  statistical  significance  (Figure  4.4).    
 
Relative frequency [%] Relative frequency [%] Relative frequency [%] 
0.05     0.1       0.15  0.05     0.1       0.15  
0.05     0.1       0.15  
a. b. c. 
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Figure  4.4.  Antibiotic  resistance  gene  profile  of  E.  coli   isolates.  Barplots  show   the  
average   frequency  of  ARGs   in  E.   coli   isolates   categorized  by  antibiotic   class   to  which  
they   confer   resistance.   Panels   a,   b,   c   show   relative   frequency   of   ARG   classes  
discriminated  by  pathotype,  lifestyle  and  clinical  status  categories  respectively.  
  
4.4.7   Virulence   content   of   pathogenic   E.   coli   strains   circulating   in   Northern  
Ecuador    
  
To   assess   the   virulence   profile   in   our  E.   coli   isolates   and   determine   if   isolates  
from   urban   subjects’   harbor,   in   general,   more   virulence   genes   than   their   rural  
counterparts,   we   performed   a   gene   content   analysis   evaluating   the   presence   and  
distribution  of  293  experimentally  validated  virulence  factors  (VF)  specific  for  E.  coli  that  
were  retrieved  from  the  Virulence  Factors  Database  (VFDB).  In  total,  we  found  245  out  
of   293   virulence   genes   in   our   collection   of   genomes,   which   represented   ~86%   of   the  
total  database.  The  analysis  of  the  distribution  of  the  virulence  genes  showed  that  more  
than  90%  of  the  isolates  harbored  a  core  set  of  32  virulence  factors.  These  genes  were  
functionally  annotated   in   four  categories:   iron  acquisition,  which   included  gene  clusters  
associated  with   the   biosynthesis   of   siderophore   systems   comprising   ferrienterobactins  
and  aerobactins;;  motility,  which  included  genes  encoding  for  several  fimbrillin  subunits  of  
the  common  pilus;;  stress  survival,  which  was  represented  by  the  ompA  gene  and  type  III  
secretion  system  effectors  including  espL1,  espL4  and  espX5  (Figure  4.5).      
  
We  also  found  that  strains  circulating   in  urban  areas  encoded,   in  general,  more  
VF   than   strains   circulating   in   rural   areas   (p=0.001)   (Figure   4.6a).   This   overall   pattern  
was   driven   by   two   pathotypes   mainly:   DAEC   (p=0.04)   and   EPECa   (p=0.009)   (Figure  
4.6b).  Analysis  for  the  remaining  pathotypes  (EAEC,  EIEC,  EPECt  or  ETEC)  showed  no  
significant   differences   between   rural   and   urban   strains.  However,   of   particular   interest  
was   the  observation   that  EPECt  strains  had  consistently  higher   virulence  content   than  
any  other  pathotype.  Analysis  of  virulence  potential  evaluated  by  clinical  status,  showed  
not   significant   differences   between   strains   isolated   from   cases   of   diarrhea   and  
asymptomatic   (Figure  4.6c  and  4.6d).  However,   for  a   few  clonal  complexes  associated  
mostly   or   exclusively  with   diarrheal   samples,   high  VF   content  was   noted   compared   to  

















Figure  4.5.  Virulence  gene  content  of  E.  coli  isolates.  Heatmap  shows  a  hierarchical  
clustering  based  on  the  presence  (dark  brown)  or  absence  (light  pink)  of  known  E.  coli  
virulence   factors   (n=293).   In   total,   245  out  of  293  virulence  genes  were  detected   in  at  
least  one  genome,  which  represented  ~86%  of  the  total  database.  Note  that  a  core  set  
of  virulence  genes  were  detected  in  >90%  of  the  collection  of  strains.  These  genes  were  




The   distribution   of   virulence   genes   along   the   core   genome   phylogeny   and  
specifically  per  pathotype  were  also  evaluated.  For  this,  all  virulence  genes  detected  in  
our   collection   of   isolates   were   categorized   in   six   main   categories   according   to   the  
classification   found   in   the   VFDB:   iron   uptake,   adherence,   type   III   secretion   system  
(TTSS),   toxins,   effectors   and   others.   Our   results   revealed   that   genes   encoding   for  
systems  related  to  acquisition  of  environmental  iron  were  the  most  frequently  found  in  all  
pathotypes.   In   DAEC   the   second   most   frequently   found   category   was   adherence  
whereas   in   EPECa   it   was   type   III   secretion   system   (TTSS).   The   latter   category   was  
significantly  more  abundant   in   isolates  from  urban  areas  than  isolates  from  rural  areas.  
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differences  were  observed  for  TTSS,  with  isolates  from  rural  areas  carrying,  in  general,  
more  TTSS  genes  than  isolates  from  urban  settings.  Finally,  in  EAEC  group,  the  second  
most   abundant   category   was   adherence.   Diarrhea-­associated   ETEC   isolates   had  




Figure   4.6.   Distribution   of   virulence   genes   in   E.   coli   isolates   by   lifestyle   and  
clinical   status.   Boxplots   shows   the   distribution   of   the   number   of   detected   virulence  
genes  found  in  the  genome  of  E.  coli  isolates  categorized  by  lifestyle  (urban  vs.  rural,  top  
left)   and   clinical   status   (diarrhea   vs.   asymptomatic,   bottom   left).   The   quantification   is  
further  separated  by  pathotype   (right  panels).   Isolates  circulating   in  urban  areas   (gray)  
carry,   in   general,   more   virulence   genes   than   isolates   circulating   in   rural   areas   (light  
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4.4.8   Detection   of   Afa/Dr   adhesion   operons   in   DAEC   strains   recovered   from  
diarrhea  and  asymptomatic  individuals  
  
Next,  we  aimed   to  determine   if   the  virulence  potential  of  our  DAEC  strains,   the  
most   prevalent   pathotype   in   our   collection   of   strains,   isolated   from   asymptomatic  
individuals   was   reduced   compared   with   those   isolates   obtained   from   individuals   who  
developed  diarrhea.  For  this  purpose,  we  characterized  three  adhesin  operons  that  have  
been   previously   described   as   key   virulence   determinants   mostly   contributing   to   the  
pathogenicity  of  the  DAEC  pathotype:  the  Afa,  Dra  and  Daa  operons  (regarded  together  
as   Afa/Dr   adhesins)   (11).   Specifically,   we   evaluated   the   frequency   of   detection   of   the  
genes  contained   in   these   three  operons   in  diarrhea  and  asymptomatic   individuals.  The  
afa   operon   is   composed   of   seven   genes   (afaFABCDGE).   The   afaC   complex   was  
composed  by  two  subunits  (I  and  II)  and  four  types  of  AfaE  have  been  described  in  the  
VFDB  database  so  far.  Thus,  in  total  we  evaluated  the  presence  of  12  genes  composing  
the  Afa  operon.  Our  results  showed  that  the  genes  afaF,  afaA,  afaB  ,  afaC-­I,  afaC-­II  and  
afaD   were   frequently   detected   in   our   set   of   DAEC   strains,   with   at   least   80%   of   the  
genomes   in   both   diarrhea   and   asymptomatic   groups   contained   these   set   of   genes  
(Figure  4.7a).    
  
Conversely,   the   gene   afaD   was   totally   absent   in   our   DAEC   dataset.      Several  
types  of  the  afaE  gene  were  detected  in  our  dataset,  which  together  composed  ~80%  of  
the  frequency  of  detection.  Although  the  genes  afaE–I  and  afaE–III  were  more  frequently  
observed   in   DAEC   isolates   coming   from   asymptomatic   than   diarrhea   cases,   this  
difference  was  not  statistically  significant  (Figure  4.7a).  Similar  results  were  observed  for  
the  Dra  (draABCDPE)  and  Daa  (daaAFCD)  operons  (Figure  4.7b  and  4.7c).  Overall,  no  
significant   differences   in   the   frequency   of   detection   of   these   adhesin   operons   were  
observed   between   diarrhea   and   asymptomatic   isolates,   which   suggests   that   other  
factors   such   as   host   immune   system   and   genotype   or   gut   microbiota   resilience   to  
perturbation   rather   than   pathogen’s   virulence   potential   might   be   contributing   to   the  
































Figure  4.7.  Detection  of  Afa/Dr  adhesion  operons  in  DAEC  isolates  recovered  from  
diarrhea  and  asymptomatic  individuals.  Panel  a  shows  the  relative  abundance  of  the  
afaFABCDGE   operon   between   isolates   recovered   from   diarrheal   and   asymptomatic  
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4.4.9  Prevalence  of   Inc   type  plasmids  and  associated   resistance  genes   in  E.  coli  
isolates  
  
To  advance  our  understanding  of  the  dynamics  behind  the  spread  of  ARGs  that  
are  disseminated  through  plasmids,  we  performed  a  screening  of  the  plasmids  that  are  
being  carried  by  the  E.  coli  isolates  in  our  dataset.  In  total,  204  plasmids  were  retrieved  
and  annotated  based  on  incompatibility  type  (Inc  type)  using  the  plasmidFinder  database  
(40).   Plasmid   incompatibility   is   defined   as   the   inability   of   two   related   plasmids   (same  
origin  of  replication)  to  be  stably  maintained  and  propagated  in  the  same  cell  line  due  to  
competition   for   cellular   machinery   (41).   Currently,   27   Inc   groups   are   recognized  
in  Enterobacteriaceae  by  the  Plasmid  Section  of  the  National  Collection  of  Type  Cultures  
(London,   United   Kingdom),   including   six   IncF   (FII   to   VII)   and   three   IncI   (I1,   Iγ,   I2)  
variants.  The  analysis  showed  that  a  large  heterogeneity  of  plasmid  Inc  types  have  been  
circulating   among   E.   coli   isolates   in   Ecuador   (Figure   4.8).   From   these,   61   replicons  
belonged   to   incompatibility   group   IncFIA   (30%)   and   63   to   incompatibility   group   IncFII  
(31%).   In   addition,   18  plasmids   (9%)  belonged   to  Shigella   boydii   group.  Within   IncFIA  
and   IncFII   groups,   the   plasmidF,   pRSB107,   and   pBS512_2   were   the   three   most  
abundant  plasmids  found  in  our  collection  and  all  three  were  also  more  prevalent  among  
rural   isolates   (Figure  4.8a).  When  classified  by  clinical  status,  we   found   that  plasmidF,  
pHN7A8,   pRSB107,   pMG828-­1,   and   pCoo   were   more   abundant   in   cases   of   diarrhea  
than   asymptomatic   individuals   (Figure   4.8b).   When   evaluated   by   pathotype,   we  
observed   that   plasmids   pMG828   and   pC15-­1a   were   more   prevalent   in   DAEC   strains  
whereas   plasmids   pBS512_2   and   pRSB107   were   more   abundant   in   EPECa   strains.  
Plasmid   pCoo   was   observed  more   frequently   in   ETEC   strains   while   plasmid   pHN7A8  
was   observed   frequently   in   EIEC   strains   (Figure   4.8c).   However,   the   distribution   of  
plasmids  by  pathotype  showed  that  plasmids  were  not  exclusively  carried  by  a  single  E.  






















Figure   4.8.   Prevalence   of   Inc   type   plasmids   and   associated   resistance   genes  
among   our  E.   coli   isolates.  Bar   plots   show   the   distribution   of   the   different   plasmids  
retrieved  from  our  collection  of  isolate  genomes.  Overall,  our  results  revealed  that  there  
was  a  large  heterogeneity  of  plasmid  Inc  types  circulating  in  Ecuador.    
  
The   genomic   content   of   plasmid   pRSB107,   the   most   abundant   multi-­resistant  
replicon   detected   in   our   isolates,   was   examined   more   closely.   Plasmid   pRSB107  
encoded  nine  different  antibiotic-­resistant  determinants,  two  iron  acquisition  systems  and  
other  putative  virulence-­associated  functions  (42).   In  total,  19  recovered  plasmids  were  
annotated   as   pRSB107   from   our   collection   and   most   of   them   were   found   in   rural  
communities   (15   from   rural   and   4   from   urban   areas).   These   plasmids   showed   partial  
recovery   of   the   entire   sequence   when   compared   to   the   reference   plasmid   pRSB107  












































from  the  recovered  sequences  against  the  genes  from  the  reference  plasmid  pRSB107  
showed   the   presence   of   genes   involved   in   virulence,   iron   sequestration   and   plasmid  
maintenance  (ugpB,  ugpA,  ugpC,  vagD,  vagC,  iucA,  iucB)  in  eight  plasmids.  In  addition,  
the  plasmid  recovered  from  one  strain  isolated  from  an  urban  area  in  Quito  (Q53)  carried  


















Figure   4.9.   Circular   plots   of   the   pRSB107   plasmid.   Black   inner   ring:   pRSB107  
sequence  used  as  reference  for  the  alignment  (AJ851089).  Blue  inner  circles  represent  
recovered   contigs   from  E.   coli   isolates   from   rural   areas   annotated   as   pRSB107;;   grey  
outer   circles   represent   contigs   from   urban   areas.   Genes   involved   in   virulence   and  
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Finally,   we   attempted   to   evaluate   if   the   phylogeny   of  E.   coli   isolates   based   on  
conserved  plasmid  genes  recapitulates  that  of  the  main  chromosome.  For  this  purpose,  
we   selected   a   subset   of   E.   coli   isolates   in   which   the   plasmid   F   was   recovered   and  
compared  the  tree  topology  of  the  plasmid  based  on  the  repA  gene  to  the  core  genome  
tree   (Figure  4.10).  Comparison  of   the   tree   topologies  showed   inconsistencies  between  
the   two   phylogenies,   revealing   that   these   plasmids   are  moving   among  E.   coli   isolates  

















Figure   4.10.   Tanglegram   comparing   tree   topologies   of   maximum   likelihood  
phylogenies   of   the   core   genome   (left)   and   the   repA   gene   from   the   plasmid   F  
(right).  Crossing  blue  lines  indicate  inconsistencies  between  the  two  topologies,  caused  
most   likely  by  the  horizontal  gene  transfer  of   the  corresponding  plasmids.  Phylogenetic  
trees  were  constructed  using  RAxML  v8.0.19  with  the  GTRGAMMA  modeling  and  1,000  
bootstraps.        
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In   this   study,   we   used   next   generation   sequencing   data   to   characterize   the  
extend   of   genomic   diversity   and   population   structure   of   279   E.   coli   isolates   from  
individuals   diagnosed   with   diarrhea   and   age-­matched   controls   living   in   large   cities  
(urban)   and   small   villages   (rural)   in   Northern   Ecuador.   We   comparatively   studied   the  
population   structure   and   virulence   potential   of   these   strains   in   three  main   categories:  
clinical   status,   lifestyle   and   pathotype.   Our   major   findings   revealed   a   significant,   but  
rather  moderate,  degree  of  genetic  cohesion  (population  structure)  in  some  isolates  that  
was   driven   by   pathotype   and   host   lifestyle   mainly   but   not   by   clinical   status.   In   other  
words,  we  found  a  non-­random  distribution  of  genomes  along  the  core  phylogenetic  tree  
which  was   found   to   be   associated  with   intrinsic   (selection   of   specific   virulence   genes)  
and   extrinsic   (environmental,   urban   vs.   rural   conditions)   factors   characterizing   each  
genome.  Our  results  also  revealed  a  slightly  greater  virulence  gene  content  in  urban  vs.  
rural  areas,  driven  by  isolates  assigned  to  DAEC  and  EPECa.  Despite  the  high  diversity  
observed   among   our   isolates   in   general,   we   identified   several   DAEC,   ETEC   and  
EIEC/Shigella   clonal   complexes   that   were   significantly   (p<0.05)   or   exclusively  
associated  with  diarrhea  relative  to  control  samples  and  encoded  the  hallmark  virulence  
factors   (VF)   of   the   pathogroup,   suggesting   that   they   might   have   caused   small-­scale  
outbreaks  in  both  rural  and  urban  settings.  
Our   collection   of   genomes   obtained   from   individuals   with   diarrhea   was  
significantly  populated  with  DAEC  strains.  In  addition,  the  epidemiological  component  of  
the   EcoZUR   study   showed   that   DAEC   was   significantly   associated   with   diarrhea   in  
urban  areas  (unpublished  data).  Consistent  with  the   latter   finding,  we  found  that  DAEC  
strains   circulating   in   urban   regions   (Quito   and   Esmeraldas)   harbored   in   general  more  
virulence   genes   than   their   rural   counterparts   and   that   they   were   most   likely   to   be  
clustered   together   in   specific   clades   within   the   phylogeny,   usually   forming   clonal  
complexes.   Collectively,   these   findings   indicated   that   DAEC   is   actually   an   important  
pathotype   causing   disease   in   Ecuador,   and   probably   other   parts   of   South   America.  
However,  DAEC   is  usually   overlooked  as  a  pathogen  because   its  main  mechanism  of  
pathogenicity   does   not   involve   the   secretion   of   specific   toxins.   Accordingly,   almost   all  
information  available   for  DAEC  pathotype  has  come   from  experiments   in   vitro   and  not  
field  studies  like  our  study.    
Despite  finding  no  association  between  clinical  status  and  phylogenetic  groups  at  
large   scale,   we   did   observe   the   occurrence   of   several   highly   related,   clustering   of  
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isolates   in   the  core  phylogeny  for  DAEC,  ETEC  and  EIEC,  which  were  mostly   found   in  
diarrhea  cases,  defined  here  as  clonal  complexes.  These  clonal  complexes  encoded  the  
hallmark  virulence  factors  (VF)  of  the  pathogroup,  which  suggested  that  they  might  have  
caused   small-­scale   outbreaks   in   both   rural   and   urban   settings.   For   example,   the  
EcoZUR  epidemiological  data  showed  a   large  association  of  EIEC  with  diarrhea.  EIEC  
isolates  also   formed  a  discrete  clonal  complex  within   the  B1  clade   in   the  core  genome  
phylogeny.  These  observations  were  consistent  with  the  findings  from  the  GEMS  study  
(13),   where   authors   reported   that   Shigella   was   among   the   top   five   pathogens  
responsible  for  diarrheal  diseases  in  sub-­Saharan  Africa  and  Southeast  Asia.    
Further,   our   study   showed   that   DAEC   (p=0.04)   and   EPECa   (p=0.009)   strains  
circulating   in   urban   areas   carry   in   general,   more   virulence   genes   than   those   strains  
circulating   in   rural  areas.  This   finding   requires   further,  more  detailed   investigation  as   it  
likely   has   important   implications   for   epidemiology   and   public   health.   It   has   been  
predicted   that   the   most   rapid   growth   in   urban   populations   will   occur   in   developing  
countries   in   the   next   10   years.   Therefore,   determining  whether   urban   areas   promotes  
the   establishment   of   more   virulent   genotypes   than   rural   regions   is   critical   in   order   to  
evaluate  potential   risks  and   to   improve  city  planning  and/or  surveillance  programs   that  
can   help   to   decrease   the   burden   of   communicable   disease.   Smith   et   al.   (unpublished  
data)  also  showed  that  travelling  to  urban  settings  in  the  same  region  of  Ecuador  was  a  
risk   factor   for   disease,   suggesting   that   investments   in   improving   conditions   in   urban  
areas  could  have  cascade  effects  in  rural  areas  as  well.    
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Escherichia  coli   infectious  diarrhea   is  an   important  contributor   to  child  morbidity  
and  mortality  worldwide.  While   important   advances   have   been  made   in   characterizing  
the   infectious  mechanisms  of  E.  coli  as  an  enteric  pathogen,  a  basic  understanding  of  
the   compositional   and   functional   alterations   that   occur   in   the   intestinal   microbiome  
during  active   infections   is  still   limited.   In  addition,   it   remains  unknown  whether  different  
pathotypes  produce  similar  or  distinct  alterations  due   to   their  characteristic  mechanism  
of  infection  and  virulence  factors.  Here,  we  analyzed  38  fecal  samples  taken  from  young  
children   in   Northern   Ecuador   suffering   infectious   diarrhea   relative   to   42   age-­matched,  
healthy   controls.   E.   coli   isolates   were   recovered   from   all   disease   samples   and   were  
categorized  in  three  pathotypes  by  PCR  and  whole-­genome  sequencing,  indicating  that  
they   were   the   etiological   agents   based   on   conventional   testing.   The   pathotypes   were  
Diffusely   Adherent   (DAEC),   Enteropathogenic   (EPEC)   and   Enterotoxigenic   (ETEC)  E.  
coli.  To  validate  these  traditional  culture-­based  methodologies,  we  obtained  companion  
shotgun  metagenomes  and   inspected   for  signatures  of  E.  coli   infection  defined  as:   i)  a  
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higher   abundance   of   the   pathogenic   isolate   relative   to   reference   commensal   strain   or  
control  samples,  ii)  high  prevalence  of  virulence  factors  and/or  toxins,  including  the  PCR-­
identified   marker   gene   for   DAEC,   ETEC   and   EPEC   in   the   metagenome-­assemble  
population  genome   (MAG)  assigned   to  E.   coli,   iii)   reduced   intra-­specific  diversity   (high  
clonality)   of   the   infectious   E.   coli   population   relative   to   healthy   individuals   and,   iv)  
significant  association  of  the  isolate  with  disease  vs.  control  samples  (epidemiology).  We  
found   that   although   the   pathogenic  E.   coli  was  PCR-­detected   in   all   diarrhea   samples,  
only   about   ~50%   of   the   samples   actually   presented   these   metagenomic   features  
consistent   with   E.   coli   infection.   The   analysis   of   the   remaining   samples   was   not  
conclusive,   which   suggested   that   likely   other   viral,   bacterial   or   eukaryotic   pathogens  
could  have  been  the  etiological  agents. Based  on  the  former  selected  samples,  we  found  
taxonomic,  but  not  metabolic  signatures  discriminating  the  microbiomes  associated  with  
DAEC   and   ETEC   infections.   Fusobacterium   mortiferum   and   Campylobacter   concisus  
were  significantly  more  abundant   in  ETEC  infections  while  Bifidobacterium  longum  and  
Alloprevotella   tannerae  were  more   enriched   in  DAEC   infections.  Overall,   these   results  
showed   that   shotgun   metagenomics   can   assist   in   the   identification   of   the   etiological  
agent  of  infectious  diarrhea  (diagnostics)  and  revealed  taxonomic  signatures  on  the  gut  




Diarrheal   diseases   remain   a  major   public   health   issue  worldwide,   especially   in  
developing  countries,  where  poor  sanitary  conditions  and   limited  access  to  clean  water  
exacerbate   the   burden   (1,   2).   Escherichia   coli   (E.   coli)   is   a   gut   commensal   of  
vertebrates,   including   humans   (3).   E.   coli   can   nevertheless   cause   a   broad   range   of  
diseases   including   intestinal   and   extra-­intestinal   infections.   The   relevance   of   this  
microorganism   in   diarrheal   disease   has   been   previously   illustrated.   For   example,   the  
Global  Enteric  Multicenter  Study   (GEMS)  demonstrated   that  Shigella  (a  distinct   lineage  
within  the  E.  coli  phylogenetic  clade)  and  Enterotoxigenic  E.  coli  (ETEC)  producing  heat  
stable   toxin   (ST)   (either  alone  or   in  combination  with  heat   labile   toxin   (LT))  are  among  
the   most   important   pathogens   associated   with   moderate-­to-­severe   diarrhea   (MSD)   in  
children   younger   than   five  years   of   age   living   in   developing   countries   (4).   Yet,   little   is  
known  about   the  effect(s)  of  diarrheagenic  E.  coli  on   the  gut  microbiome  such  as  how  
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the   structure   of   the   community   changes   during   active   infections,   especially   in   young  
children.  
While   commensal   E.   coli   is   typically   a   minor   component   of   the   colonic   gut  
microbiome   in   humans,   where   it   represents   less   than   0.1%   of   the   total   bacterial   cells  
(~108   cells/g)   (5),   during   enteric   infections   with   invading   pathogenic  E.   coli   strains   or  
another  enteric  pathogen,  the  overall  signal  of  E.  coli  in  the  gut  microbiome  can  increase  
substantially  (6,  7),  allowing  the  detection  and  recovery  of  strain(s)  that  could  accurately  
represent   the   invading   population.   In   addition,   quantifiable   shifts   in   the   proportion   and  
diversity  of   the  entire  gut  microbial  community   in   response   to   the   infection  disturbance  
have   been   also   observed   (6-­8).   Therefore,   characterizing   alterations   in   the   host   gut  
microbiome  in  addition  to  the  abundance,  intra-­population  diversity  and  virulence  content  
of  the  invading  E.  coli  population  during  an  intra-­intestinal  infection  is  important  to  better  
understand   the   overall   dynamics   of   the   gut   microbial   populations   and   for   diagnostic  
testing.    
  
Although  most   diarrheal   cases   self-­resolve   relatively   quickly   and  hence,   do  not  
require   typing   of   the   causative   agent(s),   there   are   instances   where   acute   diarrheal  
infections  could  lead  to  mortality,  making  detailed  investigations  of  the  causative  agents  
and   their   signatures   necessary.   Such   cases   include   foodborne   outbreaks   linked   to  
contaminated   food   in   developed   countries   and   acute   child   diarrhea   in   the   developing  
world.  Diagnostic  testing  for  enteric  pathogens  in  these  cases  has  relied  for  decades  on  
culture-­based   techniques   and   this   approach   is   the   foundation   for   public   health  
surveillance.  It  becomes  important  to  realize  that  these  approaches  will   frequently  miss  
moderately   or   distantly   related   relatives  of   the   reference   culture.  Further,   and  perhaps  
more   importantly,   pathogens,   including  E.   coli   (9),   can   quickly   loose   cultivability   upon  
exposure  to  laboratory  conditions,  hampering  the  full  characterization  of  infections  (63).  
Accordingly,   a   total   of   38.4   million   cases   of   foodborne   illness   per   year   cannot   be  
attributed  to  specific  causes,  and  the  proportion  caused  by  yet-­to-­be-­described  microbial  
agents   is  unknown.  Clinical  metagenomics,   the  study  of   the  genetic  material   recovered  
directly   from   a   clinical   specimen   (21),   has   emerged   as   a   powerful   tool   in   clinical  
microbiology  in  the  last  few  years,  allowing  researchers  to  explore  the  complex  microbial  
communities   of   the   human   gastrointestinal   tract   bypassing   the   need   for   isolation   or  
culturing   (64).   Its   strength   as   potential   diagnostic  method   relies   in   that   it   can   not   only  
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detect  and  recover  the  genome  sequence  of  enteric  pathogens  from  clinical  specimens,  
but   also   allows   profiling   the   surrounding   microbial   community,   which   could   be   also  
important  for  diagnosis  and  better  understanding  of  the  disease  progression.    
  
Based   on   virulence   factors,   pathogenic   E.   coli   have   been   divided   into   six  
distinguishable   pathotypes:   Enterotoxigenic   E.   coli   (ETEC),   Enteroinvasive   E.   coli  
(EIEC),   Enteroaggregative  E.   coli   (EAEC),   Enteropathogenic  E.   coli   (EPEC),   Diffusely  
adherent  E.  coli   (DAEC)  and  Shiga-­toxin  producing  E.  coli   (STEC)   (6-­12).  From   these,  
EPEC   and   ETEC   have   received   special   attention   in   developing   countries   as   they   are  
main   pathogens   causing   diarrhea   in   children   under   five   (1-­4).   While   a   variety   of  
pathogenic  E.   coli   can   directly   or   indirectly   cause   diarrhea,   i.e.,   the   production   of   net  
water   secretion   towards   the   lumen,   via   different   physiological  mechanisms,   it   remains  
undetermined  whether   different  E.   coli   pathotypes   produce   similar   or   perhaps,   distinct  
alterations   in   the   indigenous   microbiome   due   to   their   characteristic   mechanism   of  
infection  and  virulence.  Much  of  the  work  to  date  on  the  gut  microbiome  has  focused  on  
the  relationship  of  the  gut  community  composition  to  chronic  diseases  or  conditions  such  
as   obesity   (13,   14),  malnutrition   (15),   or   inflammatory   bowel   disease   (IBD)   (16-­18).   A  
much  more  limited  number  of  studies  have  examined  the  impacts  of  infectious  diarrhea  
on  the  gut  microbial  communities  of  young  children  (19,  20)  or  the  existence  (or  not)  of  
pathogen-­specific  signatures  of  the  disturbed  gut  environment.    
  
During   the   interaction   with   the   intestinal   epithelial   cells,   in   the   phase   of  
attachment   and   colonization,   distinctive  machineries   of   pathogenicity   are   known   to   be  
used,  depending  on  whether  the  pathogen  invades  the  cell,  produces  biofilms  or  secrete  
toxins.  For  example,  Enterotoxigenic  E.  coli  (ETEC)  adheres  to  the  small  bowel  mucosa  
and   delivers   secretory   enterotoxins   (7).   Enterohemorrhagic  E.   coli  (EHEC)   adheres  
intimately  to  the  colonic  mucosa  and  transduces  a  signal,  resulting  in  secretory  diarrhea.  
Concurrently,   the  organism  releases  Shiga  toxin,  resulting  in   local  and  systemic  effects  
(12).   Enteroaggregative  E.   coli  (EAEC)   adheres   in   a   thick   mucous   gel   (biofilm)   and  
causes  intestinal  secretion  and  damage  (9).  Diffusely  adherent  E.  coli  (DAEC)  has  been  
shown   to   elicit   elongation   of   microvilli  in   vitro,   although   this   effect   has   not   been  
demonstrated  in  vivo,  and  is  considered,  in  general,  not  as  virulent  as  other  pathotypes  
(11).   Enteropathogenic  E.   coli  (EPEC)   elicits   the   attaching   and   effacing   lesion   in   the  
small   bowel,   resulting   in   intestinal   secretion   (10)   and   Enteroinvasive  E.   coli   (EIEC)  
 112 
invades   the   colonic  mucosa,   giving   rise   to   inflammatory   enteritis   (8).   These   biological  
differences  might  disturb  the  gut  microbial  community  in  different,  distinguishable  ways.  
We   hypothesized   that   the   distinctive   infectious   mechanisms   used   by   different   E.   coli  
pathotypes  produce  diagnostic  taxonomic  and/or  functional  genetic  signatures  in  the  sick  
gut  microbiome  that  might  inform  about  the  pathotype  of  E.  coli  causing  the  infection.      
  
As  part  of  a  large  epidemiological,  case/control  study  of  diarrhea  carried  out  over  
a  period  of  17  months  in  Northern  coastal  Ecuador  (named  EcoZUR  for  E.  coli  en  Zonas  
Urbanas   y   Rurales),   we   examined   the   gut   microbiome   signatures   of   young   children  
during   diarrheal   disease   with   infection   by   any   of   three   major   E.   coli   pathotypes,   i.e.,  
diffusely   adherent   DAEC,   enterotoxigenic   ETEC,   and   enteropathogenic   EPEC   and   a  
group   of   age-­matched   control   children.   The   main   objectives   of   our   study   were   to:   1)  
describe  and   compare   the  overall   gut  microbiome  diversity   between  cases  of   diarrhea  
and   controls   using   both   16S   rRNA   marker   genes   and   whole   shotgun   metagenomes  
data,  2)  determine  cases  of  diarrhea  where  E.  coli  was  most  likely  the  causative  agent  of  
the  disease  based  on  a  combination  of  metagenomics,  isolate  genome  sequencing  and  
epidemiological   data,   and   3)   determine   whether   pathogen-­specific   signatures   in   the  
disease  gut  microbiome  exist  that  distinguish  among  DAEC,  EPEC  and  ETEC  infections.  
  
5.3  Methods  and  Materials  
5.3.1  The  EcoZUR  study  design    
The  EcoZUR  study,  which   took   place   in  Northern  Ecuador   over   a   period   of   17  
months,   originally   aimed   to   evaluate   the   risk   of   traveling   between   urban   and   rural  
settings   in   acquiring   diarrheal   infections   and   determining   the   distribution   of   E.   coli  
pathotype  in  these  settings.  Fecal  samples  from  individuals  diagnosed  with  diarrhea  and  
controls  living  in  four  regions  along  a  gradient  of  urban  to  rural  areas  were  taken  and  the  
traveling   patterns   of   these   individuals   were   catalogued.   The   regions   included:   Quito  
(Ecuador’s  capital)  with  approximately  1.6  million  inhabitants;;  Esmeraldas,  a  coastal  city  
in  the  northwest  of  Ecuador  with  162,000  inhabitants;;  Borbón,  a  town  in  the  Esmeraldas  
Province   with   ~7,000   inhabitants,   and   several   villages   (~150   villages)   located   along  
three   main   rivers:   The   Cayapas,   the   Santiago,   and   the   Onzole,   with   50   to   500  
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inhabitants  each  one.  Participants  were   recruited  between  April   2014-­September  2015  
from   the   Ecuadorian   Ministry   of   Health   hospitals   and/or   clinics   at   each   location.  
Individuals   were   recruited   if   they   presented   diarrhea,   defined   as   three   or   more   loose  
stools   in  a  24-­hour  period,  and  control  subjects  visiting  the  same  medical  facility  with  a  
non-­diarrheal   illness.   Individuals   were   enrolled   if   they   had   no   record   of   vomiting   or  
antibiotic   intake   in   the  previous   four  weeks  of   the  sample  day.  Data  on  demographics,  
medical  history,  water,  sanitation,  hygiene  practices,  animal  contacts,  and  recent   travel  
history   information  were  collected   from  all  participants.  Surveys  were  carried  out  using  
Android   devices   and   the   Open   Data   Kit   program   (http://opendatakit.org).   Prior   to  
enrollment,   all   participants   signed   a   consent   document   approved   by   the   Institutional  
Review  Boards  of  Emory  University   (IRB00065781)  and  Universidad  San  Francisco  de  
Quito   (USFQ)   (2013-­145M).   The   research   protocol   was   also   approved   by   the  
Ecuadorian  Ministry  of  Health  (MSP-­DIS-­2014-­0055-­O).  
In  the  EcoZUR  study,  a  total  of  980  stool  samples  were  taken.  All  diarrhea  samples  that  
resulted   in   PCR   positive   signal   for   the   presence   of   any   marker   gene   characterizing  
DAEC,  ETEC  and  EPEC  pathotypes  and  that  were  obtained  from  young  children  under  
six  years  old,  were  selected  and  prioritized  for  further  analysis.  A  subset  of  80  samples,  
which   included   diarrheal   and   control   samples   randomly   chosen   from   the   samples   that  
met   the   above   criteria   of   age   and   (for   diarrhea   samples)  E.   coli   pathotype   presence,  
were   taxonomically   screened   by   amplicon   sequencing   of   the   16S   rRNA   gene.   In  
addition,  all  diarrhea  samples  (n=38)  and  a  subset  of  control  samples  (n=23)  among  the  
80   samples   were   subjected   to   whole   shotgun   metagenomic   sequencing   for   higher  
resolution  (Appendix  C.1).  The  diarrheal  samples   included  16  samples   that  were  PCR-­
positive   for  afa,   the  virulence  marker  of  DAEC  (Diffusely  Adherent  E.  coli),  10  samples  
positive   for   bfp,   the  marker   gene   for   typical   EPEC   (Enteropathogenic  E.   coli)   and   12  
samples  positive   for  eltA   and/or  sta,  marker  genes   for  ETEC   (Enterotoxigenic  E.   coli).  
Children   included   in   control   group   (n=42)  were   all   diarrhea-­free   and  PCR-­negative   for  
any  of   the  pathotype  markers   characterized   in   the  EcoZUR  study.  All   available  E.   coli  
isolates   cultured   from   stool   samples   from   the   selected   cases   of   diarrhea   were   also  




5.3.2  E.  coli  pathotype  determination  and  Rotavirus  detection  
Fresh   stool   samples   collected   at   the   different   locations   in   Northern   Ecuador   were  
incubated   in   E.   coli-­specific   media   and   tested   for   different   pathotypes   based   on   the  
presence  of   specific   virulence   genes   determined  by  PCR.  For   each   stool   sample,   five  
lactose-­positives   colonies   were   isolated   on  MacConkey’s   agar  media   (MKL)   and   non-­
lactose  fermenting   isolates  were  further  cultured  and  tested  on  Chromocult  agar  media  
(Merck,  Darmsladt,  Germany)  (CC)  for  β-­glucoronidase  (MUG)  activity.  Colonies  unable  
to   ferment   lactose  were   identified  by  biochemical   tests  as  Shigella  or  E.  coli  using   the  
API   20E   test   (BioMérieux,   Marcy   l’Etoile,   France).   The   five   colonies   were   pooled,   re-­
suspended   in  300µl  of  sterile  distilled  water,  boiled   for  10  minutes   to  release   the  DNA,  
and   the   resulting  supernatant  was  used   for  PCR   testing.  Singleplex  PCR  assays  were  
used   on   a   set   of   nine   different   primers   to   detect   the   presence   of   virulence   genes  
associated  with  each  E.  coli  pathotype  (Table  5.1).  In  addition,  fresh  stool  samples  were  
also   tested   for   rotavirus   antigens   using   the   RIDA   Quick   Rotavirus   test   (r-­biopharm,  
Darmstadt,   Germany).   Positive   pools   for   eaeA   were   subsequently   tested   for   stx1   and  
stx2  genes  for  the  differentiation  of  potential  EHEC  infections.  If  a  pooled  sample  tested  
positive  for  any  virulence  factor,  then  each  of  the  five  isolates  were  re-­tested  individually  
to  identify  the  specific  isolate  carrying  the  virulence  gene.    
  
5.3.3  DNA  extraction,  library  preparation  and  sequencing  
DNA   from   E.   coli   isolates   was   extracted   using   the   Wizard   Genomic   DNA  
Purification   kit   (Promega).   DNA   for   stool   metagenomes   was   extracted   from   a  
homogenized  stool  mix  using  the  MoBIO  PowerSoil  DNA  isolation  Kit.  In  both  cases,  the  
purity   and   concentration   of   the   DNA   was   estimated   using   a   NanoDrop  
spectrophotometer   (Thermo  Scientific)   and  the  Qubit   2.0   dsDNA  high-­sensitivity   assay  
(Invitrogen,   Carlsbad,   CA).     Libraries   for   16S   rRNA   gene   amplicon   sequencing   were  
amplified   and   sequenced   using   16S   rRNA   primers   515F   (5′-­
GTGCCAGCMGCCGCGGTAA-­3′)   and   806R   (5′-­GGACTACHVGGGTWTCTAAT-­3′),  
which  target  the  V4  region  of  the  gene  (~254  bps)  and  are  tailed  with  Illumina  adapters  
P5  and  P7,  index,  pad  and  linker  sequences  as  previously  described  in  (26).  
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PCR   amplifications   were   performed   in   duplicates   to   a   final   volume   of   20   μl  
containing  0.5U  of  AccuPrime-­Pfx  polymerase,  1X  AccuPrime   reaction  mix,  200  nM  of  
each   primer   and   1   μl   of   template   DNA.   Amplification   conditions   included   an   initial  
denaturation  of  2  min  at  95°C,  followed  by  25  cycles  of  95°C  for  20s,  55°C  for  30s  and  
72°C  for  30s,  and  a  single  final  extension  step  at  72°C  for  6  min.  Specific  amplification  
was  verified  by  agarose  gel  electrophoresis  and  duplicate  samples  pooled  and  purified  
using   the  Sequalprep  Normalization  plate  kit   (ThermoFisher  Scientific,  USA)  according  
to  manufacturer’s  instructions.  The  concentration  of  purified  DNA  was  measured  using  a  
Qubit  fluorometer  (Thermo  Fisher  Scientific,  USA).  Purified  amplicons  were  then  pooled  
in   equimolar   concentration   (2   nM)   and   10   pM   containing   5%   PhiX   control   DNA   was  

















































software  v2.4.0.4   (MCS)  and  using  a  MiSeq   reagent   v2  kit   for  500  cycles   (2  x  250  bp  
paired  end  run)   (Illumina   Inc.,  San  Diego,  CA).  Adapter   trimming  and  demultiplexing  of  
sequenced  samples  were  carried  out  by  the  MCS.      
For   isolates   and  metagenome   DNA   sequencing,   libraries   were   prepared   using  
the   Illumina   Nextera   XT   DNA   library   preparation   kit   (Illumina)   according   to  
manufacturer’s   instruction.  After   this,   libraries  were   run  on  a  high   sensitivity  DNA  chip  
using   the   Bioanalyzer   2100   instrument   (Agilent)   to   determine   library   insert   sizes.   An  
equimolar   mixture   of   the   isolates   libraries   (final   loading   concentration   of   10   pM)   was  
sequenced   on   an   Illumina   MiSeq   instrument   (School   of   Biological   Sciences,   Georgia  
Institute  of  Technology),  using  a  MiSeq  reagent  v2  kit  for  500  cycles  (2  x  250  bp  paired  
end  run).  Metagenomic  libraries  were  sequenced  in  the  Illumina  HiSeq  2500  instrument  
in  the  rapid  run  mode  for  300  cycles  (150  bps,  paired-­end  mode).  
  
5.3.4  Read  quality  control,  assembly  and  taxonomic  annotation  
Raw  fastQ  reads  from  both  E.  coli  isolates  and  stool  metagenomes  were  quality-­
trimmed   using   the   SolexaQA++   package   (27).   Specifically,   the   scripts   dynamicTrim.pl  
and  LengthSort.pl  were  used  to  trim  individual  reads  to  the  longest  continuous  segment  
for  which  phred  quality  score  was  greater  or  equal  to  20  (Q≥20,  which  represents  ~99%  
accuracy  per  nucleotide  position).  Reads  shorter  than  50  bps  were  discarded.    
Both   isolate   and  metagenome   libraries   were   processed   using  MiGA   (Microbial  
Genomes  Atlas),  a  recently  developed  system  for  data  management  and  processing  of  
microbial   genomes   and   metagenomes   (http://microbial-­genomes.org/)   (28).   In   MiGA,  
quality-­filtered   reads   are  de   novo   assembled   using   IDBA-­UD  with   pre-­corrections   (29)  
and   protein-­coding   sequences   predicted   using  MetaGeneMark   (30).   In   addition,  MiGA  
reports  the  percent  of  contamination  and  completeness  for  genome  sequences  based  on  
recovery   of   lineage-­specific   marker   genes.   16S   rRNA   gene   sequences   are   also  
identified   using   barrnap   0.6   (https://github.com/tseemann/barrnap)   and   classified   using  
the   RDP   classifier   (33).      In   addition,   through   MiGA   all   predicted   genes   from   the  
assemblies  are  taxonomically  annotated  using  MyTaxa  (31)  and  the  taxonomic  affiliation  
of   adjacent   genes   (in   windows   of   10   genes)   in   the   genome   assembly   are   estimated,  
which   allows   the   user   to   manually   inspect   the   genomes   for   possible   contamination  
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through  the  so  called  ‘MyTaxaPlots’  barplots.  
5.3.5  16S  rRNA  library  processing  
16S   rRNA   libraries   were   processed   using   the   default   parameters   in   the   Quantitative  
Insights  into  Microbial  Ecology  (Qiime2)  pipeline  (https://qiime2.org/).  In  brief,  16S  rRNA  
gene  sequencing  data  was  first  denoised  and  quality  filtered  using  Dada2,  an  algorithm  
that   uses   a   statistical   model   for   correcting   errors   introduced   in   the   Illumina   amplicon  
sequencing  and  infers  underlying  sample  sequences  clustering  highly  similar  sequence  
variants   (SV)   (32).   After   quality   control,   a   feature   table   of   sequence   variants   that   are  
100%  identical  was  generated.  The  naïve  Bayesian  RDP  classifier  (33),  trained  with  the  
GreenGenes  database  (gg_13_8)  at  a  50%  confidence,  was  used  to  assign  taxonomy  to  
the  generated  cluster  of  sequence  variants  (SVs).  Low  abundance  SVs  (those  SVs  with  
a  total  count  fraction  lower  than  0.005%  of  the  total)  were  removed  from  the  final  feature  
table  as  suggested  by  (34).  Alpha-­diversity  estimates  were  computed  in  rarefied  libraries  
to   avoid   bias   in   the   detection   of   differentially   abundant   taxa   given   the   underlying  
differences   in   library   size.   SV   richness   was   estimated   using   Faiths’   phylogenetic  
diversity   (35).  Beta-­diversity  analyses  were  performed  using  different  distance  metrics,  
including  Bray-­Curtis,  Jaccard,  Weighted  and  Unweighted  UNIFRAC.  Resulting  distance  
matrices  were  visualized  through  principal  coordinate  analysis  plots  (PCoA).  The  same  
distance  matrices  were   then   used   to   conduct   a   statistical   test   of   dissimilarities,   i.e.,   a  
permutational  multivariate  non-­parametric  analysis  of  dissimilarities  PERMANOVA  (36),  
performed  using  the  R  package  Vegan  (37).  Differentially  abundant  OTUs  (or  sequence  
variants)   between   diarrhea   and   control   samples   were   identified   using   STAMP,   a   data  
analysis  metagenomic  software  that  reports  differentially  abundant  features  using  effect  
sizes  and  confidence  intervals  (38).  
5.3.6  Population  genome  binning  
MaxBin2   (39)  was  used   to  bin  previously  assembled  contigs   into  metagenome-­
assembled   genomes   (MAGs)   for   the   recovery   of   E.   coli   population   genome   with   a  
minimum  contig   length   threshold  of   2,000  bps.  Prior   to  binning,  Bowtie  2  was  used   to  
align  short-­read  sequences   to  assembled  contigs   (40)  and  SAMtools  was  used   to  sort  
and  convert  SAM  files  to  BAM  format  (41).  Sorted  BAM  files  were  then  used  to  calculate  
the   coverage   (mean   representation)   of   each   contig   in   each   sample  metagenome.  The  
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quality  of  each  resulting  MAG  was  evaluated  with  CheckM  v1.0.3  (42)  using  taxonomy-­
specific   workflow   for   ‘Escherichia   coli’.   Only  E.   coli   MAGs  with   a   higher   quality   score  
than  60  (from  Parks  et  al.,  2017  (43);;  calculated  as  the  estimated  completeness  minus  
five  times  the  estimated  contamination)  were  retained.  The  taxonomic  affiliation  of  each  
MAG   was   then   confirmed   with   MiGA,   which   uses   a   combination   of   the   genome-­
aggregate   Average   Nucleotide   Identity   concept,   or   ANI,   and   the   Average   Amino-­acid  
Identity,  AAI,   to   taxonomically  classify  a  query  genomic  sequence  against   its   reference  
genome  databases  and  find  the  closest  match  with  pval  <0.05.  Protein  coding  genes  on  
MAGs  were  predicted  with  Prodigal  (44).    
  
5.3.7  Microbial  community  composition  and  functional  profile  
Metagenome   community   taxonomic   composition  was   assessed,   in   addition   to   the   16S  
rRNA   gene   level   mentioned   above,   through   clade-­specific   marker   genes   using  
MetaPhlAn2   v2.0   (45).   Gene   functional   profiling   of   the   microbial   community   was  
assessed   using   the   pipeline   implemented   in   HUMAnN2   (46),   which   implements  
searches   against   two   main   databases:   UniRef,   a   comprehensive   and   non-­redundant  
UniProt   reference   cluster   for   characterization   of   gene   families   (47),   and   MetaCyc,   a  
highly  curated  database  of  experimentally  elucidated  metabolic  pathways  in  all  domains  
of   life   for   evaluating   the   completeness   of   pathways   (48).   HUMAnN2   also   implements  
MinPath,   an   algorithm   for   biological   pathway   reconstruction   using   protein   family  
predictions   (49).   Metagenomic   virulence   profiling   was   examined   using   the   Virulence  
Factors  Database  (VFDB,  http://www.mgc.ac.cn/VFs/)  (50)  filtered  for  E.  coli  specifically.  
Metagenomic  reads  were  mapped  against  the  VF  database  and  gene  presence/absence  
was  determined  by  the  number  of  reads  recruited  by  the  VF  genes  (≥1X)  and  the  length  
of  the  gene  that  was  covered  by  reads  (≥70%;;  lower  gene  abundance  or  coverage  was  
considered  gene  absence).  
5.3.8  Phylogenetic  analysis  of  genomes  of  isolates  and  MAGs  
Orthologous  genes  for  isolates,  MAGs  and  reference  E.  coli  strains  were  identified  using  
reciprocal   best   matches   (RBM)   with   protocols   detailed   in   (51).   Sequences   of   core  
orthologous  genes,   i.e.,  genes  present   in  all   the  genomes,  were  extracted  and  aligned  
using  MUSCLE   v3.8.35   (52).   The   resulting   alignment   was   concatenated   and   trimmed  
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with   Gblocks   0.91b   (53)   to   remove   noisy/uninformative   regions.   Phylogenetic  
reconstructions  were  estimated  using  FastTree  version  2.1.7   (54)  with  1,000  bootstrap  
replicates   and   the   GTR-­GAMMA   substitution   model   for   nucleotide   sequences   and  
visualized  in  iTOL  (55).  
  
5.4  Results  and  Discussion  
5.4.1  Demographics  of  the  individuals  sampled    
The   demographic   and   clinical   information   for   diarrhea   and   control   groups   are  
presented   in  Table  5.2.   Individuals  sampled  from  Quito  and  Esmeraldas  composed  the  
set  of  urban  specimens  while   the  ones  sampled   in  Borbón  and   the  villages  composed  
the  set  of   rural  samples.  The  more  urban  centers   (Quito  and  Esmeraldas)  are  densely  
populated   regions   with   greater   access   to   clean   water,   sanitation,   roads,   and   medical  
infrastructure;;   whereas,   the   more   rural   regions   (Borbón   and   rural   villages)   are   less  
densely   populated,   with   minimal   sanitary   infrastructure.   Overall,   no   significant  
differences  in  demographic  features  including  age,  gender  or  race  were  found  between  
cases  and  controls.  However,  and  as  expected,  control  samples  were  mostly   retrieved  
from   parents   reporting   improved   household   sanitation   including   flush   toilets,   personal  
latrines   and/or   septic   systems   (66.7%)   relative   to   cases   (39.5%).   In   addition,   no  
significant   differences   in   drinking   water   source   or   treatment   were   observed   between  
cases  and  controls  (Table  5.2).      
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Table  5.2.  Characteristics  of  the  study  participants  by  site  and  disease  status.  No  
significant  differences   in  demographic  or  socio-­demographic  characteristics  were   found  
between   cases   and   controls   within   any   given   site.   Total   number   of   participants   =   80;;  


































Region!! ! ! !
!!!!!Urban!(Quito!+!Esmeraldas)! 38!(47.5)! 20!(52.6)! 18!(42.9)!
!!!!!Rural!(Borbón!+!Villages)! 42!(52.5)! 18!(47.4)! 24!(57.1)!
! ! ! !
Age! ! ! !
!!!!!0I24!months! 36!(45.0)! 22!(57.9)! 14!(33.3)!
!!!!!25I60!months! 28!(35.0)! 12!(31.6)! 16!(38.1)!
!!!!!61I180!months! 16!(20.0)! 4!(10.5)! 12!(28.5)!
! ! ! !
Gender! ! ! !
!!!!Male! 42!(52.5)! 16!(42.1)! 26!(61.9)!
!!!!Female! 38!(47.5)! 15!(39.4)! 23!(60.5)!
! ! ! !
Race! ! ! !
!!!!!White! 1!(1.2)! 0!(0.0)! 1!(2.4)!
!!!!!Black! 29!(36.2)! 12!(31.6)! 17!(40.5)!
!!!!!Manaba! 5!(6.2)! 3!(7.9)! 2!(4.8)!
!!!!!Indigenous! 4!(5.0)! 2!(5.3)! 2!(4.8)!
!!!!!Mixed! 41!(51.2)! 21!(55.3)! 20!(47.6)!
! ! ! !
Sociodemographics- ! ! !
Family!receives!government!welfare! 15!(18.8)! 1!(2.6)! 14!(33.3)!
! ! ! !
Family!member!employed! 26!(32.5)! 12!(31.6)! 14!(33.3)!
! ! ! !
Highest!level!household!education! ! ! !
!!!!!Elementary! 12!(15.0)! 4!(10.5)! 8!(19.0)!
!!!!!High!School! 45!(56.2)! 24!(63.2)! 21!(50.0)!
!!!!!University! 23!(28.8)! 10!(26.3)! 13!(31.0)!
! ! ! !
Water-and-Sanitation-
Improved!household!sanitationa! 43!(53.8)! 15!(39.5)! 28!(66.7)!
! ! ! !
Improved!drinking!water!sourceb! 72!(90.0)! 36!(94.7)! 36!(85.7)!
! ! ! !







5.4.2  High  frequency  of  co-­eluting  human  DNA  in  diarrhea  samples  
The   metagenomes   obtained   showed   differences   in   the   proportion   of   microbial  
and  human  reads.  The  average  percent  of  human  reads  detected  in  diarrhea  group  was  
17.8%   vs.   0.07%   in   the   control   group.   The  metagenomic   recovery   of   large   amount   of  
human  reads  indicated  infectious  (as  opposed  to  osmotic)  diarrhea.  Case  samples  with  
large  fraction  of  human  reads  yielded  mostly  DAEC(+)  and  EPEC(+)  pathotype  isolates  
(Figure  5.1A;;  See  also  next  section  for  DAEC  infection).  Next,  we  evaluated  whether  or  
not  the  fraction  of  human  reads  detected  in  each  dataset  correlated  with  the  severity  of  
the   disease,  measured   as   the   number   of   days  with   diarrhea   previous   to   the   sampling  
day  and   the  detection  of  blood  and/or  mucus   in   the  specimen.  Our   results   showed  no  
significant   correlation   with   the   number   of   days   with   diarrhea   or   presence   of   blood.  
However,   we   did   observe   a   significant   increase   in   the   fraction   of   human   reads   in  
samples   with   detection   of   mucus   in   stool   specimens   versus   those   with   no   mucus  
detected  (Welch’s  two  sample  test,  pval=0.004).  This  observation  might  be  related  to  the  
intestinal   niche   that  E.   coli   (and   other   enteric   pathogens)   colonizes.   Previous   studies  
based   on   fluorescent   in   situ   hybridization   microscopy   (FISH)   of   thin   sections   of   the  
cecum  of  streptomycin-­treated  mice  have  revealed  that  colonized  E.  coli  do  not  attach  to  
the  epithelial  cells,  but  growth  takes  place  predominantly  in  the  mucus  layer  instead  (3,  
56-­58).   Failure   to   penetrate   the  mucus   and   grow   as   dispersed   cells   prevented  E.   coli  
from  effective   colonization   of   the   gut   (57).   The  mucus   layer   itself   is   in   a   dynamic,   yet  
highly  regulated  state,  constantly  being  synthesized  and  secreted  by  specialized  goblet  
cells,   and   it   is   degraded   to   a   large   extend   by   the   indigenous   intestinal   microbes.  
Degraded   mucus   components   are   shed   into   the   intestinal   lumen   and   excreted   in   the  
feces   (3,   58).   Collectively,   our   observations   suggested   that   during   acute   infectious  
diarrhea,  a   large   fraction  of  mucus   (presumably  containing  both  epithelial  and   immune  
cells  derived  from  tissue  damage  and/or  pro-­inflammatory  responses)  is  washed  out  into  
the  lumen  and  excreted  in  diarrhea  possibly  together  with  the  pathogen.    
Following   removal   of   human   reads,   between   147Mb   and   1.7Gb   of   reads   per  
metagenome  remained  for  analysis.  To  evaluate  the  fraction  of  the  total  extracted  DNA  
from  the  stool  sample  that  was  sequenced  (i.e.,  determine  the  coverage  of  the  microbial  
community  by  sequencing),  we  estimated   the  sequencing  coverage  using  Nonpareil,  a  
read   redundancy-­based  algorithm   to  estimate   coverage   (59).  Although   the  sequencing  
coverage  varied  among  samples  and  pathotype  groups,  generally  ≥80%  of  the  microbial  
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community  was  covered   in   the  majority  of   samples,  except   for  one  EPEC  sample   that  
had  very  low  coverage  and  was  therefore,  discarded  from  further  analysis  (Figure  5.1B).  
The   coverage   estimates   also   reflected   differences   in   the   complexity   of   the   microbial  
communities,   showing   that   DAEC   group   contained,   in   general,   metagenomes   with  
simpler   microbial   communities   when   compared   to   the   other   pathotypes,   while   control  
group   comprised   the   individuals   with   the   more   complex   (diverse)   gut   microbial  
communities.   Overall,   our   results   in   community   coverage   suggested   that   our  
metagenomic   sequencing   effort   was   adequate   to   assess   the   microbial   community  
disturbance  during  diarrhea  and  for  potential  pathogen  detection  and  recovery.  
  
5.4.3  Microbial  community  composition  in  diarrhea  and  control  samples  
To  assess  the  overall  microbial  community  composition  and  diversity  in  diarrhea  
and  control  groups,  16S  rRNA  gene  amplicons  sequences  were  analyzed.  Comparison  
of  the  normalized  relative  abundance  at  the  phylum  level  indicated  that  three  major  phyla  
dominated   the   gut   microbial   communities   in   both   diarrhea   and   control   individuals,  
namely   Bacteroidetes,   Firmicutes   and   Proteobacteria.   In   general,   Bacteroidia   and  
Clostridia  were  the  two  most  abundant  classes  in  all  samples.  However,  the  majority  of  
samples  in  the  diarrhea  group  also  exhibited  a  large  proportion  of  sequences  belonging  
to  Gammaproteobacteria,  a  bacterial  group  comprising  several  enteric  pathogens,  which  
suggested   a   possible   underlying   bacterial   infection   in   individuals  with   diarrhea   (Figure  
5.2A).      
Alpha-­diversity   analysis   based   on   Faiths’s   phylogenetic   diversity   also   revealed  
significant   differences   between   case   and   control   datasets.   As   expected,   control   stool  
samples  presented,   in  general,  a  significantly  higher  microbial  diversity   than   the  cases  
(Kruska-­Wallis   test,   H=15.9,   qval=   6.06e-­05)   (Figure   5.2B).   These   results   were  
consistent   with   the   study   reported   by   Pop   and   colleagues   (2014)   (19)   where   the   gut  
microbiota  composition  in  children  from  low-­income  countries  in  Sub-­saharan  Africa  and  





Figure   5.1.   Abundance   of   human   reads   and   estimated   coverage   of   the  
metagenomic  datasets  obtained   in   this   study.     Panel   (A)   shows   the  assignment   of  
recovered  metagenomic   raw   reads   to   three   groups:   human   (purple),   discarded   due   to  
low  quality  (orange),  and  the  fraction  passing  quality  control  and  not  be  of  human  origin  
(green).   Panel   (B)   shows   the   fitted   Nonpareil   curves   and   the   estimated   average  
coverage  for  each  metagenome.  The  horizontal  dashed  lines  indicate  100%  (upper  red  
line)   and  95%   (bottom   red   line)   coverage.  Empty   circles   indicate   the   size   (x-­axis)   and  
estimated  average  coverage   (y-­axis)  of   the  datasets,   and   the   lines  after   that   point   are  
projections  of   the   fitted  model.   Inset   plot   shows   the  distribution  of  estimated   coverage  
values  in  a  query  subset  of  1,000  reads  per  library  in  each  pathotype  and  control  groups.  
Note   that   samples   were   DAEC   was   isolated   from   showed   less   diverse   communities  
























































































































































































































































































































































Figure   5.2.   16S   rRNA   gene-­based  microbial   community   composition   differences  
between   diarrhea   and   control   samples.  Panel   (A)   shows   the   relative   abundance   of  
bacterial  groups  classified  at   the  class   level   for  cases  of  diarrhea  and  control  samples.  
Only   the   top   ten   more   abundant   phylogroups   are   displayed.   Note   that   a   higher  
abundance  of  Gammaproteobacteria  was  observed  in  case  versus  control  groups.  Panel  
(B)  shows  significant  differences  in  the  phylogenetic  diversity  between  case  and  control  
samples.   Consistent   with   previous   literature,   diarrhea   samples   presented   lower  
community   diversity   than   control   ones.   Panel   (C)   represents   the   overall   community  
dissimilarity   based   on   the   taxonomic   composition   at   the   genus   level.   Pink   circles  
represent   cases   of   diarrhea   and   gray   squares   represent   control   samples.   Panel   (D)  
shows  the  estimated  relative  abundance  percent  of  the  16S  rRNA  gene-­based  OTU  (or  
sequence  variant)  taxonomically  assigned  to  E.  coli.  
  
Analysis   of   the   overall   community   dissimilarity   based   on   the   16S   rRNA   gene-­
based   taxonomic   composition   at   the   genus   level   also   revealed   significant   differences  
between   diarrhea   and   control   groups   (PERMANOVA,   pseudo-­F=2.47,   p=0.002).  








































































































































































some   overlap   between   several   samples   of   the   two   groups  was   also   observed   (Figure  
5.2C).  Difference   in   the  overall   relative  abundance  of   the  16S   rRNA  gene-­based  OTU  
taxonomically   assigned   to  Escherichia   coli   in   diarrhea   and   control   samples   were   also  
detected.   The   estimated   abundance   of  E.   coli   16S   rRNA   gene   reads   in   the   diarrhea  
group  was  higher  than  the  control  group  by  about  one  order  of  magnitude  (mean  6.39%  
of  total  reads  in  cases  versus  0.81%  in  control,  p=  0.009),  and  a  few  of  the  samples  had  
as  much  as  30%  of  their  totals  sequences  represented  by  the  E.  coli  OTU.  However,  a  
large  range  in  E.  coli  abundance  in  the  diarrhea  group  was  also  observed,  with  several  
samples  having  very   low  E.  coli   abundances   that  were  comparable   to   those   in   control  
samples  (Figure  5.2D).  Conversely,  a  couple  of  control  samples  had  as  much  as  3-­5%  
relative  abundance  of  E.  coli,  which  generated  intriguing  questions  regarding  the  role  of  
E.  coli  as   the  causative  agent  of  disease.  To   follow  up   in   these  observations,  we  next  
aimed  to  identify  samples  where  pathogenic  E.  coli  was  most  likely  the  causative  agent  
of  the  diarrheal  disease.  
5.4.4  Identification  of  disease  samples  where  E.  coli  was  the  causative  agent  
Our  observations  of   the  overall  community  composition,  diversity  and  estimated  
taxon  abundance  in  the  diarrheal  samples  (e.g.,  Figure  5.2)  suggested  that  E.  coli  was  
likely  not  the  causative  agent  of  diarrhea  disease  in  all  (sick)  individuals,  even  though  E.  
coli  was  isolated  from  all  case  samples.  In  other  words,   isolation  and  PCR  detection  of  
E.  coli  pathotypes  in  stool  samples  from  individuals  with  diarrhea  might  have  reflected  a  
stage   of   infection   with   E.   coli   but   not   necessarily   disease   caused   by   E.   coli,   or   the  
recovery  of   a   rare   isolate   in-­situ   that  was  not   involved   in   infection.  Therefore,  we  next  
aimed   to   determine   the  diarrheal   cases   that  were   attributable   to   pathogenic  E.   coli   by  
assessing   the   metagenomic   datasets   for   four   main   lines   of   evidence:   first,   the   in-­situ  
metagenomic   abundance   of   the   E.   coli   pathotype   isolate   based   on   the   case  
metagenome   that   the   isolate   was   recovered   from   should   be   higher   than   that   in   the  
control   samples,   after   one   accounts   for   reads   representing   commensal   E.   coli  
populations;;   the   latter  reads  were   identified  by  a  competitive  search  against   the   isolate  
genome   and   that   of   the   commensal   E.   coli   strain   HS   (NC_009800.1).   Second,   the  
pathotype-­specific  toxins  and  virulence  factors  should  be  detectable  in  the  metagenomic  
reads  (no  effect  of  assembly)  at  similar  (or  higher)  abundances  the  corresponding  isolate  
from   the   same   sample   and/or   present   in   the   E.   coli   MAG   recovered   from   the  
metagenome.   Third,   the   degree   of   intra-­population   diversity   (or   clonality)   of   the  
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pathogenic   E.   coli   population   should   be   lower   (more   clonal)   compared   to   the   E.   coli  
population  in  control  samples  as  it   is  often  the  case  for  infection-­associated  pathogens.  
The  degree  of  clonality  was  estimated  by  calculating   the  average  nucleotide   identity  of  
the   metagenomic   reads   mapping   to   the   reference   genome   (isolate   or   reference  
commensal)  with  percent   identity  between  90-­100%  (ANIr),   i.e.,   reads  representing   the  
total  E.  coli  population  in  a  sample.  Finally,  the  epidemiology  of  the  clonal  complex  that  
the   pathotype   isolate   was   assigned   to   should   be   consistent   with   infection,   i.e.,   other  
isolates   in   the  same  complex   to  be  associated  more  strongly  with  disease   than  control  
samples   (Appendix   C.2,   C.3   and   C.4).   Apperloo-­Renkema   et   al   (1990)   reported   that  
despite  colonization  resistance,  humans  are  colonized  on  average  with   five  different  E.  
coli  strains  and  there  is  a  continuous  succession  of  strains  in  individuals  (61,  revised  in  
3).   Based   on   this   finding,   our  working   hypothesis  was   that   control   individuals   carry   in  
general,   a  more  diverse  population  of  E.  coli,  whereas  diarrhea  samples  carry  a  more  
clonal   pathogenic   population   that   is   present   in   higher   abundance   and   encodes   more  
virulence   genes   than   the   commensal   population.   We   tested   our   hypothesis   for   three  
pathotype   groups   (DAEC,   ETEC   and   EPEC)   for   which   we   obtained   enough   diarrheal  
samples  (about  a  dozen  samples/individuals  per  pathotype).  
  
Diffusely  adherent  E.  coli  (DAEC)  group  
Our  observations  for  the  DAEC  group  showed  consistent  results  with  our  working  
hypothesis   for   approximately   50%   of   the   samples   that   DAEC   isolates   were   obtained  
from  (eight  samples  out  of  sixteen)   (Figure  5.3).  These  samples  corresponded   to  Q51,  
Q196,   E158,   Q56,   Q65,   E230,   E124   and   E27   and   therefore,   were   selected   as  
representative  samples  of  DAEC  infection.  In  general,   this  set  of  samples  exhibited  the  
following   metagenomic   signatures:   1)   higher   abundance   of   the   pathogenic   isolate  
compared   to   the   reference   commensal   or   the   total   E.   coli   population   in   the   control  
samples  (Figure  5.3E),  on  average  (27.81%  vs.  0.6%;;  Figure  5.3A);;  2)  recovery  of  high-­
quality  E.  coli  MAGs  that  encoded  the  pathotype  (afaB-­I)  and  other  E.  coli  (40  or  more)  
virulence  factors  or  the  virulence  factors  were  present  in  metagenomic  contigs  that  were  
not  binned  into  MAGs  (Figure  5.3B);;  3)  reduced  intra-­population  sequence  diversity  with  
ANIr  values  ≥  99%  for  the  isolate  and  usually  lower  values  for  the  reference  commensal  
genome  (Figure  5.3C)  and   finally,  4)   the  recovered  pathotype   isolate(s)  were  generally  
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grouped  in  phylogenetic  clusters  where  more  isolates  originated  from  cases  of  diarrhea  










Figure  5.3.  Characteristics  of  samples  where  DAEC  was  most  likely  the  causative  
agent.   Panel   (A)   shows   the   estimated   metagenomic   abundance   of   the   reference  
commensal  E.  coli  (strain  HS,  in  light  red)  and  the  sample-­specific  DAEC  isolate  (in  red)  
recovered   from  stool   specimens,  along  with   the  Elisa-­based  detection  of  Rotavirus   (+)  
and   Adenovirus_F.   Samples   where   high-­quality   E.   coli   MAGs   were   recovered   are  
denoted  by  a  star.  Panel  (B)  shows  the  number  of  total  E.  coli  virulence  genes  observed  
in  the  metagenome  and  an  array  of   four  hallmark  virulence  factors   including  the  DAEC  
marker   gene   (afaB-­I)   and   three   enterotoxins,   i.e.,   the   hemolysin   subunit   B   (hlyB),   the  
heat-­labile   enterotoxin   (eltA),   and   the   secreted   autotransporter   toxin   (sat).   Panel   (C)  
shows  the  estimated  E.  coli  intra-­population  diversity  measured  by  ANIr  of  reads  against  
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sample  (dark  brown).  To  avoid  any  potential  bias  by  low  in-­situ  abundance,  only  samples  
where   the  average  sequence  depth  of   the   reference  genome  was  ≥1X  were  evaluated  
for  ANIr.  Panel  (D)  shows  the  relative  abundance  of  isolates  from  cases  of  diarrhea  and  
control  in  the  core-­genome-­based  phylogenetic  clade  where  the  isolate  was  assigned  to  
(epidemiology).  Panels  (E),  (F)  and  (G)  shows  the  same  information  than  panel  A,  B  and  
C  for  control  samples.    
  
Although  some  other  DAEC-­positive  diarrhea  samples  showed  ANIr  values  >99%  
and  presence  of  the  afaB-­I  gene  (for  example  samples  Q310  and  Q49),  they  presented  
lower  metagenomic  abundances  of  the  isolate  compared  with  the  control  samples  and/or  
other  positive  samples,  and   relatively   lower  number  of  virulence  genes.   In  addition,   for  
these   low  abundance  populations  no  MAGs  were  recovered.  Therefore,   these  samples  
were  not  conclusive  with  respect  to  whether  or  not  the  isolate  was  the  etiological  agent.  
Of  particular  interest  was  the  observation  that  samples  E27  and  B89  were  also  positive  
for   Rotavirus   and   samples   B274   and   Q310   showed   a   metagenomic   signal   of   reads  
mapping   to  Adenovirus_F,  a  non-­enveloped,  double-­stranded  DNA  virus  causing  acute  
gastroenteritis   primarily   in   children   (62).   These   results   indicated   that   despite   the   PCR  
detection  of  DAEC  marker  gene  in  these  individuals,  other  viral  pathogens  rather  than  E.  
coli   might   have   been   responsible   for   the   diarrhea   phenotype.   Next,   we   evaluated  
whether  any  correlation  existed  between  the  percentage  of  human  reads  detected  in  the  
DAEC   metagenomes   and   the   estimated   metagenomic   abundance   of   the   isolate,  
specifically   in   the   set   of   eight   samples   that   had   strong   evidence   of   DAEC-­caused  
infection.  Our   results   showed   a   significant,   positive   linear   correlation   between   the   two  
variables  (Pearson’s  R=0.83,  p=0.01)  (Figure  5.4)  suggesting  that  the  fraction  of  human  
reads   observed   in   the   metagenome   might   be   directly   related   with   the   infection   by  














Figure  5.4.  Correlation  between  recovered  fraction  of  human  metagenomic  reads  
and  DAEC  pathogen  abundance.  The  barplot  shows  the  observed  percent  of  the  total  
metagenomic   reads   assigned   to   human   (purple)   and   the   estimated   metagenomic  
abundance   of   the   E.   coli   genome   for   the   samples   with   strong   evidence   of   DAEC  
infection.   Inset   plot   shows   the   Pearson   correlation   analysis   of   the   two   variables,  
revealing  a  significant,  positive  linear  correlation.    
  
Enterotoxigenic  E.  coli  (ETEC)  group  
A   similar  metagenomic  assessment  was  performed   in   the  ETEC  pathogroup   to  
identify  representative  samples  of  infection  (Figure  5.5).  In  this  sample  set,  the  signal  of  
E.  coli  infection  was,  in  general,  more  clear  than  DAEC.  Seven  samples  out  of  ten  (70%)  
had  strong  evidence  of  infection  caused  by  the  ETEC  isolate,  i.e.,  samples  E184,  Q294,  
B295,  B45,  B62,  B244  and  B255.  In  these  samples,  at  least  one  of  the  two  ETEC  marker  
genes,  heat-­labile   (eltA)   and/or  heat-­stable   (sta)  enterotoxins  was  detected,  except   for  
individual  B200.  The  remaining  three  samples  (i.e.,  B109,  B68  and  B200)  showed  very  
low  abundance  of  E.  coli,  and/or  the  absence  of  at  least  one  ETEC  marker  gene  and/or  
relatively  low  clonality  (ANIr  <99%)  and  therefore,  no  strong  evidence  of  E.  coli  infection.  
Of   particular   interest   was   the   observation   that   in   general,   ETEC   samples   presented  


















































lower  average  metagenomic  abundance  of   the  pathogen   (5.07%)   than  DAEC  samples  
(27,81%)  by  ~  5  fold,  on  average,  for  the  cases  with  clear  evidence  of  E.  coli  pathotype  
infection.   This   observation   suggested   that   ETEC   infection   might   require   a   lower  
pathogen   load   in   order   to   elicit   disease   than  DAEC.   In   general,   ETEC   pathogens   are  
widely   recognized   by   the   production   of   two   enterotoxins:   heat-­labile   (LT)   and/or   heat-­
stable   (ST)   enterotoxins   (7).   These   proteins   affect   a   variety   of   cellular   processes   that  
alter  the  concentration  of  important  cellular  messengers  such  as  cyclic  AMP,  cyclic  GMP  
and  Ca2+   leading   to   increased   ion  secretion  and  acute  watery  diarrhea.     DAEC,  on   the  
other  hand,  is  characterized  by  the  production  of  a  fimbrial  adhesin  F1845  that  is  used  to  
strongly   attach   to   the   cell   surface.   DAEC   strains   induce   a   cytopathic   effect   that   is  
characterized   by   the   development   of   long   cellular   extensions,   which   wrap   around   the  
adherent   bacterial   cell   (11).   These   differences   in   mechanisms   of   pathogenicity   might  
explain,  at   least   in  part,   the  differences   in  pathogen  abundance   that  were  observed   in  
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Figure  5.5.  Characteristics  of  samples  where  Enterotoxigenic  E.  coli   (ETEC)  was  
most   likely   the   causative   agent.   Panel   (A)   shows   the   estimated   metagenomic  
abundance  of   the   reference  commensal  E.  coli   (strain  HS,   in   light  blue)  and   the  ETEC  
isolate  (in  blue)  recovered  from  stool  specimens,  along  with  the  Elisa-­based  detection  of  
Rotavirus  (+).  Samples  where  high-­quality  E.  coli  MAGs  were  recovered  are  denoted  by  
a   star.   Panel   (B)   shows   the   number   of   total   E.   coli   virulence   genes   observed   in   the  
metagenome   and   an   array   of   four   hallmark   virulence   factors   including   the   two   ETEC  
marker   genes   (eltA  and   sta)   and   two  additional   enterotoxins   (the   hemolysin   subunit  B  
(hlyB)   and   the  secreted  autotransporter   toxin   (sat)).  Panel   (C)   shows   the  estimated  E.  
coli   intra-­population   diversity   measured   by   ANIr   of   reads   against   the   reference  
commensal   strain   HS   (light   brown)   and   the   isolate   obtained   from   the   sample   (dark  
brown).  To  avoid  any  potential  bias  by   low   in-­situ  abundance,  only  samples  where   the  
average   sequence   depth   of   the   reference   genome  was   ≥1X  were   evaluated   for   ANIr.  
Panel  (D)  shows  the  relative  abundance  of  isolates  from  cases  of  diarrhea  and  control  in  
the   core-­genome-­based   phylogenetic   clade   where   the   sample-­specific   isolate   was  
assigned   to   (Appendix  C.4).  Panels   (E),   (F)  and   (G)  shows   the  same   information   than  
panel  A,  B  and  C  for  control  samples.    
  
Enteropathogenic  E.  coli  (EPEC)  group  
The   pathogenicity   analysis   performed   in   the   EPEC   pathogroup   was   the   least  
conclusive  (Figure  5.6).  In  general,  the  EPEC  marker  gene  (eaeA)  was  recovered  in  only  
two  samples   (E187  and  E162)  out  of  eight   in   total   (20%).  However,  even   for   the   latter  
two   sample,   the   analysis   in   intra-­population   diversity   revealed   no   clonal   population.  
Recovery  of  high-­quality  MAGs  was  possible  only   in  one  sample   (R135)  but   less   than  
50%  of  the  total  number  of  virulence  genes  searched  in  the  metagenomes  were  found  in  
general.  Given  that  no  strong  metagenomic  signature  of  pathogenicity  was  observed  in  
the  majority  of  EPEC  samples,  we  excluded   this  pathogroup   from   further  analysis   that  














Figure  5.6.  Characteristics  of  samples  where  Enteropathogenic  E.  coli  (EPEC)  was  
most   likely   the   causative   agent.   Panel   (A)   shows   the   estimated   metagenomic  
abundance   of   the   reference   commensal   E.   coli   (strain   HS,   in   light   yellow)   and   the  
sample-­specific   EPEC   isolate   (in   dark   yellow)   recovered   from   stool   specimens,   along  
with   the   Elisa-­based   detection   of   Rotavirus   (+).   Samples   where   high-­quality   E.   coli  
MAGs  were  recovered  are  denoted  by  a  star.  Panel  (B)  shows  the  number  of  total  E.  coli  
virulence   genes   observed   in   the  metagenome  and   an   array   of   four   hallmark   virulence  
factors  including  the  EPEC  marker  gene  (eaeA,  intimin)  and  three  enterotoxins,  i.e.,  the  
hemolysin   subunit   B   (hlyB),   the   enterotoxin   (set1A),   and   the   secreted   autotransporter  
toxin  (sat).  Panel  (C)  shows  the  estimated  E.  coli  intra-­population  diversity  measured  by  
ANIr  of  reads  against  the  reference  commensal  strain  HS  (light  brown)  and  the  obtained  
from  the  sample  (dark  brown).  To  avoid  any  potential  bias  by  low  in-­situ  abundance,  only  
samples  where   the   average   sequence   depth   of   the   reference   genome  was   ≥1X  were  
evaluated   for   ANIr.   Panel   (D)   shows   the   relative   abundance   of   isolates   from   cases   of  
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specific  isolate  was  assigned  to  (Appendix  C.5).  Panels  (E),  (F)  and  (G)  shows  the  same  
information  than  panel  A,  B  and  C  for  control  samples.  
  
5.4.5   Detection   of   differentially   abundant   phylogroups   driving   the   differences  
between  diarrhea  and  control  samples  
  
The   identified   samples   with   strong   evidence   of   DAEC   or   ETEC   infection   were  
analyzed   further   in   order   to   elucidate   any   signatures   of   the   infection   on   the   gut  
microbiome.  First,  we  aimed  to  elucidate  which  taxa  were  contributing  to  the  differences  
between  diarrhea  and  control   groups   for   this   subset  of   samples.  For   this  purpose,   the  
metagenomes   were   analyzed   for   the   presence   of   clade-­specific   marker   genes,   which  
allowed  for  a  more  accurate  species-­level  characterization  (see  Materials  and  Methods).  
Differentially  abundant  features  were  reported  if  they  had  a  corrected  p-­value  ≤  0.05  (q-­
val)   and   an   effect   size   ≥0.8   based   on   the   Kruska-­Wallis   test.   In   total,      seven  
discriminative   taxa   between   diarrhea   and   control   samples   were   detected:   Prevotella  
copri   (p=0.048),   Escherichia   coli   (p=2.26e-­5),   Alloprevotella   tannerae   (p=0.046),  
Campylobacter   concisus   (p=0.011),      Haemophylus   haemolyticus   (p=0.05),  
Fusobacterium   mortiferum   (p=0.025)   and   Bifidobacterium   longum   (p=0.040)   (Figure  
5.7A).  Prevotella  copri  was  most  strongly  enriched  in  the  control  group  while  E.  coli  was  
the   phylogroup   mostly   differentiating   the   diarrhea   group,   revealing   an   anti-­correlation  
abundance  pattern  for  these  two  species  (Speraman’s  rho=  -­0.39,  p=0.012).  A  principal  
component   analysis   of   species   abundance   indicated   that   microbial   communities   from  
DAEC   vs.   ETEC   (probable)   infection   clustered   separately,   in   general   (Figure  
5.7B).  Therefore,   we   next   evaluted   in   more   resolution   the   differences   in   the   diarrheal  















Figure   5.7.   Differentially   abundant   taxa   between  E.   coli   infectious   diarrheal   and  
control  samples.  Panel  (A)  shows  a  heatmap  with  the  relative  abundance  of  the  seven  
significantly  differentially  abundant  species  between  diarrhea  and  control  groups.    Panel  
(B)   shows   a   principal   component   plot   of   the   taxonomic   relatedness   of   samples   with  
pathotype   infection   and   controls   using   MetaPhlAn2.   Panel   (C)   shows   the   estimated  
metagenomic  abundance  of  E  coli,  using  strain  HS  as  the  reference  commensal  genome  
to   recruit   E.   coli   reads   (NC_009800.1)   and   Prevotella   copri,   using   as   reference   the  
genome  of  strain  DSM18205,  a  gut  fermentative  microbe  (NZ_ACBX00000000.2),  based  
on  the  number  of  metagenomic  reads  recruited  by  these  genomes.  
  
  
5.4.6   Lack   of   pathotype-­specific   signatures   on   gut   microbiome   distinguishing  

































































































































































Next,   we   aimed   to   determine   whether   pathotype-­specific   signatures   in   the   gut  
microbiome   existed   that   can   distinguish   among   DAEC   and   ETEC   infections.   For   this  
purpose,   we   profiled   the   taxonomic   composition   and   metabolic   pathways   in   the  
metagenomes   of   both   diarrhea   groups   and   compared   with   control   samples   after  
removing   human   and   E.   coli   reads   and   normalizing   for   the   size   of   the   resulting  
metagenomic   (sub-­)datasets.   The   initial   taxonomic   characterization   revealed   at   least  
four  species  that  were  discriminatory  of  DAEC  infections  versus  ETEC  ones  (Figure  5.8).  
Fusobacterium   mortiferum   and   Campylobacter   concisus   were   significantly   more  
abundant   in   ETEC   infections   (Figure   5.8AB)   while   Bifidobacterium   longum   and  
Alloprevotella   tannerae   were   significantly   more   enriched   in   DAEC   infections   (Figure  
5.8CD).  Principal  component  analysis  also  revealed  that  ETEC  metagenomes  tended  to  
be  taxonomically  more  similar  among  them  while  DAEC  samples  showed  more  diversity.  
One  DAEC  sample   (E124)   for  which   the  eltA  and  sat  genes  were  also  detected   in   the  
metagenome,  grouped  closely  with  ETEC  samples  suggesting  that   this   individual  could  
have  suffered   from  a  co-­infection  with  ETEC.   Indeed,   the  estimated  sequencing  depth  
for  the  gene  eltA  (marker  gene  of  ETEC)  in  this  sample  was  6X  whereas  the  estimated  
sequencing   depth   for   the   afaB-­I   (marker   gene   for   DAEC)   was   2X.   Therefore,   we  
concluded   that   this   sample   was   a   co-­infection   with   ETEC   and   its   clustering   position  
within  ETEC  samples  was  attributable  to  the  high  abundance  of  ETEC  genotype.  On  the  
other   hand,   the   metabolic   profiling   did   not   revealed   differences   among   groups.    
Pathways  related  to  E.  coli  virulence  or  antibiotic  resistance  as  enterobactin  biosynthesis  
(p=4.07e-­6)   and   polymyxin   resistance   (p=4.48e-­5)   were   observed   to   be   significantly  
abundant  among  disease  samples   relative   to  controls,  due   to   the  significant   increased  
signal  of  E.  coli   infection.  However,  after  removing  E.  coli  reads  from  the  metagenomic  
libraries  from  DAEC  and  ETEC  pathogroups  and  re-­evaluating  the  metabolic  profiles,  no  
significant   differences   were   detected.   In   addition,   we   estimated   kmer-­based  
dissimilarities   among   the  E.   coli   and   human-­subtracted   metagenome   based   on   Mash  
distances  (63).  Our  results  in  community  dissimilarity  based  on  k-­mers  of  25  nucleotides  
length   or   metabolic   pathway   abundance   showed   no   clear   separation   among   DAEC,  
ETEC  and   control   groups.   Therefore,  we   concluded   that   taxonomic,   but   not  metabolic  








Figure   5.8.   Differentially   abundant   taxa   distinguishing   between  DAEC   and  ETEC  
infections.  Differentially  abundant  species  were  reported  if  they  had  a  corrected  p-­value  
≤0.05  and  an  effect  size  (the  magnitude  of  the  difference  between  groups)  ≥0.8  .  Panels  
(A)  and   (B)  shows   the  proportion  of  sequences  assigned   to  Fusobacterium  mortiferum  
and   Campylobacter   concisus,   respectively.   Similarly,   panels   (C)   and   (D)   show   the  
proportion   of   sequences   assigned   to   Bifidobacterium   longum   and   Alloprevotella  
tannerae,   respectively.   Panel   (E)   shows   a   principal   component   plot   based   on   the  
taxonomic   composition   of   each   metagenome   (annotated   at   the   species   level   using  
clade-­specific  marker  genes  with  MetaPhlAn2)  after  removing  human  and  E.  coli   reads  
from  the  libraries  
     
  
5.5  Conclusions  and  recommendations  
In   this   study,   we   developed   a   bioinformatic   approach   to   examine   specific  
microbiome   signatures   in   order   to   identify   samples  where  E.   coli   was   presumably   the  
etiological  agent  causing  diarrhea  and  assess  pathotype-­specific  signatures.  Our  major  
findings  revealed  the  presence  of  at  least  seven  species  differentially  abundant  between  















the   most   discriminative.   In   addition,   our   results   evidenced   at   least   four   species   that  
discriminate   DAEC   from   ETEC   infections:   Fusobacterium   mortiferum   and  
Campylobacter  concisus  were  more  abundant  in  ETEC  infections  while  Bifidobacterium  
longum  and  Alloprevotella  tannerae  were  significantly  more  enriched  in  DAEC  infections.  
At  the  functional  level,  not  major  differences  were  detected.  Our  metagenomic  approach  
has  important   implications  for  clinical  microbiology  and  public  health.  Diagnostic  testing  
for  diarrheic  pathogens  has  relied  for  decades  on  culture-­based  techniques  that  do  not  
provide  a  quantitative  picture  of  the  pathogen  or  the  response  of  the  gut  microbiome  to  
the   infection.   Consequently,   a   significant   fraction   of   diarrhea   episodes   remains   un-­
diagnosed  due  to  the  challenges  associated  with  the  accurate  detection  of  the  pathogen  
responsible  for   the  disease  using  traditional   techniques.  For  example,   the  GEMS  study  
reported  that  approximately  60%  of  the  cases  of  moderate-­to-­severe  diarrhea  (MSD)  in  
seven   impoverished   countries   of   Sub-­Saharan   Africa   and   South   Asia   remained  
undiagnosed   because   no   known   pathogen   could   be   implicated   using   conventional  
diagnostic  methods   (65).  Here,  we   show   that  metagenomic  approaches   can  provide  a  
higher  resolution  approach  for  the  accurate  detection  of  the  pathogen  responsible  for  the  
disease  and  for  a  better  understanding  of  the  disturbance  of  the  gut  microbiome  by  the  
infection.  Specifically,  the  metagenomic  picture  consistently  revealed  that  those  diarrhea  
samples  where  E.  coli  was  most  likely  the  causative  agent  exhibited  features  consistent  
with   a   higher   abundance   of   the   pathogenic   isolate   compared   to   the   control   or   the  
commensal  population,  high  prevalence  of  virulence  factors  and/or  toxins,   including  the  
metagenomic   detection   of   the   pathotype-­specific   marker   gene   for   DAEC,   ETEC   and  
EPEC,  and  a   reduced  E.  coli   intra-­population  diversity  compared  with  control  samples.      
In  comparison,  about  50%  of  the  diarrheal  cases,  which  were  identified  by  the  traditional  
methodology   to   be   (probably)   caused   by   E.   coli   pathotypes,   did   not   have   strong  
metagenomic  evidence   for  E.   coli   infection.  The  analysis   for   the  other   half   of   samples  
was   not   conclusive,   which   suggested   that   maybe   other   viral,   bacterial   or   eukaryotic  
pathogens  could  have  contributed  to  the  development  of  disease.  Alternatively,  sample  
heterogeneity,   e.g.,   our   sample   did   not   represent   well   the   gut   microbiome   and   thus,  
under-­sampled   the   (potential)  E.   coli,   could   account   for   some   of   the   samples   with   no  
strong  metagenomic   evidence   of  E.   coli   infection.  Multiple   replicate   samples   and   high  
sampling   volumes   (e.g.,   2-­5   gr   or   more)   should   be   used   to   avoid   such   sample  
heterogeneity  issues.  Regardless  of  the  (probable)  effects  of  sample  heterogeneity,  our  
finding   collectively   highlight   that   metagenomics   is   a   promising   diagnosis   tool   for  
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infectious  diseases  and   the  bioinformatic   framework  developed  here  can  be  applied   to  
other   pathogens   of   interest.   Although   several   samples   were   excluded   from   the  
pathogen-­specific  signatures  of  the  infection  based  on  relatively  low  coverage  observed  
in  comparison  with  other  positive  samples  or  with  controls,  it  is  important  to  highlight  that  
finding  a  0.1-­0.2X  coverage  still  translates  to  a  relative  large  number  of  cells  in  situ  that  
potentially  could  produce  successful  infections.  The  average  E.  coli  genome  size  is  5Mb  
and  our  metagenome  libraries  were  in  average  ~2Gbs  in  size.  Finding  0.2X  coverage  for  
an  E.  coli  genome  would  represent  ~0.05%  of  the  total  metagenome.  Our  extracted  DNA  
came  from  an  average  of  1012  cells  in  total.  Therefore,  0.05%  of  1012  would  be  5*1010  in  
total,   which   is   still   a   large   number   of   cells   that   could   potentially   cause   a   disease.  
Therefore,  although  metagenomics  can  advance  clinical  diagnosis,  it  has  also  limitations  
as  for  example,  detection  of  low  abundant  microorganisms.    
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A.1   Draft   genome   sequence   of   Bacillus   cereus   LA2007,   a   human-­pathogenic  
isolate  harboring  anthrax-­like  plasmids.  
Partially   reproduced   with   permission   from   Angela   Pena-­Gonzalez,   Chung   K.  Marston,  
Luis   M.   Rodriguez-­R,   Cari   B.   Kolton,   Julia   Garcia-­Diaz,   Amanda   Theppote,   Michael  
Frace,  Konstantinos  T.  Konstantinidis  and  Alex  R.  Hoffmaster.  Genome  Announc.  2017,  
5(16),  pil:e00181-­17.  Copyright  2017,  American  Society  for  Microbiology.  
  
A.1.1  Summary  
We  present  the  genome  sequence  of  Bacillus  cereus  LA-­2007,  a  strain  isolated  in  2007  
from  a   fatal  pneumonia  case   in  Louisiana.  Sequence-­based  genome  analysis   revealed  
that  LA-­2007  carries  a  plasmid  highly   similar   to  Bacillus  anthracis   pXO1,   including   the  
genes  responsible  for  production  and  regulation  of  anthrax  toxin.      
A.1.2  Genome  announcement  
Bacillus   cereus   strains   encoding   genetic   determinants   that   confer   pathogenic  
capabilities  similar  to  those  found  on  B.  anthracis  have  been  recently  described  (1-­5).  In  
B.   anthracis,   virulence   determinants   are   encoded   on   two   large   plasmids,   pXO1   and  
pXO2,   including   the  genes  necessary   to  produce   the  anthrax   toxin   (lef,  cya  and  pagA)  
and   a   D-­polyglutamic   acid   capsule   (capBCADE)   allowing   the   pathogen   to   evade   host  
immune  response.  Plasmids  similar  to  pXO1  and  pXO2  have  been  found  in  a  number  of  
previously  sequenced  B.  cereus  sensu  lato  strains  causing  anthrax-­like  diseases  (1-­5).  It  
has   not   been   determined   yet   whether   or   not   lateral   transfer   has   occurred   between  
members   of   B.   cereus   and   B.   anthracis,   the   direction   of   such   a   transfer,   or   the  
phylogenetic   relationships   of   the   strains   based   on   the   plasmid   sequences.   To   gain  
deeper  insights  into  the  evolution  of  B.  cereus  strains  causing  anthrax-­like  diseases,  we  
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present   the   draft   genome   of   LA-­2007,   a   bacterial   pathogen   isolated   from   a   fatal  
pneumonia  case  in  a  female  welder  from  Louisiana.    
DNA  was  extracted  from  overnight  culture  on  trypticase  soy  agar  with  5%  sheep  
blood  using  the  Maxwell  16  Promega  Instrument  and  sequencing  was  performed  on  an  
Illumina  GAIIx  platform.  Read  quality  control,  assembly  and  annotation  were  performed  
as  described  in  Tsementzi  (2016)  (6).  The  assembled  genome  of  LA-­2007  consisted  of  
67   contigs   with   a   GC   content   of   35%   and   a   total   genome   size   of   5,224,740   bp.   The  
estimated   percent   of   completeness   and   contamination   were   99.15%   and   0.28%,  
respectively.   The   genome   was   predicted   to   contain   a   total   of   5,777   putative   protein-­
coding   sequences,   15   rRNA   operons   and   57   tRNAs   genes.   The   calculated   Average  
Nucleotide   Identity   (ANI)   (7)   of   LA-­2007   against  B.   anthracis   Ames  was   94.76%,   and  
against   a   set   of   B.   cereus   strains   previously   reported   to   be   associated   with   severe  
pneumonia   similar   to   LA-­2007,   i.e.,   strains  G9241   (2),   03BB87   (3)   and  BcFL2013   (1),  
was  99.99%   in  all   three  cases,   indicating   that  all   four  B.  cereus   strains  are  part  of   the  
same  clonal  complex.        
Characterization  of  plasmid  gene  content  showed  that   the  genome  of  B.  cereus  
LA-­2007   contains   a   pXO1-­like   plasmid   assembled   in   eight   contigs,   each   one   of   them  
showing   at   least   99.70%  ANI   and   80%  gene   coverage  with  B.   anthracis   Ames   pXO1.  
The  latter  results  suggest  that  LA-­2007  (or  its  ancestors)  might  have  acquired  the  pXO1  
plasmid  horizontally  from  B.  anthracis  (since  ANI  of  the  plasmid  is  higher  than  that  of  the  
main  chromosome),  although  detailed  phylogenetic  analysis  will  be  required  to  robustly  
test   this   finding.   Comparison   with   plasmid   pBCXO1   from   strains  G9241,   03BB87   and  
BcFL2013  revealed  an  ANI  of  ≥99.99%   in  all   three  cases,  similar   to   the  chromosomes  
mentioned  above.  A  plasmid  homologous  to  pBc210  reported  in  B.  cereus  G9241,  was  
also   identified   in  LA-­2007.  The   latter  plasmid  was  assembled   in  9  contigs  and  showed  
99.98%  ANI  when  compared   to   the  plasmid  of  G9241.  Anthrax   toxin  genes  as  well  as  
complete   genes   for   production   of   hyaluronic   acid   synthases   (hasACB)   and   exo-­
polysaccharides   (bpsH-­X)   were   also   identified   in   LA-­2007,   suggesting   its   ability   to  
produce  protective  capsules.      
  
A.1.3  Nucleotide  sequence  accession  numbers.    
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This   Whole   Genome   Shotgun   project   has   been   deposited   at   GenBank   under   the  
accession   MUBB00000000.   The   version   described   in   this   paper  
is  version  MUBB01000000.  
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SUPPLEMENTARY  TABLES  FOR  CHAPTER  4  
Table  B.1.  Genes  and  primers  used  in  the  PCR  identification  of  E.  coli  pathotypes  
E.  coli   Gene   Primer  sequence  5  –  3’   Size  (bp)  




eltAb   5’GCGACAAATTATACCGTGCT3’   708  
5’CCGAATTCTGTTATATATGT3’  




bfpd   5’CAATGGTGCTTGCGCTTGCT3’   324  
5’GCCGCTTTATCCAACCTGGT3’  
  eaeAe   5’GACCCGGCACAAGCATAAGC3’   384  
5’CCACCTGCAGCAACAAGAGG3’  
  EIEC   ipaHf   5’GCTGGAAAAACTCAGTGCCT3’   424  
5’CCAGTCCGTAAATTCATTCT3’  




stx1h   5’ATAAATCGCCATTCGTTGACTAC3’   180  
5’AGAACGCCCACTGAGATCATC3’  
  stx2h     
5’GGCACTGTCTGAAACTGCTCC3’  
255  5’TCGCCAGTTATCTGACATTCTG3’  
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Table   B.2.   Clinical   and   demographic   information   of   individuals   from   Ecuador  
enrolled  in  the  EcoZUR  study  where  E.  coli  isolate  was  cultured.      




Gender   Age  [months]  
  
B001_5   rural   diarrhea   DAEC   DAEC   male   14  
B100_5   rural   asymptom
atic  
DAEC   DAEC   female   325  
B101_1   rural   asymptom
atic  
DAEC   DAEC   male   6  
B108_3   rural   diarrhea   EAEC   EAEC   male   11  
B109_1   rural   diarrhea   ETEC   ETEC   female   70  
B118_2   rural   asymptom
atic  
DAEC   DAEC   female   657  
B119_1   rural   diarrhea   EAEC   EAEC   male   11  
B119_2   rural   diarrhea   EPECa   EAEC   male   11  
B12_1   rural   diarrhea   DAEC   DAEC   male   22  
B124_2   rural   asymptom
atic  
EPECa   NA   female   50  
B135_1   rural   diarrhea   EIEC   NA   female   52  
B141_2   rural   asymptom
atic  
EAEC   EAEC   female   55  
B143_4   rural   asymptom
atic  
EIEC   EIEC   male   11  
B145_4   rural   asymptom
atic  
EAEC   EAEC   male   9  
B147_1   rural   asymptom
atic  
DAEC   DAEC   male   15  
B169_1   rural   asymptom
atic  
EAEC   EAEC   female   9  
B188_1   rural   asymptom
atic  
EAEC   EAEC   female   124  
B196_1   rural   diarrhea   EPECa   EPECa  
Stx1AB  
female   394  
B200_2   rural   diarrhea   ETEC   ETEC   female   31  
B201_1   rural   diarrhea   EPECa   EIEC   male   52  
B201_3   rural   diarrhea   EAEC   EAEC   male   52  
B201_5   rural   diarrhea     EAEC   EAEC   male   52  
B202_2   rural   diarrhea   EAEC   EAEC     male   184  
B207_2   rural   diarrhea   DAEC   DAEC   female   147  
B215_5   rural   Diarrhea   EAEC   EAEC   female   20  
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Table  B.2  continued  
  
              
B225_3   rural   asymptom
atic  
EPECa   EPECa   female   36  
B226_1   rural   diarrhea   DAEC   DAEC   male   773  
B228_2   rural   diarrhea   EPECa   NA   female   68  
B231_1   rural   asymptom
atic  
EPECt   EPECt   female   11  
B231_2   rural   asymptom
atic  
EPECa   EPECa   female   11  
B234_1   rural   asymptom
atic  
DAEC   DAEC     male   353  
B235_3   rural   diarrhea   EPECt   EPECt   female   1024  
B24_1   rural   diarrhea   DAEC   DAEC   male   27  
B244_3   rural   diarrhea   ETEC   ETEC   male   15  
B246_1   rural   diarrhea   EPECa   EPECa   male   368  
B252_1   rural   diarrhea   EPECa   NA   male   418  
B255_1   rural   diarrhea   ETEC   ETEC   female   21  
B259_1   rural   asymptom
atic  
EPECa   EPECa   female   79  
B262_1   rural   diarrhea   EIEC   EIEC   female   795  
B270_2   rural   diarrhea   ETEC   ETEC   male   531  
B274_2   rural   diarrhea   DAEC   DAEC   female   16  
B280_4   rural   asymptom
atic  
EAEC   EAEC   male   479  
B28_1   rural   diarrhea   EAEC   NA   missing   missing  
B295_2   rural   diarrhea   ETEC   ETEC   male   27  
B309_1   rural   diarrhea   EIEC   EIEC   female   42  
B311_2   rural   diarrhea   EPECa   NA   female   800  
B312_4   rural   asymptom
atic  
EPECa   EPECa   female   18  
B313_5   rural   asymptom
atic  
EPECa   NA   female   399  
B323_2   rural   asymptom
atic  
EPECa   NA   female   14  
B327_1   rural   asymptom
atic  
EPECa   NA   male   145  
B329_2   rural   asymptom
atic  
DAEC   DAEC   male   9  
B36_1   rural   asymptom
atic  
EPECa   EAEC   female   19  
B37_1   rural   diarrhea   DAEC   NA   female   530  
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Table  B.2  continued  
  
  
              
B37_2   rural   diarrhea   DAEC   NA   female   530  
B37_3   rural   diarrhea   DAEC   NA   female   530  
B37_6   rural   diarrhea   DAEC   NA   female   530  
B42_1   rural   diarrhea   DAEC   NA   male   365  
B42_3   rural   diarrhea   DAEC   NA   male   365  
B45_2   rural   diarrhea   ETEC   ETEC   female   25  
B46_1   rural   asymptom
atic  
ETEC   ETEC   male   17  
B62_5   rural   diarrhea   ETEC   ETEC   female   18  
B66_1   rural   diarrhea     EAEC   EAEC   male   8  
B66_4   rural   diarrhea   ETEC   EAEC   male   8  
B68_1   rural   diarrhea   ETEC   ETEC   male   27  
B69_1   rural   diarrhea   EPECa   NA   female   24  
B75_4   rural   diarrhea   EPECa   NA   male   14  
B75_5   rural   diarrhea   DAEC   DAEC   male   14  
B84_2   rural   diarrhea   ETEC   ETEC     female   13  
B84_3   rural   diarrhea   EIEC   EIEC   female   13  
B88_3   rural   diarrhea   EIEC   EIEC   female   15  
B89_1   rural   diarrhea   DAEC   DAEC   female   13  
B95_1   rural   diarrhea   DAEC   DAEC   female   6  
B99_5   rural   asymptom
atic  
EPECa   EPECa   male   95  
C101_1   rural   diarrhea   ETEC   ETEC   male   50  
C102_1   rural   asymptom
atic  
EPECa   EPECa   male   30  
C110_5   rural   asymptom
atic  
EPECa   EPECa   female   47  
C1_2   rural   diarrhea   ETEC   ETEC   missing   missing  
C13_2   rural   diarrhea   EPECa   NA   male   30  
C14_2A   rural   diarrhea   DAEC   DAEC   female   113  
C14_2B   rural   diarrhea   DAEC   DAEC   female   113  
C21_2   rural   asymptom
atic  
EAEC   EAEC   female   35  
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Table  B.2  continued  
C21_4   rural   asymptom
atic  
EAEC   EAEC   female   35  
C23_1   rural   asymptom
atic  
EAEC   EAEC   male   15  
C25_2   rural   asymptom
atic  
EIEC   EIEC   female   183  
C26_2   rural   asymptom
atic  
EPECa   EPECa   male   40  
C32_3   rural   diarrhea   ETEC   NA   male   14  
C33_3   rural   diarrhea   EAEC   EAEC   male   52  
C34_2   rural   diarrhea   DAEC   DAEC   male   23  
C36_1   rural   diarrhea   DAEC   DAEC   male   15  
C38_1   rural   diarrhea   ETEC   NA   male   25  
C46_4   rural   asymptom
atic  
ETEC   ETEC   male   31  
C50_4   rural   asymptom
atic  
DAEC   DAEC   female   446  
C70_1   rural   asymptom
atic  
EPECa   EPECa   male   16  
C71_2   rural   asymptom
atic  
DAEC   DAEC   male   17  
C72_3   rural   diarrhea   EAEC   EAEC   missing   missing  
C79_1   rural   diarrhea   DAEC   DAEC   male   14  
C80_4   rural   asymptom
atic  
EAEC   EAEC   male   5  
C85_1   rural   diarrhea   ETEC   NA   female   40  
C86_4   rural   asymptom
atic  
EAEC   EPECa   female   15  
C87_3   rural   diarrhea   ETEC   NA   female   325  
C9_2   rural   diarrhea   EPECa   EPECa   male   91  
E100_4   urban   diarrhea   DAEC   DAEC   female   50  
E100_5   urban   diarrhea   DAEC   DAEC   female   50  
E101_1   urban   asymptom
atic  
DAEC   DAEC   male   37  
E106_1   urban   diarrhea   EAEC   EAEC   male   19  
E119_5   urban   asymptom
atic  
DAEC   DAEC   female   40  
E124_5   urban   diarrhea   EAEC   EAEC   female   14  
E124_6   urban   diarrhea   DAEC   DAEC   female   14  
E129_3   urban   diarrhea   EPECa   EPECt   male   6  
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Table  B.2  continued  
E130_1   urban   asymptom
atic  
ETEC   EAEC   male   20  
E132_5   urban   asymptom
atic  
DAEC   EAEC   male   15  
E135_2   urban   diarrhea   EAEC   EAEC   male   124  
E135_5   urban   diarrhea   EAEC   EAEC   male   124  
E135_6   urban   diarrhea   DAEC   DAEC   male   124  
E139_2   urban   asymptom
atic  
ETEC   ETEC   female   19  
E13   urban   diarrhea   DAEC   DAEC   male   166  
E140   urban   diarrhea   DAEC   DAEC   male   355  
E143_1   urban   asymptom
atic  
EPECa   NA   male   443  
E144   urban   diarrhea   EPECa   EPECa   female   835  
E158   urban   diarrhea   DAEC   DAEC   male   13  
E162   urban   diarrhea   EPECa   EPECa   female   78  
E16_6   urban   asymptom
atic  
DAEC   DAEC   male   66  
E166   urban   diarrhea   DAEC   DAEC   male   125  
E167_5   urban   asymptom
atic  
DAEC   DAEC   female   99  
E170   urban   diarrhea   DAEC   DAEC   male   225  
E173   urban   diarrhea   DAEC   DAEC   male   934  
E175_4   urban   asymptom
atic  
EAEC   EAEC   female   28  
E175_5   urban   asymptom
atic  
ETEC   ETEC   female   28  
E177_6   urban   diarrhea   DAEC   DAEC   male   9  
E179_6   urban   asymptom
atic  
DAEC   DAEC   male   14  
E184_3   urban   diarrhea   ETEC   NA   male   16  
E187_2   urban   diarrhea   EPECt   EPECt   female   21  
E188_2   urban   diarrhea   DAEC   DAEC   female   157  
E192   urban   diarrhea   DAEC   DAEC   male   11  
E195_3   urban   diarrhea   ETEC   NA   female   16  
E195_5   urban   diarrhea   EPECa   EPECa   female   16  
E197_5   urban   asymptom
atic  
DAEC   DAEC   male   16  
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Table  B.2  continued  
E20_1   urban   asymptom
atic  
EAEC   EAEC   male   24  
E205   urban   diarrhea   EPECa   NA   female   21  
E212_4   urban   diarrhea   DAEC   DAEC   female   796  
E21_3   urban   asymptom
atic  
missing   NA   male   17  
E215_4   urban   asymptom
atic  
ETEC   NA   male   28  
E218   urban   diarrhea   DAEC   DAEC   female   190  
E228_3   urban   asymptom
atic  
EAEC   EAEC   female   7  
E230_4   urban   diarrhea   DAEC   DAEC   male   14  
E236_4   urban   asymptom
atic  
EAEC   EAEC   female   14  
E238_3   urban   asymptom
atic  
EAEC   EAEC   female   5  
E238_5   urban   asymptom
atic  
DAEC   DAEC   female   5  
E240_5   urban   asymptom
atic  
EPECa   EPECa   female   3  
E26   urban   diarrhea   DAEC   DAEC   female   51  
E27   urban   diarrhea   DAEC   DAEC   male   15  
E28   urban   diarrhea   DAEC   DAEC   male   162  
E29_1   urban   diarrhea   ETEC   ETEC   male   232  
E33_4   urban   asymptom
atic  
EPECa   EPECa   female   161  
E34   urban   diarrhea   DAEC   DAEC   male   292  
E35_4   urban   asymptom
atic  
EPECa   EPECa   male   23  
E43   urban   diarrhea   DAEC   DAEC   male   368  
E44_6   urban   diarrhea   DAEC   DAEC   male   24  
E55_5   urban   asymptom
atic  
ETEC   ETEC   male   16  
E55_6   urban   asymptom
atic  
DAEC   DAEC   male   16  
E5_5   urban   diarrhea   EPECa   EPECa   male   15  
E57   urban   diarrhea   DAEC   DAEC   female   140  
E58_3   urban   diarrhea   DAEC   DAEC   male   6  
E61_3   urban   diarrhea   ETEC   NA   male   10  
E64_6   urban   missing   missing   NA   missing   missing  
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E67_5   urban   diarrhea   DAEC   DAEC   male   8  
E70_3   urban   asymptom
atic  
EAEC   EAEC   female   105  
E71_6   urban   diarrhea   EIEC   EIEC   male   336  
E71   urban   diarrhea   EPECa   EPECa   male   336  
E72_3   urban   diarrhea   EPECa   NA   male   97  
E72   urban   diarrhea   DAEC   DAEC   male   97  
E76_1   urban   asymptom
atic  
EAEC   EAEC   male   700  
E84   urban   diarrhea   EPECa   NA   male   356  
E88_3   urban   diarrhea   DAEC   DAEC   male   84  
E88_4   urban   diarrhea   EAEC   EAEC   male   84  
E89_4   urban   diarrhea   EAEC   EAEC   male   147  
E92_5   urban   asymptom
atic  
DAEC   DAEC   male   9  
E99_3   urban   asymptom
atic  
DAEC   DAEC   female   483  
Q106   urban   asymptom
atic  
ETEC   ETEC   male   92  
Q108   urban   diarrhea   EIEC   EIEC   female   126  
Q128   urban   diarrhea   EIEC   EIEC   female   238  
Q132   urban   asymptom
atic  
ETEC   ETEC   male   43  
Q142   urban   diarrhea   DAEC   DAEC   female   402  
Q145   urban   asymptom
atic  
DAEC   DAEC   female   365  
Q147   urban   diarrhea   DAEC   DAEC   female   379  
Q16_1   urban   diarrhea   ETEC   ETEC   female   720  
Q186   urban   asymptom
atic  
EAEC   EAEC   male   106  
Q196   urban   diarrhea   DAEC   DAEC   male   59  
Q199   urban   asymptom
atic  
DAEC   DAEC   female   10  
Q21_2   urban   diarrhea   DAEC   DAEC   female   570  
Q212   urban   asymptom
atic  
EAEC   EAEC   male   152  
Q223   urban   diarrhea   DAEC   DAEC   female   483  
Q23_1   urban   diarrhea   DAEC   DAEC   female   498  
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Q233   urban   diarrhea   EPECa   EPECa   male   32  
Q240   urban   diarrhea   DAEC   DAEC   male   530  
Q243   urban   diarrhea   DAEC   DAEC   female   518  
Q245_2   urban   asymptom
atic  
DAEC   DAEC   male   44  
Q249   urban   asymptom
atic  
EPECa   EPECa   male   56  
Q250_1   urban   asymptom
atic  
EAEC   EAEC   female   0  
Q253   urban   asymptom
atic  
EPECa   EPECa   male   32  
Q270   urban   diarrhea   EPECa   EPECa   female   242  
Q27_1   urban   asymptom
atic  
EPECa   EPECa   male   27  
Q275   urban   asymptom
atic  
EPECa   EPECa   female   594  
Q279_1   urban   diarrhea   EIEC   EIEC   male   146  
Q282   urban   asymptom
atic  
EPECa   EPECa     female   30  
Q284   urban   asymptom
atic  
EPECa   EPECa   female   16  
Q288   urban   asymptom
atic  
ETEC   ETEC   male   99  
Q289   urban   asymptom
atic  
EPECa   NA   female   360  
Q294   urban   diarrhea   ETEC   ETEC   female   18  
Q295   urban   diarrhea   ETEC   ETEC   female   947  
Q300   urban   diarrhea   EPECa   NA   male   59  
Q307_1   urban   asymptom
atic  
DAEC   DAEC   female   0  
Q308   urban   diarrhea   DAEC   DAEC   female   23  
Q310   urban   diarrhea   DAEC   DAEC   female   16  
Q312_1   urban   asymptom
atic  
DAEC   DAEC   male   7  
Q31_6   urban   diarrhea   EIEC   EIEC   female   325  
Q33_6   urban   diarrhea   EIEC   EIEC   female   70  
Q34_6   urban   diarrhea   EIEC   EIEC   female   239  
Q35_1   urban   diarrhea   DAEC   DAEC   female   522  
Q37_4   urban   asymptom
atic  
EPECa   EPECa   male   408  
Q38_1   urban   diarrhea   ETEC   ETEC     male   467  
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Q40   urban   diarrhea   DAEC   DAEC   male   465  
Q49   urban   diarrhea   DAEC   NA   male   21  
Q51   urban   diarrhea   DAEC   DAEC   male   48  
Q53   urban   diarrhea   ETEC   ETEC   female   61  
Q56   urban   diarrhea   DAEC   DAEC   female   17  
Q65   urban   diarrhea   DAEC   DAEC   female   24  
Q71_1   urban   diarrhea   ETEC   ETEC   male   13  
Q85_1   urban   diarrhea   DAEC   DAEC   male   128  
Q86   urban   asymptom
atic  
EPECa   EPECa   male   22  
Q87   urban   asymptom
atic  
ETEC   ETEC   male   22  
Q89   urban   diarrhea   EAEC   EAEC   male   380  
Q91   urban   diarrhea   DAEC   DAEC   male   313  
R104_2   rural   asymptom
atic  
EPECa   EPECa   male   111  
R109_1   rural   asymptom
atic  
EPECa   EPECa  
Stx1AB  
female   19  
R110_5   rural   asymptom
atic  
EPECa   NA   male   8  
R113_1   rural   diarrhea   DAEC   DAEC   male   6  
R113_3   rural   diarrhea   ETEC   ETEC     male   6  
R116_2   rural   asymptom
atic  
ETEC   ETEC     male   204  
R119_3   rural   asymptom
atic  
ETEC   ETEC   male   94  
R12_1   rural   asymptom
atic  
ETEC   NA   female   22  
R122_4   rural   diarrhea   EAEC   EAEC   male   134  
R127_3   rural   diarrhea   EPECa   EPECa   male   91  
R137_1   rural   diarrhea   EPECa   NA   male   28  
R138_1   rural   asymptom
atic  
EPECa   NA   female   176  
R17_2   rural   diarrhea   ETEC   ETEC   male   453  
R36_1   rural   diarrhea   EAEC   EAEC   male   21  
R42_2   rural   diarrhea   DAEC   DAEC   male   362  
R43_2   rural   diarrhea   EPECa   EPECa   male   32  
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R46_3   rural   diarrhea   ETEC   ETEC     male   60  
R55_1   rural   asymptom
atic  
EPECa   EPECa   female   191  
R56_3   rural   asymptom
atic  
EAEC   EAEC   male   190  
R58_1   rural   asymptom
atic  
EPECa   NA   male   160  
R60_2   rural   asymptom
atic  
EPECa   NA   female   461  
R66_4   rural   diarrhea   ETEC   ETEC   female   99  
R66_5   rural   diarrhea   ETEC   ETEC   female   99  
R67_3   rural   asymptom
atic  
DAEC   DAEC   male   130  
R83_3   rural   asymptom
atic  
EAEC   EAEC   male   28  
R84_2   rural   diarrhea   EPECa   NA   male   15  
R8_4   rural   asymptom
atic  
DAEC   DAEC   male   21  
R85_2   rural   asymptom
atic  
ETEC   ETEC   female   25  
R86_1   rural   diarrhea   DAEC   DAEC   female   961  
R92_5   rural   asymptom
atic  
EAEC   EAEC   male   41  
  
  
Table  B.3.  Multilocus  sequence  analysis  in  the  collection  of  E.  coli  isolates.      
strain  ID   adk   fumC   gyrB   icd   mdh   purA   recA   ST   Phylogroup  
B001_5   6   11   4   8   8   78   2   1312   A  
B100_5   53   40   47   13   36   28   29   131   B2  
B101_1   35   37   29   25   4   5   73   405   D  
B108_3   6   4   5   26   7   8   14   200   B1  
B109_1   9   6   162   131   24   8   7   3857   B1  
B118_2   10   11   4   8   8   8   2   10   A  
B119_1   10   11   4   8   8   8   2   10   A  
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B119_2   154   187   22   52   130   129   4   973   D  
B12_1   53   40   47   13   36   28   29   131   B2  
B124_2   6   11   4   10   7   8   6   93   A  
B135_1   6   4   14   16   24   5   14   1049   B1  
B141_2   6   6   5   136   9   7   7   678   B1  
B143_4   6   4   7   1   11   3   56   270   B1  
B145_4   10   11   4   8   8   8   2   10   A  
B147_1   21   35   61   52   5   5   4   394   D  
B169_1   35   132   2   27   37   5   4   501   D  
B188_1   10   11   4   8   8   8   2   10   A  
B196_1   16   4   12   16   9   7   7   21   B1  
B200_2   9   6   33   131   24   8   7   641   B1  
B201_1   6   4   7   1   11   3   56   270   B1  
B201_3   10   11   4   8   8   8   2   10   A  
B201_5   10   11   4   8   8   8   2   10   A  
B202_2   9   23   64   18   11   8   6   278   B1  
B207_2   10   11   4   8   8   9   2   4238   A  
B215_5   10   11   4   1   8   8   2   34   A  
B225_3   6   4   4   16   43   8   6   603   B1  
B226_1   4   26   2   25   5   5   19   38   D  
B228_2   21   35   61   52   5   5   4   394   D  
B231_1   13   21   13   22   17   14   15   28   B2  
B231_2   6   4   14   16   24   8   14   155   B1  
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B234_1   10   11   4   1   8   9   2   227   A  
B235_3   13   21   13   22   17   14   15   28   B2  
B24_1   6   11   4   8   8   8   2   48   A  
B244_3   6   5   4   8   8   8   2   4   A  
B246_1   10   11   4   8   8   8   49   752   A  
B252_1   6   11   4   8   8   8   2   48   A  
B255_1   11   7   4   8   12   8   2   na   A  
B259_1   109   65   5   1   9   13   14   517   B1  
B262_1   6   4   7   1   11   3   56   270   B1  
B270_2   6   11   4   8   331   78   2   3931   A  
B274_2   10   11   4   1   8   9   2   227   A  
B28_1   6   4   15   246   11   8   6   8097   B2  
B280_4   10   7   4   8   12   8   2   746   A  
B295_2   49   4   44   141   11   35   7   na   A  
B309_1   11   63   7   1   14   7   7   152   Shigella  
B311_2   38   39   9   13   17   44   34   7804   B2  
B312_4   10   11   4   1   8   66   2   378   A  
B313_5   6   19   124   16   11   8   105   na   B2  
B323_2   6   1037   3   18   11   122   71   na   B2  
B327_1   10   11   272   8   8   13   2   na   A  
B329_2   10   11   4   8   8   8   2   10   A  
B36_1   10   11   4   8   8   8   2   10   A  
B37_1   10   11   4   8   8   140   2   1078   A  
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B37_2   111   11   4   8   8   8   2   559   A  
B37_3   6   23   15   225   11   8   7   na   B2  
B37_6   82   749   491   595   458   425   406   5792   B2  
B42_1   6   11   4   10   7   8   6   93   A  
B42_3   6   11   4   10   7   8   6   93   A  
B45_2   6   5   4   8   8   8   2   4   A  
B46_1   6   5   4   8   8   8   2   4   A  
B62_5   6   5   4   8   8   8   2   4   A  
B66_1   10   11   4   8   8   8   2   10   A  
B66_4   10   11   4   8   8   8   2   10   A  
B68_1   9   6   162   131   24   8   7   3857   B1  
B69_1   10   11   4   8   8   13   73   617   A  
B75_4   53   40   47   13   36   28   29   131   B2  
B75_5   4   26   2   25   5   5   19   38   D  
B84_2   9   6   162   131   24   8   7   3857   B1  
B84_3   6   4   7   1   11   3   56   270   B1  
B88_3   8   7   1   1   10   8   6   6   A  
B89_1   10   11   4   8   8   8   7   44   A  
B95_1   4   26   2   25   5   5   19   38   D  
B99_5   6   135   12   16   9   7   7   2836   B1  
C1_2   10   27   5   10   96   8   2   4121   A  
C101_1   6   11   551   713   331   1   156   na   B1  
C102_1   10   11   4   1   8   66   2   378   A  
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C110_5   76   24   244   89   17   14   79   4554   B2  
C13_2   24   11   4   8   8   8   2   43   A  
C14_2A   4   26   2   25   5   5   19   38   D  
C14_2B   35   37   29   25   4   5   73   405   D  
C21_2   10   11   4   8   8   8   2   10   A  
C21_4   10   11   4   8   8   8   2   10   A  
C23_1   10   11   4   1   8   8   2   34   A  
C25_2   6   4   7   1   11   3   56   270   B1  
C26_2   109   65   5   1   9   13   14   517   B1  
C32_3   21   35   27   6   5   5   4   69   D  
C33_3   6   4   12   1   9   2   7   295   B1  
C34_2   6   4   566   1   20   13   7   na   B1  
C36_1   6   4   12   1   20   13   7   23   B1  
C38_1   21   35   27   6   5   5   4   69   D  
C46_4   6   5   4   8   8   8   2   4   A  
C50_4   83   627   245   404   91   17   181   5148   D  
C70_1   142   67   13   150   91   115   11   788   B2  
C71_2   35   37   29   25   4   5   73   405   D  
C72_3   35   132   2   27   37   5   4   501   D  
C79_1   10   7   4   8   12   8   2   746   A  
C80_4   10   11   4   1   8   8   2   34   A  
C85_1   41   6   5   16   11   8   7   94   B1  
C86_4   6   68   5   1   24   8   7   na   B2  
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C87_3   6   11   4   8   8   8   557   7684   A  
C9_2   6   4   12   16   9   7   7   29   B1  
E100_4   4   26   2   25   5   5   19   38   D  
E100_5   83   627   245   404   91   17   181   5148   D  
E101_1   6   11   4   8   8   78   2   1312   A  
E106_1   6   4   5   26   7   8   14   200   B1  
E119_5   10   11   4   8   8   8   2   10   A  
E124_5   6   4   5   26   7   8   14   200   B1  
E124_6   14   14   10   200   17   7   10   1193   B2  
E129_3   6   7   5   1   8   18   2   206   A  
E13   53   40   47   13   36   28   29   131   B2  
E130_1   21   35   27   6   5   5   4   69   D  
E132_5   10   11   4   8   8   8   2   10   A  
E135_2   10   11   4   8   8   8   2   10   A  
E135_5   10   11   4   8   8   8   2   10   A  
E135_6   83   627   245   404   91   17   181   5148   D  
E139_2   10   27   5   10   96   8   2   4121   A  
E140   21   35   27   6   5   5   4   69   D  
E143_1   10   11   183   8   8   8   2   1141   A  
E144   6   4   5   26   20   8   14   40   B1  
E158   4   26   2   25   5   5   19   38   D  
E16_6   4   26   2   25   5   5   19   38   D  
E162   129   311   13   150   91   12   25   6125   B2  
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E166   35   37   29   25   4   5   73   405   D  
E167_5   10   11   4   8   8   8   2   10   A  
E170   53   40   47   13   36   28   29   131   B2  
E173   21   35   61   52   5   5   4   394   D  
E175_4   6   4   12   1   9   2   7   295   B1  
E175_5   6   95   3   274   9   8   2   2602   B1  
E177_6   53   40   47   13   36   28   29   131   B2  
E179_6   53   na   47   13   36   28   29   na   B2  
E184_3   274   4   96   1   24   8   6   2332   A  
E187_2   13   21   13   22   17   14   15   28   B2  
E188_2   83   627   245   404   91   17   181   5148   D  
E192   4   26   2   25   5   5   19   38   D  
E195_3   41   6   5   16   11   8   7   94   B1  
E195_5   142   67   13   150   91   115   11   788   B2  
E197_5   35   183   29   25   4   5   73   964   D  
E20_1   10   11   4   8   8   8   2   10   A  
E205   21   35   61   52   5   5   4   394   D  
E21_3   6   11   4   10   7   8   6   93   A  
E212_4   4   26   2   25   5   314   19   na   A  
E215_4   274   4   96   1   24   8   6   2332   A  
E218   4   26   2   25   5   5   19   38   D  
E228_3   35   132   2   27   37   5   4   501   D  
E230_4   10   63   7   1   14   7   7   na   B2  
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E236_4   24   11   4   8   8   8   2   43   A  
E238_3   10   11   4   8   8   8   2   10   A  
E238_5   13   108   10   97   18   68   93   636   B2  
E240_5   13   21   13   22   17   14   15   28   B2  
E26   53   40   47   13   36   28   29   131   B2  
E27   53   40   47   13   36   28   29   131   B2  
E28   621   26   2   25   5   5   19   na   D  
E29_1   6   11   4   223   8   78   2   1491   A  
E33_4   109   65   5   1   9   13   14   517   B1  
E34   4   26   2   25   5   5   19   38   D  
E35_4   10   27   13   10   12   8   49   382   A  
E43   21   35   27   6   5   8   4   106   D  
E44_6   21   35   27   6   5   5   4   69   D  
E5_5   19   23   18   24   21   2   16   32   D  
E55_5   6   5   4   8   8   8   2   4   A  
E55_6   4   26   2   25   5   5   19   38   D  
E57   10   11   4   8   8   8   2   10   A  
E58_3   6   11   4   8   8   78   2   1312   A  
E61_3   274   4   96   1   24   8   6   2332   A  
E64_6   53   40   47   13   36   28   29   131   B2  
E67_5   10   11   4   1   8   429   2   5824   A  
E70_3   na   1003   4   8   8   8   2   na   A  
E71   13   21   13   22   17   14   15   28   B2  
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E71_6   11   63   7   1   14   7   7   152   Shigella  
E72   4   816   2   625   507   5   19   na   D  
E72_3   4   26   2   25   5   5   19   38   D  
E76_1   18   22   20   23   5   15   4   414   D  
E84   6   617   57   45   11   7   7   na   B2  
E88_3   6   11   4   8   8   78   2   1312   A  
E88_4   10   7   4   8   12   8   2   746   A  
E89_4   10   7   4   8   12   8   2   746   A  
E92_5   4   26   2   25   5   5   19   38   D  
E99_3   53   40   47   13   36   28   29   131   B2  
Q106   4   26   39   25   5   31   19   115   D  
Q108   6   4   7   1   11   3   56   270   B1  
Q128   6   4   7   1   11   3   56   270   B1  
Q132   24   83   4   8   8   8   2   na   A  
Q142   13   108   10   97   18   68   93   636   B2  
Q145   10   11   4   8   8   8   2   10   A  
Q147   10   11   4   8   8   8   2   10   A  
Q16_1   6   4   4   16   24   8   14   58   B1  
Q186   6   212   4   1   9   48   7   1136   B1  
Q196   21   35   61   52   5   5   4   394   D  
Q199   6   11   4   8   8   78   2   1312   A  
Q21_2   83   627   245   404   91   17   181   5148   D  
Q212   10   11   4   8   8   8   2   10   A  
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Q223   13   108   10   97   18   68   93   636   B2  
Q23_1   1   4   4   26   20   8   381   na   B2  
Q233     109   520   5   1   9   13   14   517   B1  
Q240   10   11   4   8   8   8   2   10   A  
Q243   21   35   61   52   5   5   4   394   D  
Q245_2   6   11   4   10   7   8   6   93   A  
Q249   109   65   5   1   9   13   14   517   B1  
Q250_1   18   22   20   23   5   15   4   414   D  
Q253   6   4   5   26   20   8   14   40   B1  
Q27_1   109   65   5   1   9   13   14   517   B1  
Q270   6   4   4   85   43   12   7   327   B1  
Q275   109   65   5   1   9   13   14   517   B1  
Q279_1   6   4   7   1   11   3   56   270   B1  
Q282   536   11   22   16   522   7   2   na   A  
Q284   6   4   12   476   9   7   7   4550   B2  
Q288   6   11   4   223   8   78   2   1491   A  
Q289   10   11   4   8   8   8   2   10   A  
Q294   6   5   4   8   8   8   2   4   A  
Q295   53   40   47   13   36   28   29   131   B2  
Q300   10   11   4   8   8   8   2   10   A  
Q307_1   10   11   4   8   8   8   2   10   A  
Q308   6   11   4   10   7   8   6   93   A  
Q31_6   6   5   4   323   8   8   2   na   B2  
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Q310   13   108   10   97   18   68   93   636   B2  
Q312_1   6   5   4   323   8   8   2   na   A  
Q33_6   11   63   7   1   14   7   7   152   Shigella  
Q34_6   11   63   7   1   14   7   7   152   Shigella  
Q35_1   10   11   4   8   8   8   2   10   A  
Q37_4   6   4   12   16   9   7   7   29   B1  
Q38_1   6   5   4   8   8   8   2   4   A  
Q40   10   902   4   8   8   8   2   na   A  
Q49   6   29   32   16   11   8   44   4407   B2  
Q51   53   40   47   13   36   28   29   131   B2  
Q53   6   5   553   52   42   8   216   na   A  
Q56   53   40   47   13   36   28   29   131   B2  
Q65   49   185   60   45   12   35   381   na   B2  
Q71_1   6   11   4   223   8   78   2   1491   A  
Q85_1   10   11   4   8   8   8   2   10   A  
Q86   10   11   4   1   8   8   2   34   A  
Q87   6   4   12   16   24   8   14   616   B1  
Q89   10   899   4   8   12   8   2   na   A  
Q91   49   4   44   9   11   35   7   120   B1  
R104_2   78   27   5   10   12   8   2   301   A  
R109_1   603   4   573   16   9   7   12   na   B2  
R110_5   6   165   4   10   7   8   6   773   A  
R113_1   4   26   2   25   5   5   19   38   D  
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R113_3   9   6   33   131   24   108   7   749   B1  
R116_2   6   11   4   223   8   78   2   1491   A  
R119_3   6   5   4   323   8   8   2   na   A  
R12_1   6   4   32   16   12   8   7   164   B1  
R122_4   8   11   4   8   7   8   6   181   A  
R127_3   76   24   244   89   17   14   79   4554   B2  
R137_1   10   27   5   8   8   7   2   226   A  
R138_1   10   11   57   8   7   18   6   216   A  
R17_2   6   5   4   8   8   8   2   4   A  
R36_1   10   11   4   8   8   8   2   10   A  
R42_2   10   11   4   8   8   8   2   10   A  
R43_2   78   27   5   10   12   8   2   301   A  
R46_3   10   27   5   10   96   8   2   4121   A  
R55_1   6   4   12   16   24   8   14   616   B1  
R56_3   18   22   17   6   5   5   4   31   D  
R58_1   10   11   4   1   8   9   2   227   A  
R60_2   10   11   4   8   8   8   2   10   A  
R66_4   6   5   4   8   8   8   2   4   A  
R66_5   6   5   4   8   8   8   2   4   A  
R67_3   10   11   4   8   8   8   2   10   A  
R8_4   6   11   4   8   8   78   2   1312   A  
R83_3   6   4   12   1   9   2   7   295   B1  
R84_2   10   11   4   361   8   8   2   3281   A  
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R85_2   10   11   4   8   8   8   2   10   A  
R86_1   53   40   47   13   36   28   29   131   B2  
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Table  C.1.  Metagenomic   yield,   human   read   content   and   read   quality   of   diarrhea   and  






















Table  C.3.  Epidemiology  of  DAEC  isolates  assigned  to  clonal  complexes  based  on  
MLSA   and   core   phylogeny   phylogroups.   Strain   ID   in   bold   denotes   those   isolates  
specific   for   each   pathotype   group.   Isolates   for  which   no   sequence   type   (ST)   could   be  

























MLSA& and& core& phylogeny& phylogroups." Strain" ID" in" bold" denotes" those" isolates"
pecific" for" each" pathotype" group." Isolates" for"which" no" sequence" type" (ST)" could" be"
assigned,"are"denoted"with"na.""
"
Strain"ID" Pathotype" case/control" ST" Phylogroup" Clonal"
Complex"
E124_6& DAEC" case" 1193" B2" 1"
E238_5" DAEC" control" 636" B2" 1"
Q223" DAEC" case" 636" B2" 1"
Q310& DAEC" case" 636" B2" 1"
Q142" DAEC" case" 636" B2" 1"
Q56& DAEC" case" 131" B2" 2"
E27& DAEC" case" 131" B2" 2"
R86" DAEC" case" 131" B2" 2"
E170" DAEC" case" 131" B2" 2"
E179_6" DAEC" control" na" B2" 2"
E26& DAEC" case" 131" B2" 2"
Q51& DAEC" case" 131" B2" 2"
E205" EPEC" case" 394" D" 3"
B228_2" EPEC" case" 394" D" 3"
Q196& DAEC" case" 394" D" 3"
Q243" DAEC" case" 394" D" 3"
E173" DAEC" case" 394" D" 3"
B147_1" DAEC" control" 394" D" 3"
E230_4& DAEC" case" na" B1" 4"
E144" EPEC" case" 40" B1" 4"
Q253" EPEC" control" 40" B1" 4"
E124_5& DAEC" case" 200" B1" 4"
E106_1" EAEC" case" 200" B1" 4"
B108_3" DAEC" control" 200" B1" 4"
R92_5" EAEC" control" 200" B1" 4"
Q65& DAEC" case" na" B1" 5"
Q23_1" DAEC" case" na" B1" 5"
Q91" DAEC" case" 120" B1" 5"
E158& DAEC" case" 38" D" 6"
E100_4" DAEC" case" 38" D" 6"
E212_5" DAEC" case" 38" D" 6"
E16_6" DAEC" control" 38" D" 6"
E92_5" DAEC" control" 38" D" 6"
B75_5" DAEC" case" 38" D" 6"





Table  C.4.  Epidemiology  of  ETEC  isolates  assigned  to  clonal  complexes  based  on  
MLSA   and   core   phylogeny   phylogroups.   Strain   ID   in   bold   denotes   those   isolates  
specific   for   each   pathotype   group.   Isolates   for  which   no   sequence   type   (ST)   could   be  



















MLSA& and& core& phylogeny& phylogroups." Strain" ID" in" bold" denotes" those" isolates"




Strain"ID" Pathotype" case/control" ST" Phylogroup" Clonal"
Complex"
B244_3& ETEC" case" 4" A" 1"
Q294& ETEC" case" 4" A" 1"
Q38_1" ETEC" case" 4" A" 1"
R119_3" ETEC" control" na" A" 1"
B295_2& ETEC" case" na" A" 1"
B255_1& ETEC" case" na" A" 1"
B46_1" ETEC" control" 4" A" 1"
B45_2& ETEC" case" 4" A" 1"
R66_4" ETEC" case" 4" A" 1"
R66_5" ETEC" case" 4" A" 1"
R17" ETEC" case" 4" A" 1"
C46_4" ETEC" control" 4" A" 1"
B62_5& ETEC" case" 4" A" 1"
E195_3" ETEC" case" 94" B1" 2"
C85_1" ETEC" case" 94" B1" 2"
C86_4" EAEC" control" na" B1" 2"
R113_3" ETEC" case" 749" B1" 2"
B109_1& ETEC" case" 3857" B1" 2"
B84_2" ETEC" case" 3857" B1" 2"
B68_1& ETEC" case" 3857" B1" 2"
B200_2& ETEC" case" 641" B1" 2"
E61_3" ETEC" case" 2332" A" 3"
E184_3& ETEC" case" 2332" A" 3"










Table  C.5.  Epidemiology  of  EPEC  isolates  assigned  to  clonal  complexes  based  on  
MLSA   and   core   phylogeny   phylogroups.   Strain   ID   in   bold   denotes   those   isolates  







MLSA& and& core& phylogeny& phylogroups.! Strain! ID! in! bold! denotes! those! isolates!




Strain!ID! Pathotype! case/control! ST! Phylogroup! Clonal!
Complex!
E205& EPEC! case! 394! D! 1!
B228_2& EPEC! case! 394! D! 1!
Q196! DAEC! case! 394! D! 1!
Q243! DAEC! case! 394! D! 1!
E173! DAEC! case! 394! D! 1!
B147_1! DAEC! control! 394! D! 1!
E240_5! EPEC! control! 28! B2! 2!
E71! EPEC! case! 28! B2! 2!
E187_2& EPEC! case! 28! B2! 2!
B235_3! EPEC! case! 28! B2! 2!
B231_1! EPEC! control! 28! B2! 2!
Q275! EPEC! control! 517! B1! 3!
C26_2! EPEC! control! 517! B1! 3!
Q233& EPEC! case! 517! B1! 3!
Q249! EPEC! control! 517! B1! 3!
E33_4! EPEC! control! 517! B1! 3!
B259_1! EPEC! control! 517! B1! 3!
Q27_1! EPEC! control! 517! B1! 3!
Q300& EPEC! case! 10! A! 4!
E20_1! EAEC! control! 10! A! 4!
C21_2! EAEC! control! 10! A! 4!
C21_4! EAEC! control! 10! A! 4!
!!
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